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I. Abstract/Resumo 
 
Abstract 
 
Background 
Cardiac magnetic resonance (CMR) and multidetector computed tomography 
(MDCT) are high-resolution techniques that revolutionized cardiac imaging, with an especial 
impact in the non-invasive diagnosis of coronary artery disease (CAD). While MDCT is a 
purely anatomic method and is particularly useful in the early detection or exclusion of 
coronary artery disease, CMR is capable of perfusion, contractility and scar evaluation, being 
particularly fitted for the discrimination of the functional relevance of coronary artery disease 
and less efficient for the exclusion of subclinical coronary disease. However, CMR perfusion 
is not fully validated in clinical routine of non-academic hospitals. 
Frequently, in clinical practice, both anatomical and functional tests need to be 
combined for a better disease assessment and management. It would be highly attractive to 
have an integration of detailed morphological and functional evaluation in a single test. Both 
CMR and MDCT are potential candidates for this comprehensive “one-stop-shop” approach. 
This could be either achieved with the addition of MR coronary angiography to a stress-rest 
CMR perfusion protocol or with the addition of stress-rest CT perfusion and CT delayed 
enhancement to a classic CT angiography protocol. Despite these techniques are available 
and have been described, its performance and additive value as part of comprehensive CMR 
and MDCT protocols have never been validated in the clinical setting of symptomatic patients 
with suspected coronary artery disease.  
Purpose 
Our research project aimed to study how CMR and CT may be used to improve 
current ability to detect functionally significant coronary disease and myocardial ischemia. 
The evaluation of the potential additional value of the integration of anatomy and function in a 
single exam was a specific aim of our project. Main research goals were: 
- To validate stress-rest CMR myocardial perfusion accuracy for detection of 
functionally significant coronary artery disease in the clinical setting and to test it’s 
incremental value over exercise testing. 
- To study the additive value of CT perfusion and CT delayed enhancement over CT 
angiography for detection of coronary disease and to directly compare the diagnostic 
performances of comprehensive stress-rest protocols using MDCT or CMR. 
- To test the potential additive value of MR coronary angiography as part of a 
comprehensive stress-rest CMR protocol, including functional analysis, perfusion and late 
gadolinium enhancement. 
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Population and methods 
Between February 2009 and November 2011, 176 individuals consecutively referred 
to the cardiology department outpatient clinic of Centro Hospitalar de Vila Nova de 
Gaia/Espinho, EPE, with suspected coronary artery disease were screened. Symptomatic 
patients, aged 40 years or more, with two or more risk factors (≥1 for the exercise testing vs. 
CMR subanalysis) or a previous positive/inconclusive exercise treadmill-test were included. 
Patients with known coronary artery disease, valvular heart disease, atrial fibrillation, anemia 
(hgb<8.5 g/dl), clinical instability and standard contra-indications to magnetic resonance, 
adenosine, contrast media or Gadolinium chelates were excluded. 
Patients were screened for study participation following a pre-established protocol 
including assessment of clinical information and previous tests, physical exam and ECG. 
Patients with inclusion criteria underwent echocardiography, treadmill exercise testing and 
blood sampling. After signed informed consent, patients were sequentially referred to a 
stress-rest cardiac magnetic resonance perfusion protocol (including functional assessment 
and scar imaging - as well as coronary angiography in a subgroup), stress-rest multidetector 
computed tomography (including angiography, perfusion and delayed enhancement imaging) 
and invasive coronary angiography (including fractional flow reserve assessment in patients 
with moderate or severe stenosis).  
Main Results 
In the different tested scenarios adenosine CMR perfusion combined with late 
gadolinium enhancement had very good diagnostic accuracy for the detection of significant 
CAD as assessed by invasive coronary angiography and fractional flow reserve, with an 
accuracy ranging from of 86% to 88% in the different subgroups analysis. It was clearly 
superior to CT coronary angiography for discriminating the functional significance of CAD in 
patients with stenosis (AUC=0.84 vs. 0.60, p<0.03), and added incremental value over 
exercise testing (AUC= 0.87 vs. 0.70; p=0.002) in all groups of pre-test probabilities. In this 
subanalysis, integration of exercise test and CMR results achieved a global accuracy of 89% 
(AUC 0.88) and was clearly superior to an approach based solely in the results of exercise 
testing (AUC 0.70, p<0.001) and similar to isolated CMR-MPI (AUC=0.87, p=ns). 
CT perfusion (AUC=0.81) tends to perform worse than CMR perfusion (AUC=0.88, 
p=0.06), having similar specificity (93% vs. 88%, p=0.51) but significantly inferior sensitivity 
(68% vs. 89%, p<0.005). It was also superior to CT coronary angiography for discriminating 
the functional significance of CAD in presence of stenosis (p<0.02). Its integration into a 
comprehensive protocol further improved MDCT performance for detection of significant 
coronary disease as assessed by quantitative coronary angiography or fractional flow reserve 
in patients with intermediate or high pretest probability (89% sensitivity, 83% specificity and 
global accuracy of 85%). These results were similar to those achieved by CMR (89% 
sensitivity, 88% specificity and global accuracy of 88%). When comparing test accuracies 
using non- inferiority analysis, differences greater than 11% in favor of CMR perfusion could 
be excluded. 
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CT delayed enhancement was able to identify scar as assessed by CMR with good 
accuracy (90%), despite a low sensitivity is reported (53%). Its integration into a MDCT 
comprehensive protocol did not improve global accuracy for detection of functionally 
significant coronary artery disease: sensitivity did not change (90%) while specificity 
decreased from 81% to 77%). Similarly, integration of anatomic information using MR 
coronary angiography (96% sensitivity, 68% specificity) into a classical functional CMR 
stress-perfusion test had a positive but non-significant impact in CMR performance for 
detection of functionally significant coronary disease. Using an intention-to-diagnose 
analysis, MR coronary angiography improved CMR global performance from an accuracy of 
86% to 93% (ns), due to an increased sensitivity (79% to 96%). However, a decrease in 
specificity (from 95% to 89%) was observed. 
Conclusions 
Cardiac magnetic resonance and multidetector computed tomography provide 
accurate information concerning coronary artery disease. Integration of functional and 
anatomic information using either technique is feasible and may further improve diagnostic 
performance for detection of relevant coronary artery disease. Its use may expand the 
indications and clinical utility of these techniques. 
The integration of CT perfusion with CT angiography improves overall performance 
of MDCT for detection of functionally relevant CAD achieving results that are comparable to 
those achieved with CMR stress-rest perfusion. Scar imaging is also possible using CT, 
similarly to CMR, but is less sensitive and did not improve MDCT accuracy for detection of 
functionally relevant coronary artery disease. Magnetic resonance myocardial perfusion 
imaging is a robust and accurate method for detection of relevant coronary disease in the 
clinical setting and adds incremental value over exercise testing in all groups of pre-test 
probabilities. In this context, a combined protocol of exercise treadmill testing and CMR 
imaging may improve accuracy for detection of significant disease, while reducing inadequate 
referrals to invasive angiography and costs. MR coronary angiography, despite limited, is 
feasible in the clinical setting, slightly improving sensitivity, but is associated with a non-
negligible increase in scan-time duration and does not significantly improve CMR global 
accuracy for detection of functionally relevant disease.  
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Resumo 
 
Introdução 
A ressonância magnética e a tomografia computorizada multidetetores são técnicas 
de elevada resolução espacial que revolucionaram a imagiologia cardíaca, com especial 
impacto na deteção não-invasiva da doença coronária. Enquanto que a angiografia coronária 
por tomografia multidetetores é um método puramente anatómico, com especial interesse na 
deteção precoce e/ou exclusão de doença coronária, a ressonância magnética é um método 
capaz de avaliar perfusão, contractilidade e presença de fibrose miocárdica, sendo 
particularmente eficaz na discriminação do significado funcional da doença coronária. 
Porém, o seu desempenho na prática clínica de centros não académicos, não está ainda 
bem estabelecido. 
Na prática clínica é muitas vezes necessária a utilização combinada de testes 
anatómicos e funcionais, de forma a optimizar a deteção e terapêutica da doença coronária. 
A integração da avaliação anatómica e funcional usando um único teste é, por isso, 
conceptualmente atrativa. Esta integração poderia ser conseguida quer com a ressonância 
(adicionando a coronariografia não-invasiva, a um protocolo de perfusão e realce tardio), 
quer com a tomografia computorizada multidetetores (através da adição do estudo de 
perfusão sob stress farmacológico e do realce tardio após a injeção de contraste iodado a 
uma aquisição para angiografia coronária). Apesar desta integração ser possível e estas 
técnicas terem sido recentemente descritas, o seu desempenho e valor aditivo como parte 
de um protocolo integrado de ressonância ou tomografia computorizada nunca foram 
validados na avaliação de indivíduos sintomáticos com suspeita de doença coronária. 
Objectivo 
O nosso projeto teve por objectivo estudar de que forma a ressonância magnética 
cardíaca e a tomografia computorizada multidetetores poderiam ser usadas para melhorar a 
capacidade atual de detetar isquemia miocárdica e/ou doença coronária funcionalmente 
relevante. Especificamente, planeámos testar o valor aditivo da integração morfológica e 
funcional num único exame. Os principais objectivos da nossa investigação foram: 
- Validar o valor da perfusão miocárdica por ressonância magnética na deteção de 
doença coronária significativa no contexto clínico e testar o seu valor aditivo em relação à 
prova de esforço. 
- Estudar o valor aditivo da perfusão e do realce tardio por tomografia computorizada 
em relação à angiografia coronária não invasiva e comparar o desempenho diagnóstico dos 
protocolos integrados de ressonância e tomografia computorizada na deteção de doença 
coronária. 
- Testar o potencial valor aditivo da angiografia coronária por ressonância como 
parte de um protocolo integrado de ressonância, incluindo avaliação da contractilidade, 
perfusão e realce tardio. 
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População e métodos 
Entre Fevereiro de 2009 e Novembro de 2011, estudámos 176 indivíduos 
consecutivamente referenciados ao serviço de cardiologia do Centro Hospitalar de Vila Nova 
de Gaia/Espinho, EPE, por suspeita de doença coronária. Foram incluídos doentes 
sintomáticos com 40 ou mais anos de idade e com 2 ou mais factores de risco (≥1 no caso 
do subestudo de comparação da prova de esforço com a ressonância) ou uma prova de 
esforço prévia descrita como positiva ou inconclusiva. Excluímos pacientes com doença 
coronária já conhecida, cardiopatia valvular, fibrilação auricular, anemia (hgb<8,5 g/dl), 
instabilidade clínica e contra-indicação para ressonância, adenosina, contraste iodado e 
quelatos de gadolínio. 
O rastreio inicial foi realizado de acordo com um protocolo pré-estabelecido que 
incluiu a obtenção da informação clínica e dos exames prévios, exame objectivo e 
electrocardiograma. Os pacientes que cumpriam os critérios de inclusão realizaram 
ecocardiograma, prova de esforço em tapete e colheita de sangue em jejum. Após assinar o 
consentimento informado, foram sequencialmente referenciados para um protocolo de 
ressonância magnética de perfusão (incluindo avaliação da contractilidade segmentar, 
perfusão sob adenosina e em repouso e avaliação de fibrose/ cicatriz miocárdica; num 
subgrupo foi ainda realizada angiografia coronária por ressonância), tomografia 
computorizada multidetetores (incluindo coronariografia, estudo de perfusão e realce tardio) 
e coronariografia invasiva (incluindo a avaliação da reserva fraccional miocárdica na 
presença de estenoses moderadas ou severas).  
Principais resultados 
A ressonância magnética cardíaca de perfusão teve um desempenho muito bom na 
deteção de doença coronária significativa (definida pela angiografia coronária convencional 
adicionada da avaliação funcional invasiva), com uma acuidade que variou entre os 86% e 
os 88% nos diferentes cenários avaliados. Foi claramente superior à coronariografia por 
tomografia computorizada na discriminação do significado funcional de estenoses 
(AUC=0.84 vs. 0.60, p<0.03), e acrescentou valor diagnóstico ao estudo com prova de 
esforço (AUC= 0.87 vs. 0.70; p=0.002), independentemente da probabilidade pré-teste. 
Nesta subanálise, o melhor protocolo de integração dos dois exames atingiu uma acuidade 
de 89% (AUC 0.88) e foi claramente superior a um protocolo baseado apenas em prova de 
esforço (AUC 0.70, p<0.001) mas não à ressonância magnética de perfusão isolada 
(AUC=0.87, p=ns). 
A perfusão por tomografia computorizada (AUC=0.81) tem tendência a um pior 
desempenho quando comparada com a ressonância magnética (AUC=0.88, p=0.06): tem 
especificidade semelhante (93% vs. 88%, p=0.51) mas sensibilidade claramente inferior 
(68% vs. 89%, p<0.005). É também melhor que a coronariografia por tomografia 
computorizada na discriminação do significado funcional da doença coronária em pacientes 
com estenoses documentadas (p<0.02). A sua integração no protocolo de tomografia 
computorizada aumentou o desempenho da técnica na deteção de doença coronária 
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significativa em pacientes com probabilidade pré-testes intermédia ou elevada, tal como 
avaliado quer com angiografia coronária quantitativa, quer com avaliação da reserva 
fraccional miocárdica (sensibilidade de 89%, especificidade de 83% e acuidade global de 
85%). Estes resultados estão muito próximos dos obtidos com a ressonância (sensibilidade 
de 89% especificidade de 88% e acuidade global de 88%). Na análise de não-inferioridade, 
foi possível excluir com segurança diferenças superiores a 11% no desempenho destes 
testes. 
A técnica de deteção de realce tardio por tomografia computorizada foi capaz de 
identificar cicatriz isquémica, tal como detetada por ressonância, com elevada acuidade 
(90%) mas baixa sensibilidade (53%). Para além disso, a sua integração no protocolo de 
tomografia computorizada não melhorou a acuidade global na deteção de doença coronária: 
a sensibilidade manteve-se nos 90%, enquanto que a especificidade reduziu dos 81% para 
os 77%. Da mesma forma, a integração da coronariografia por ressonância magnética no 
protocolo de ressonância magnética de perfusão teve um discreto impacto positivo no 
desempenho desta técnica na deteção de doença coronária significativa. Neste subestudo, 
usando uma análise de acordo com a “intenção de diagnosticar”, a coronariografia por 
ressonância melhorou o desempenho global de uma acuidade de 86% para 93% (ns), com 
base num aumento da sensibilidade (de 79% para 96%) e diminuição da especificidade (de 
95% para 89%). 
Conclusões 
A ressonância magnética cardíaca e a tomografia computorizada multidetetores 
providenciam informações detalhadas acerca da doença coronária com elevado 
desempenho diagnóstico. A integração de informação funcional e anatómica é possível 
usando qualquer das técnicas e pode melhorar o seu desempenho diagnóstico na deteção 
de doença coronária relevante – o que poderá expandir ainda mais as suas indicações e a 
sua utilidade clínica. 
Usando tomografia computorizada, a integração da perfusão com a coronariografia 
melhora o desempenho da técnica na deteção de doença funcionalmente relevante, 
atingindo valores comparáveis aos obtidos por ressonância. A deteção de cicatriz usando 
tomografia computorizada é também possível mas é menos sensível que a ressonância e 
não melhorou a acuidade global da técnica na deteção de doença coronária. A ressonância 
magnética de perfusão é um método robusto e com elevada acuidade diagnóstica no 
contexto clínico e tem um valor aditivo importante em relação à prova de esforço qualquer 
que seja a probabilidade pré-teste estudada.  Neste âmbito, um protocolo combinado de 
prova de esforço e ressonância poderá melhorar a acuidade diagnóstica na deteção de 
doença coronária com redução das referenciações inadequadas para coronariografia 
invasiva. A coronariografia por ressonância, apesar das suas limitações, pode ser realizada 
no contexto de uma ressonância magnética de perfusão em ambiente clínico mas está 
associada a um aumento não-negligenciável do tempo necessário para o exame e, apesar 
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de aumentar de forma discreta a sensibilidade, não melhora de forma significativa a 
acuidade global da ressonância na deteção de doença coronária.  
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II. Introduction 
 
Coronary heart disease is one of the major causes of morbidity and mortality in 
western countries.1 In Portugal cardiovascular disease is the leading cause of death, 
representing about 40% of annual deaths (“Risco de morrer em Portugal 2006”, Direcção-
Geral da Saúde, Lisboa, 2009).2 Since coronary artery disease (CAD) is associated with a 
high mortality and morbidity, most efforts must be aimed at detecting the early stages of 
disease thus preventing myocardial damage (myocardial infarction and heart failure).3, 4 
Reliable non-invasive methods are essential to early identify the presence of coronary 
disease and guide management.5  
Recent decades have witnessed the development of increasingly advanced imaging 
methods for the detection of coronary disease.6 In addition to clinical history, physical 
examination, electrocardiography and exercise stress testing, perfusion scintigraphy and 
stress echocardiography became important auxiliary methods, both in terms of diagnosis and 
prognosis.7-9  
In recent years, technical and computational progress allowed the emergence of new 
techniques with better anatomic definition and greater spatial and temporal resolution, which 
have been implemented with great success in the cardiovascular field.6 Cardiac magnetic 
resonance (CMR) and cardiovascular multidetector computed tomography (MDCT) 
revolutionized the diagnosis of ischemic heart disease. It is now possible to directly (and 
noninvasively) visualize coronary arteries and to identify myocardial perfusion defects with 
greater detail than never before and to discriminate between viable and non-viable 
myocardium, scar and fibrosis. All this additional information translates into important 
diagnostic and prognostic information, both in patients with known coronary disease and in 
asymptomatic individuals at risk for disease.10 
One of the major goals of imaging in the context of coronary disease is the 
identification of stenosed coronary segments that lead to ischemia. Two approaches are 
possible: direct visualization of the coronary arterial tree (non-invasive coronary angiography 
by MDCT or CMR) or demonstration of the effects caused by coronary stenoses, such as 
wall motion abnormalities or impaired myocardial perfusion (echocardiography, nuclear 
cardiology and CMR).6 
Computed tomographic coronary (CT) angiography is a first-line test to evaluate 
congenitally abnormal coronary arteries and, along with stress magnetic resonance 
myocardial perfusion imaging, is useful in symptomatic patients with nondiagnostic 
conventional stress tests.11-13 Aditionally, it is an alternative to stress testing in symptomatic 
patients, even if they have an interpretable electrocardiogram and are able to exercise.14-16  
Cardiac magnetic resonance is particularly indicated for visualizing cardiac structure 
and function, and is a first-line test for assessing myocardial viability.10  
At present, nuclear scintigraphy is still the most commonly used technique for 
assessing myocardial perfusion in cardiovascular medicine. However, over the next years, 
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techniques with improved spatial resolution are expected to become progressively used and 
may shift the present paradigm.17 Both CMR and MDCT are good candidates to become 
clinical gold standards for non-invasive detection of hemodynamically significant coronary 
disease. Recent advances, including new hardware, contrast agents, protocols, acquisition 
sequences and post-processing tools, bring the promise of better diagnostic imaging, better 
understanding of the pathophysiology and most of all, a better management of patients with 
suspected coronary disease.18, 19  
 
1. Cardiac Magnetic Resonance 
CMR is being increasingly used for the evaluation of morphology and physiology of 
the cardiovascular system.20 The excellent spatial resolution, optimal definition of endocardial 
and epicardial borders, the ability for tissue characterization and flow quantification are 
unequivocal advantages of the method in the evaluation of the pericardium, myocardium and 
great vessels. Thus, CMR is already an important diagnostic tool in the evaluation of 
pericardial diseases, intra- and extra-cardiac masses and in the study of congenital heart 
disease.21 However, the major potential application of CMR is undoubtedly, ischemic heart 
disease. Its superior spatial resolution facilitates visualization of the ventricular wall, with a 
detail unmatched by any other imaging modality. The ability for tissue characterization allows 
identification and quantification of fibrosis and scar, while CMR perfusion enables the 
detection of ischemia. Additionally, evaluation of the coronary tree using CMR is possible, 
with recent papers confirming a good accuracy of the method for the detection of 
atherosclerotic plaques in the proximal and middle segments of epicardial arteries.22 
The combination of CMR stress perfusion, function, Late-Gadolinium-Enhancement 
and, even, MR coronary angiography, allows the use of CMR as a unique form of testing for 
the identification of patients with ischemic heart disease. CMR is well suited to detect many 
of the physiologic consequences of ischemia through the assessment of myocardial 
abnormalities of perfusion, contractility, and metabolism. This unique combination offers the 
ability to reliably identify subendocardial ischemic processes, overcoming an important 
limitation of the methods currently used in clinical practice.12 
1.1. Detection of ischemia using Stress CMR 
Myocardial ischemia detection using CMR is usually performed with pharmacological 
stress. Two different Stress CMR methods may be performed, according to the 
pharmacological agent used and the physiologic mechanism tested. Perfusion CMR focuses 
on the detection of perfusion abnormalities and is more frequently done with adenosine as 
pharmacologic stressor. Dobutamine stress CMR (DSMR) is based on detection of 
dobutamine inducible abnormal wall motion.23 
1.1.1. Magnetic Resonace Myocardial Perfusion Imaging 
Detection of ischemia is accomplished through the comparison of myocardial 
perfusion imaging at rest and during adenosine / dipyridamole infusion.24 As in Single-photon 
computed emission tomography (SPECT), ischemia is identified by the presence of a 
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reversible myocardial perfusion deficit under vasodilator stress (dipyridamole or adenosine). 
Myocardial perfusion is displayed during contrast first passage.23 
CMR perfusion was first introduced in 1990 and is currently under rapid 
development,25-27 and is starting to challenge previously established methods.28 Current 
available methods for ischemia detection, such as scintigraphy, echocardiography, or 
positron emission tomography, are limited by low spatial resolution and / or exposure to 
ionizing radiation.29 CMR offers better spatial resolution, allowing detection of subendocardial 
ischemia30-32 and does not expose patients to harmful radiation.33, 34 It integrates anatomic 
and functional information in a single exam, and has been favorably compared to other 
methods.35-40 Furthermore, it has been shown to correctly evaluate the prognosis of patients 
with ischemic heart disease.41-43 However, CMR availability is still limited and its incremental 
value over more established tests in clinical practice is not fully validated. Additionally, it is 
still not clear which patients would benefit from CMR for detection of coronary artery disease 
in a multiple-test strategy context. 
Technique: 
Adenosine is the most commonly used stressor in stress CMR-perfusion studies. It 
binds to specific membrane receptors, inducing relaxation of smooth muscle tissue of the 
coronary artery wall. Dipyridamole, another stress agent commonly used, acts by inhibiting 
re-uptake of adenosine, increasing its bioavailability in the smooth muscle plaque. Both drugs 
result in coronary vasodilation, which increases coronary blood flow by a factor of 3 to 5 in 
normal arteries.44, 45 However, in coronary arteries with significant stenoses, additional 
vasodilation is no longer possible, since arteriolar vasodilatation (a compensatory response 
to the presence of stenosis) is already maximal. This differential induced vasodilation leads to 
a diversion of blood from areas supplied by a stenotic vessel ("coronary steal"), allowing the 
detection of hypoperfused myocardium (distal to stenosis) as low signal areas during the first 
passage of contrast.27 In clinical practice, adenosine (140 µg/kg/min) is usually the preferred 
pharmacological agent. It has an excellent safety profile and tolerability. Side effects, like 
flushing, dyspnea and chest discomfort are usually mild. More serious side effects such as 
bronchospasm and atrioventricular block are rare and rapidly reversible with infusion 
discontinuation. Contraindications to the use of adenosine include the presence of unstable 
angina, severe hypotension (systolic blood pressure <90 mm Hg), uncontrolled asthma and 
chronic obstructive pulmonary disease and second or third grade atrioventricular block.46 
CMR perfusion imaging is performed using a T1-weighted sequence to visualize first 
passage of a Gadolinium-based contrast agent in transit through the heart. Usually 3 to 6 
slices are continuously acquired in each cardiac cycle during the first pass of contrast 
(gadolinium chelates).28 This approach has the advantage of allowing the coverage of 16 
myocardial segments according to AHA segmentation,47 while maintaining a high temporal 
resolution.27 In terms of spatial resolution, it is possible to obtain resolutions from 1 to 3 for 1 
to 3 mm, which allows differentiation between subendocardial and subepicardial perfusion.23 
This can be useful in detecting smaller myocardial perfusion defects, undetectable by other 
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diagnostic modalities.35 Following peripheral injection, the contrast is detected against the 
background of nulled (dark) myocardium with rapid enhancement during vasodilation stress. 
Signal intensity correlates with contrast concentration and analysis can be performed in a 
quantitative, semi-quantitative, or qualitative fashion. The qualitative method is the one that is 
used clinically: an experienced observer examines the myocardium for regions of low signal 
or hypoperfusion relative to normally perfused segments. These areas represent ischemic 
myocardium. Because the contrast agents rapidly redistribute into the extracellular space, 
quantitative analysis is limited to the initial upslope in the tissue intensity curve, which has 
been shown to correlate well with measures of microsphere blood flow.48 As a way to 
increase the diagnostic accuracy of the test, the results of stress perfusion may be integrated 
with the perfusion study at rest, wall motion analysis and tissue characterization (late 
enhancement).49-53 
1.1.2. Dobutamine Stress Magnetic Resonance (DSMR) 
Myocardial ischemia may also be detected using CMR by visualization of inducible 
wall-motion abnormalities during a pharmacological stress agent (usually dobutamine) 
infusion – just like it is done using stress echocardiography. The comparison of these 
techniques has demonstrated CMR superiority, especially due to the absence "acoustic 
window" limitations.38  
A meta-analysis of Nandalur showed good sensitivity and specificity in a population 
of 735 patients with a coronary disease prevalence of 70%.54 A recent study evaluated the 
prognostic value of DSMR, showing that this method is an important marker of morbidity and 
mortality in patients with impaired ventricular function of ischemic etiology.55 In another study, 
Jahnke et al. demonstrated the utility of DSMR in the prognostic evaluation of patients with 
suspected coronary disease. However, its discriminating power was slightly lower than 
Adenosine CMR perfusion.42  
1.2. Detection of ischemic scar (Late Gadolinium Enhancement) 
CMR has the ability to correctly identify the presence, location and extent of 
myocardial fibrosis, with a spatial resolution of about 1 mm. The identification and 
characterization of fibrosis using delayed enhancement after paramagnetic contrast, is a 
validated method both in experimental animal models and in humans. It has been shown to 
have independent prognostic value in dilated cardiomyopathy and in ischemic heart 
disease.56 
There is large evidence on the usefulness of late gadolinium enhancement in the 
diagnosis of ischemic heart disease and in the study of patients with suspected coronary 
disease, either independently or integrated with wall motion or perfusion analysis.57-60  
1.3. Magnetic Resonance Coronary Angiography 
The use of CMR for non-invasive coronary angiography has been a goal pursued by 
researchers for nearly two decades now.61-63 
Coronary CMR angiography is more technically challenging than angiography of 
other vascular beds due to several unique issues including: the small caliber of the coronary 
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arteries (3- to 6-mm diameter), the near constant motion of the coronary arteries (during both 
the respiratory and the cardiac cycles), the high level of tortuosity of the coronary arteries, 
and the surrounding signal from adjacent epicardial fat and myocardium. To overcome these 
obstacles, CMR approaches employ cardiac triggering, respiratory motion suppression,64 pre-
pulses to enhance contrast-to-noise ratio of the coronary arterial blood (e.g., fat saturation, 
T2 preparation65), and 3D acquisitions (superior post-processing capabilities).66 
Bright blood sequences are most commonly used without an exogenous contrast 
agent;12 focal disease is depicted as local signal attenuation. This method showed good 
results in the evaluation of proximal coronary segments in patients with high-quality 
images.67-69 It allows the exclusion of left main stenoses and multi-vessel disease and may 
be considered to complement late gadolinium enhancement in determining the etiology of 
dilated cardiomyopathy.70 
MR coronary angiography may be particularly useful for the evaluation of heavily 
calcified segments where evaluation by MDCT is limited.71 Liu et al showed that MR coronary 
angiography has a better diagnostic performance than CT angiography for the detection of 
significant stenosis in patients with high calcium scores.71  
Current data concerning the clinical utility of MR coronary angiography for native 
vessel integrity are based on high-risk populations referred for X-ray angiography. No data 
are available regarding its use in patients presenting with chest pain. In addition, the majority 
of MR coronary angiography data has been generated in a few highly specialized centers 
and generalization of findings is questionable. Therefore, MR coronary angiography as an 
auxiliary tool in clinical practice has never been tested.12 
1.3.1. Integration of coronary anatomy and functional imaging using CMR 
MR coronary angiography allows limited morphologic evaluation of the coronary 
arteries72 and could potentially be used as a complementary tool to improve CMR diagnostic 
performance in patients with suspected coronary disease. However, the potential additive 
value of MR coronary angiography integration into a CMR protocol including stress-rest MPI 
and late gadolinium enhancement is not well established.73 Compared with computed 
tomography coronary angiography, MR coronary angiography is still a cumbersome method 
with a higher failure rate, longer scan times, and less accuracy due to the lower positive 
predictive value.70 However, recent published data22 show that MR coronary angiography is 
slowly but steadily evolving. Clearly, a noninvasive test to determine the significance of 
coronary artery stenosis (stress perfusion imaging) and visualizing the morphologic correlate 
(coronary artery imaging) in 1 examination without the use of ionizing radiation would be 
highly attractive.70  
 
2. Multidetector computed tomography 
2.1. Computed Tomography coronary angiography  
CT coronary angiography emerged in the last decade as a robust noninvasive 
technique, with high diagnostic accuracy for detection of coronary disease. It is currently an 
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established non-invasive standard for assessment of coronary anatomy.74 Despite being a 
relatively new technique, it had rapid implantation in Portugal and several centers acquired 
substantial expertise with its use in different scenarios.74-84 
CT angiography is particularly useful for the exclusion of coronary disease in patients 
with intermediate to low pre-test probability, largely due to its high negative predictive 
value.85-88 Normal results can accurately rule out the presence of hemodynamically significant 
lesions and have shown good prognostic value.89-91 However, one major limitation is that it 
cannot provide information on the hemodynamic consequences of a detected lesion.92 
Comparative studies between CT angiography and functional tests have revealed a 
substantial discrepancy between the presence of a stenosis on CT angiography and 
myocardial ischemia.93, 94 Therefore, despite the excellent negative predictive value, CT 
angiography is a poor discriminator of patients with myocardial ischemia, having low 
specificity and positive predictive value.92 Since the presence and extent of ischemia is 
important in determining management, detection of coronary stenoses using CT angiography 
generally involves additional studies to confirm the functional significance of the findings, as 
the degree of stenosis is often overestimated and its physiologic significance remains 
uncertain.95, 96 Furthermore, its diagnostic accuracy is severely limited by calcification, having 
a limited value in patients with higher pre-test probabilities. In these cases, it is generally 
preferable to use functional tests, able to assess the presence of myocardial ischemia.96  
2.2. Computed Tomography Perfusion 
To overcome the limitations of exclusive morphologic information, myocardial 
perfusion techniques using multidetector computed tomography (MDCT) have been recently 
described. These techniques allow the detection of inducible perfusion defects, by examining 
the differences in contrast distribution between normal and hypoperfused myocardium during 
contrast administration.97-103 To this end, several approaches are available, depending on the 
MDCT system used. Explorative studies have described a dynamic imaging approach for 
absolute quantification of myocardial perfusion, in which attenuation differences are 
dynamically detected over time during the entire infusion of contrast media.103 A second 
approach is ECG-gated helical scanning; this protocol may be used by 64-slice MDCT 
systems and achieves full cardiac coverage by scanning the entire heart in multiple 
heartbeats. Advantages of helical scanning technique are full cardiac coverage and reduced 
radiation exposure when compared to dynamic imaging. However, since data are acquired 
during several heartbeats, attenuation artifacts may occur.102 The recent introduction of 256- 
and 320-slice MDCT systems enabled volumetric scanning, covering the entire heart within a 
single rotation, which may allow volumetric perfusion scanning using either technique.104, 105 
Owing to its high spatial resolution and fast acquisition time, MDCT may have 
advantages over conventional perfusion imaging. Furthermore, the ability to investigate 
patients with metal implants provides a potential advantage over CMR perfusion. Preliminary 
studies have shown the potential of myocardial CT perfusion for ischemia detection in both 
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animal and humans and a reasonable accuracy for detecting significant coronary disease as 
assessed by invasive coronary angiography but further validation is still needed.106-109  
2.3. Computed Tomography Delayed Enhancement  
The iodinated contrast agents used in MDCT have similar kinetics to the gadolinium-
chelates used in CMR.110 Thus, CT images acquired 4-30 min after contrast administration 
may show regional hyperenhancement (CT delayed enhancement), corresponding to areas 
of myocardial scar, which have delayed wash-out of contrast and increased distribution 
volume, similarly to late gadolinium enhancement.111-113 However, differently from CMR late 
gadolinium enhancement where the contrast can be optimized using specific inversion times 
selected to null the normal myocardium, CT delayed enhancement has to rely in different 
tones of gray, corresponding to different Hounsfield units, according to the different radio-
opacity of the tissues. No consensus exists regarding the optimal CT delayed enhancement 
protocol and contrast doses of 120-150 ml or 2 ml/kg and delay times ranging from 5 to 15 
min after contrast material injection have been described.113, 114  
The feasibility of CT delayed enhancement has already been shown but its clinical 
value as an adjunctive tool to improve MDCT accuracy for the detection of coronary disease 
has never been validated.107 
2.4. Multidetector Computed Tomography Integrative Protocols 
Similarly to CMR, MDCT has the potential to be used as a comprehensive exam, 
including anatomic and functional information. The ability to integrate detailed morphological 
data from CT coronary angiography together with functional information provided by CT 
myocardial perfusion imaging and late-enhancement in a single examination may improve 
MDCT accuracy for the diagnosis of clinically relevant coronary disease.115, 116 The feasibility 
of these integrated protocols is currently under investigation but direct comparisons with 
established stress perfusion techniques or validation against the invasive functional standard 
(fractional flow reserve) are lacking.117-121 Therefore, a MDCT stress-rest integrative protocol 
has never been fully validated in a clinical scenario as an additive tool to improve MDCT 
ability to detect significant stenoses in symptomatic patients with suspected coronary 
disease. 
The addition of adenosine stress CT perfusion to a cardiac MDCT protocol 
comprising coronary artery calcium quantification, prospectively ECG-triggered CT 
angiography, and delayed acquisition appears promising for the comprehensive assessment 
of coronary artery luminal integrity, cardiac function, perfusion, and viability with a single 
modality.122 In this context, reduction of radiation exposure without compromising diagnostic 
accuracy is a crucial step before these protocols can be generalized in clinical practice. 
Several algorithms for dose reduction can be applied to substantially reduce radiation 
exposure but a strict low-dose 64-slices MDCT protocol combining different strategies of 
dose-reduction was never validated.125, 126 
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3. Evaluation of significance of coronary artery disease using FFR 
In a landmark study, Boden et al showed that revascularization should not be 
routinely attempted in the presence of significant stenosis visualized on invasive coronary 
angiography, even in symptomatic patients.127, 128 In stable angina, optimal medical therapy 
was non-inferior to an interventional strategy based in visual assessment of coronary 
disease. Furthermore, the DEFER129 and FAME130 trials clearly demonstrate that diameter 
stenosis is not a good marker of significance of disease and that treatment should be guided 
according to functional evaluation.131 In this context, Fractional flow reserve has emerged as 
an invasive functional reference-standard against which other tests should compare. It is 
independent of heart rate, blood pressure, and left ventricular contractility and takes into 
account the contribution of collateral flow to myocardial perfusion.132 
Prompted by these recent trials, one of the most exciting challenges currently faced 
by cardiovascular imaging is no longer the simple detection of coronary disease but rather 
the evaluation of its significance. The role of imaging in the context of ischemic heart disease 
is now evolving from detection to functional assessment, aiming to identify patients that may 
benefit from specific therapies, namely revascularization, and to improve management and 
prognosis.  
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III. Purpose  
 
 
This research project aimed to study the place of new advanced cardiovascular 
imaging techniques, namely specific CMR and CT, in the improvement of the current ability to 
detect functionally significant coronary disease and myocardial ischemia. The potential 
additional value of an integrative approach (anatomy and function) in a single examination 
using either technique was evaluated. Despite the potential benefits of this integration, there 
are no clinical studies that demonstrate the usefulness of this integration, using either CMR 
or MDCT. 
The following research goals were established: 
1. To evaluate stress-rest CMR myocardial perfusion accuracy for detection of 
functionally significant coronary artery disease. 
2. To test the incremental value of stress-rest CMR myocardial perfusion over 
exercise testing in the clinical setting of patients with suspected coronary 
disease. 
3. To study the additive value of CT perfusion over CT angiography in patients with 
suspected coronary disease and intermediate/high pre-test probability. 
4. To compare the diagnostic performance of a MDCT protocol including CT 
perfusion with a stress-rest CMR myocardial perfusion protocol for the detection 
of coronary disease. 
5. To study the diagnostic performance of CT delayed enhancement for detection of 
ischemic scar and to test its additive value as part of a comprehensive MDCT 
protocol including CT angiography and CT perfusion. 
6. To test the potential additive value of magnetic resonance coronary angiography 
as part of a comprehensive stress-rest CMR protocol, including functional 
analysis, perfusion and late gadolinium enhancement. 
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IV. Population and Methods 
 
This project was conceived as the sum of independent studies linked by the 
integrating concept of optimizing ischemia and coronary disease detection using cardiac 
magnetic resonance and computed tomography and their specific ability for a comprehensive 
functional and anatomic assessment.  
In this section we will describe shortly and generally the population and methods 
used for the project. A detailed description is presented further ahead for each specific study.  
Population: 
Data collection concerning this project started in February 2009 and ended in 
November 2011. One hundred seventy six individuals consecutively referred to the 
cardiology department outpatient clinic of Centro Hospitalar de Vila Nova de Gaia/Espinho, 
EPE, due to suspected coronary artery disease were screened for the inclusion and 
exclusion criteria of the entire project:  
a) Inclusion criteria. 
Age >40 years 
Symptoms compatible with CAD 
Presence of two* or more risk factors** or a previous positive/inconclusive 
exercise treadmill-test 
Ability to provide written informed consent 
* In the study testing the additive value of CMR over exercise treadmill-testing patients 
with a single risk factor were also included 
** Hypertension, Hypercholesterolemia, Diabetes, Tabagism, Family history of CAD 
b) Exclusion criteria. 
Known coronary artery disease (Previous myocardial infarction; percutaneous 
coronary intervention; coronary artery bypass grafting) 
Known allergies or contra-indication to iodinated contrast and Gadolinium 
chelates 
Anemia (hgb<8,5 g/dl) 
Valvular heart disease  
Atrial fibrillation 
Unstable angina pectoris (CCS IV) 
Heart failure (NYHA IV) 
Uncontrolled severe hypertension (>220/120 mmHg) 
ICD/Pacemaker 
Self-reported claustrophobia 
Pregnancy 
Renal insufficiency (creatinine clearance ≤60 ml/min) 
Asthma (<3 months since last crisis) 
Refusal to provide written informed consent 
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Methods 
Patients were screened for study participation following a pre-established protocol 
including assessment of clinical information, physical exam and electrocardiogram. Patients 
with inclusion criteria underwent echocardiographic evaluation, treadmill exercise testing and 
blood sampling. After signed informed consent, included patients were referred to cardiac 
magnetic resonance, multidetector computed tomography and invasive coronary 
angiography.  
Assessment of clinical history and known risk factors 
Clinical information (including cause of referral, symptoms, previous clinical history, 
known risk factors, previous tests, and medication) was obtained from a standardized health 
questionnaire and referral letters. 
Hypertension was defined as history of known hypertension for at least 1year or 
prescriptions of antihypertensive drugs. Diabetes Mellitus was defined as requirement for 
insulin or oral hypoglycemic drugs. Hyperlipidemia was defined as previously detected 
elevation of serum total cholesterol (>200 mg/dl), triglycerides (>200 mg/dl) or LDL-
cholesterol (>150 mg/ dl) – known for at least 1 year – or use of lipid-lowering agents. 
Smoking status was defined in 3 categories: current smoker - smoking exposure within the 
last 12 months; ex-smoker - life smoking exposure greater than 2 pack years with an 
absence of smoking in the last year; non-smoker - no smoking within the last 12 months and 
a life consumption less than 2 pack years. Family history of coronary artery disease was 
defined as having a first degree relative with history of myocardial infarction, coronary 
revascularization, or sudden death at a young age (men <55 years; women <65 years).  
Anthropometric measures 
Abdominal circumference was measured by a single investigator, using standard 
methods,1 and body mass index was calculated from simultaneous measurements of height 
(fixed stadiometer) and weight (Tanita Column Adult Weighing Scale®), as previously 
described.2, 3 
Assessment of pre-test probability 
Pretest probability of coronary artery disease was estimated using a modified Morise 
Score, excluding the estrogen status.4 According to this method, a pre-test probability score 
(varying from 0 to 24 points) is calculated based on clinical variables with different 
ponderations for the final summation score (age, gender, symptoms, risk factors and body 
mass index). Following this approach, patients were categorised in groups of low (0-8 points), 
intermediate (9-15 points) or high (16-24 points) pre-test probability. 
Blood pressure and blood tests 
Measurements of sitting heart rate and blood pressure were obtained and peripheral 
blood sampling collected in overnight fasting state. 
Electrocardiogram 
A rest electrocardiogram was obtained from all screened patients using commercially 
available hardware (ELI-350, Mortara, Milwaukee, Wisconsin, USA). 
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Echocardiogram 
All patients with inclusion criteria were studied and screened for exclusion criteria 
using a commercially available ultrasound system (iE33, Philips Medical Systems, Best, The 
Netherlands) equipped with a broadband S5-1 transducer. Left ventricular ejection fraction 
was calculated for all patients by bidimensional echocardiography, using the modified 
Sympson rule. 
Exercise treadmill test 
An exercise treadmill test using the standard Bruce protocol was performed in all 
patients with an interpretable baseline electrocardiogram who were able to exercise - using a 
Schiller CS-200 Ergospiro (Barr, Switzerland). 
Cardiac Magnetic Resonance 
Cardiac magnetic resonance was performed using established protocols on a 1.5T 
Siemens Symphony (Siemens, Erlangen, Germany), with a 12-channel receiver coil, within 
one week before invasive coronary angiography. 
Multidetector Computed Tomography 
Multidetector computed tomography was performed using a Somatom Sensation 64 
scanner (Siemens Medical Solutions, Forchheim, Germany) within one week before invasive 
coronary angiography. 
Invasive coronary angiography and fractional flow reserve assessment 
Invasive coronary angiography was performed according to standard techniques on a 
Siemens Axiom Artis Cath Lab (Siemens Medical Solutions, Erlanger, Germany). Pressure 
Wire Certus (St Jude Medical, St Paul, MN, USA) and RadiAnalyzer (Jude Medical, St Paul, 
MN, USA) were used to determine coronary arteries fractional flow reserve. 
 
The 9 scientific papers that integrate this thesis were developed in order to fulfil the 
research goals detailed in the purpose section: 
1. Bettencourt N, Nagel E. Comparison of MR and CT for the assessment of the 
significance of coronary artery disease: a review. Curr Cardiovasc Imaging Rep, 
2013; 6(2): 102-6. 
2. Bettencourt N, Chiribiri A, Schuster A, Ferreira N, Sampaio F, Duarte R, Santos L, 
Melica B, Rodrigues A, Braga P, Teixeira M, Simões L, Leite-Moreira A, Silva-
Cardoso J, Nagel E, Portugal P, Gama V. Cardiac magnetic resonance myocardial 
perfusion imaging for detection of functionally significant obstructive coronary artery 
disease: A prospective study. Int J Cardiol. 2013 Sep 30;168(2):765-73.  
3. Pereira E, Bettencourt N, Ferreira N, Schuster E, Chiribiri A, Primo J, Teixeira M, 
Simões L, Leite-Moreira A, Silva-Cardoso A, Gama V, Nagel E. Incremental value of 
adenosine stress cardiac magnetic resonance in coronary artery disease detection. 
Int J Cardiol. 2013 Oct 9;168(4):4160-7. 
4. Bettencourt N, Rocha J, Ferreira N, Pires-Morais G, Carvalho M, Leite D, Melica B, 
Santos L, Rodrigues A, Braga P, Teixeira M, Simões L, Leite-Moreira A, Cardoso S, 
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Nagel E, Gama V. Incremental value of an integrated adenosine stress-rest MDCT 
perfusion protocol for detection of obstructive coronary artery disease. J Cardiovasc 
Comput Tomogr. 2011 Nov-Dec;5(6):392-405. 
5. Bettencourt N, Chiribiri A, Schuster A, Ferreira N, Sampaio F, Pires-Morais G, 
Santos L, Melica B, Rodrigues A, Braga P, Azevedo L, Teixeira M, Leite-Moreira A, 
Silva-Cardoso J, Nagel E, Gama V. Direct Comparison of Cardiac Magnetic 
Resonance and Multidetector Computed Tomography Stress-Rest Perfusion Imaging 
for Detection of Coronary Artery Disease. J Am Coll Cardiol. 2013. Mar 
12;61(10):1099-107. 
6. Bettencourt N, Nagel E. Reply to Letter to the Editor: Multidetector Computed 
Tomography Stress-Rest Perfusion Imaging for Detection of Coronary Artery 
Disease. J Am Coll Cardiol. 2013 Jul 23;62(4):353.  
7. Bettencourt N, Nagel E. Reply to Letter to the Editor: Comparison of Cardiac 
Magnetic Resonance and Computed Tomography Stress-Rest Perfusion Imaging for 
Detection of Coronary Artery Disease.J Am Coll Cardiol. 2013 Jul 23;62(4):354. 
8. Bettencourt N, Ferreira ND, Leite D, Carvalho M, Ferreira W, Schuster A, Chiribiri A, 
Leite-Moreira A, Silva-Cardoso J, Nagel E, Gama V. CAD Detection in Patients With 
Intermediate-High Pre-Test Probability: Low-Dose CT Delayed Enhancement 
Detects Ischemic Myocardial Scar With Moderate Accuracy But Does Not Improve 
Performance of a Stress-Rest CT Perfusion Protocol. JACC Cardiovasc Imaging. 
2013 Oct;6(10):1062-71. 
9. Bettencourt N, Ferreira N, Chiribiri A, Schuster A, Sampaio F, Santos L, Melica B, 
Rodrigues A, Braga P, Teixeira M, Leite-Moreira A, Silva-Cardoso J, Portugal P, 
Gama V, Nagel E. Additive Value of Magnetic Resonance Coronary Angiography in a 
Comprehensive Cardiac Magnetic Resonance stress-rest protocol for detection of 
functionally significant Coronary Artery Disease – A pilot study. Circ Cardiovasc 
Imaging. 2013 Sep;6(5):730-8. 
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Abstract Multidetector computed tomography (MDCT)
and cardiac magnetic resonance (CMR) are advanced,
state-of-the-art imaging tools for detection of coronary
artery disease (CAD), providing important complemen-
tary information in patients with suspected or estab-
lished disease. While MDCT coronary angiography is
an anatomical method and seems to be especially pre-
pared for CAD detection, even in subclinical phases,
CMR allows evaluation of ischemia and myocardial scar
and is particularly efficient in the assessment of the
functional significance of CAD and in guiding manage-
ment. Over the last years, research focused on the
development of anatomical and functional integrated
techniques using both methods. While CMR coronary
angiography is slowly but steadily developing, MDCT
myocardial perfusion and MDCT virtual fractional flow
reserve estimation are promising tools that may change
the way noninvasive assessment of CAD is made in the
near future. This review article focuses on CMR and
MDCT ability for assessing CAD significance, taking
into account the relevant research published in recent
years.
Keywords Coronary artery disease . CMR . Fractional flow
reserve . MDCT .Myocardial ischemia . Resonance .
Review . Tomography
Introduction
Coronary artery disease (CAD) is one of the major causes of
morbidity and mortality in western countries [1–3]. Recent
years witnessed the development of increasingly advanced
imaging tools for detection of CAD. Technical and compu-
tational progress allowed the emergence of new techniques
with better spatial and temporal resolution, namely Cardiac
Magnetic Resonance (CMR) and Cardiovascular Multide-
tector Computed Tomography (MDCT), which have been
implemented with great success in the cardiovascular field,
revolutionizing the diagnosis of ischemic heart disease
(IHD) [4]. It is now possible to directly and noninvasively
visualize coronary arteries and to identify myocardial per-
fusion defects, fibrosis, and scar with greater detail than ever
before. These additional data translate into important diag-
nostic and prognostic information in patients with suspected
or known CAD [5].
One of the major goals of imaging in the context of IHD is
the identification of patients with functionally significant
CAD that may benefit from specific therapies, namely revas-
cularization. In a landmark study, Boden et al showed that
revascularization should not be routinely attempted in the
presence of significant stenosis visualized on x-ray coronary
angiography (XA), even in symptomatic patients [6, 7]. In
stable angina, optimal medical therapy was noninferior to an
interventional strategy based in visual assessment of CAD.
Furthermore, the FAME trials clearly demonstrate that diam-
eter stenosis is not a good marker of significance of disease
and that treatment should be guided according to functional
evaluation [8]. Prompted by these recent trials, one of the most
exciting challenges currently faced by cardiovascular imaging
is no longer the simple detection of CAD but rather the
evaluation of its significance. The compass has shifted from
detection to assessment, aiming to improve management and
prognosis. This article will review CMR and MDCT perform-
ances for evaluation of CAD, focusing in the assessment of
the functional significance of CAD.
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Only a few studies directly comparedMDCTand CMR for
the assessment of CAD. The vast majority used XA quantita-
tive coronary angiography (QCA) or visual assessment as
reference. In 2006 a comparative meta-analysis revealed that
computed tomography coronary angiography (CTA) per-
formed better than CMR for detection of stenosis ≥50 %
on XA [9]. Recently, Scheffel et al compared CTA and CMR
in 43 patients with known or suspected CAD, using the same
reference-standard.(10) CTA outperformed CMR with regard
to sensitivity and negative predictive value (NPV) whereas
CMR was more specific and had a higher positive predictive
value (PPV) [10]. These comparisons, however, were per-
formed taking a morphological test as the reference-standard
without any additional functional assessment, which obvious-
ly underestimates the diagnostic performance of CMR and
overestimates CTA’s. Comparison of noninvasive tests for the
significance of CAD should be performed against a functional
standard. In this context, invasive assessment of pressure
wire – derived fractional flow reserve (FFR) has emerged as
an important reference-standard. It can reliably identify flow-
limiting stenosis in an epicardial coronary artery and can be
advantageously used to guide management [11, 12]. It is
independent from heart-rate, blood pressure, and ventricular
contractility and takes into account the contribution of collat-
eral flow to myocardial perfusion [13]. A FFR ≤0.75–0.80
confirms that the stenosis being interrogated has the potential
to induce ischemia [14, 15]. Interestingly, CMR-MPI has
recently been used as a reference-standard in studies trying
to validate MDCT myocardial perfusion (CTP) and a very
good correlation for the assessment of myocardial perfusion
defects has been reported (higher than with SPECT) [16–20].
However, a direct comparison of both techniques against a
functional invasive standard such as FFR is missing.
Cardiac Magnetic Resonance
CMR is particularly well suited for the noninvasive func-
tional evaluation of the cardiovascular system. The absence
of ionizing radiation, excellent spatial resolution, optimal
definition of endocardial and epicardial borders, and the
ability for tissue characterization are unequivocal advan-
tages of the technique [21]. The ability to identify ischemia
in a comprehensive exam including evaluation of contrac-
tility and myocardial fibrosis makes CMR one of the most
complete exams in patients with suspected or known CAD.
The combination of CMR stress perfusion, function, late
gadolinium enhancement (LGE), and, eventually, CMR cor-
onary angiography, allows a comprehensive assessment of
IHD and may be particularly useful in the selection of
patients for revascularization procedures [22, 23]. Further-
more, it has been shown to correctly differentiate the prog-
nosis of IHD patients [24–26].
Myocardial ischemia detection using CMR is usually
performed with pharmacological stress. Two methods may
be described, according to the pharmacological agent used
and the physiologic mechanism tested: Dobutamine stress
magnetic resonance (DSMR), and CMR myocardial perfu-
sion imaging (CMR-MPI). DSMR was described first and is
based on detection of stress inducible wall motion abnor-
malities during pharmacological stress, similar to stress
echocardiography but with no “acoustic window” limita-
tions [27]. Meta-analysis of published data reveals its high
sensitivity (83 %) and specificity (86 %) [28]. However,
DSMR is somewhat more complex than CMR-MPI and its
prognostic discriminating power seems to be slightly inferi-
or [25]. Therefore, high-dose DSMR is usually reserved for
patients with contra-indications to adenosine or gadolinium-
chelate agents or in patients with complex disease and
previous revascularization. Furthermore, DSMR seems to
be an established technique and no significantly relevant
advances were published in recent years on this topic. As
such, our review will focus on CMR-MPI performance,
which has been a field of intense research and development
in the last few years.
CMR Stress Myocardial Perfusion Imaging (CMR-MPI)
In CMR-MPI, detection of ischemia is accomplished using a
real-time visualization of the first passage of a gadolinium-
chelate bolus through the heart during maximal hyperemia –
usually achieved with an adenosine/dipyridamole infusion
[29]. Similar to SPECT, ischemia is identified by the pres-
ence of a reversible myocardial perfusion deficit under
stress. It is routinely combined with tissue characterization
using LGE to improve diagnostic accuracy [30, 31]. Unlike
XA or CTA, which identify luminal stenosis without any
information on their hemodynamic significance, CMR-MPI
detects the downstream changes in blood flow [32]. Thus, it
may be particularly useful for discriminating the significance
of a specific stenosis and to guide management [22, 23].
Validation Against Invasive X-Ray Coronary Angiography/
Quantitative Coronary Angiography
Validation of CMR-MPI in humans has been performed
in a number of clinical studies employing a variety of
contrast agents, analysis techniques, and reference-standards
(Table 1).
In the first years of research, important animal-model
studies proved CMR-MPI superiority over SPECT for the
identification of hemodinamically significant CAD, taking
advantage of the increased spatial resolution that allows
subendocardial ischemia detection [33]. Since then, the po-
tential advantages of CMR-MPI for detection of functionally
Curr Cardiovasc Imaging Rep (2013) 6:102–116 103
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Table 1 Diagnostic accuracy of CMR-MPI for detection of significant CAD
Author Year n Inclusion Reference
Standard
CAD
(%)
Sens
(%)
Spec
(%)
Comments
Visual or QCA
as standard
Ishida et al.
[96]
2003 104 P referred for XA + No
previous MI
XA≥70 % 74 90 85 Subgroup of 69 P compared
with SPECT.
Dipyridamole as stressor.
Doyle et al.
[97])
2003 184 Women + symptoms XA≥70 % 14 58 78
Nagel et al.
[32]
2003 84 Suspected or known CAD
referred to XA
XA≥75 % 51 88 90 Evaluation of MPR.
Plein et al. [98] 2004 68 Non-ST segment
elevation ACS
XA>70 % 82 88 83 Perfusion-CMR vs
comprehensive CMR.
Takase et al.
[99]
2004 102 Suspected or known CAD
referred to XA
XA>50 % 75 93 85 Dypiridamole as stressor.
Wolff et al. [100] 2004 75 Suspected or known CAD
referred to XA
XA≥70 % 49 93 75 Multicenter study. Optimal
Gd dose (visual)
= 0.05 mmol/kg.
Giang et al.
[101]
2004 44 Suspected or known CAD XA≥50 % 64 93 75 Multicenter study. Optimal
Gd dose (semi-
quantitative)
= 0.1-0.15 mmol/kg.
Kawase et al.
[102]
2004 50 Suspected or known CAD XA≥70 % 66 94 94 Nicorandil as stressor.
Paetsch et al.
[103]
2004 79 Suspected or known CAD
referred to XA
XA>50 % 67 91 62 Comparison of CMR-MPI
and DSMR
Plein et al.
[104]
2005 82 Suspected or known CAD XA>70 % 72 88 74 SENSE-TGE.
Pilz et al.
[105]
2006 171 Class II indication for XA XA>70 % 66 96 83
Klem et al. [30] 2006 92 Suspected CAD XA≥50 % 48 77 88 Perfusion-CMR vs
comprehensive CMR.XA≥70 % 40 89 87
Cury et al.
[106]
2006 46 Suspected or known CAD
referred to XA
XA≥70 % 65 97 75
Cheng et al.
[107]
2007 61 Suspected or known CAD
referred to XA
XA≥50 % 66 98 76 3 T vs 1.5 T comparison.
Gebker et al.
[108]
2007 40 Suspected or known CAD
referred to XA
XA≥50 % 55 86 78 Kt-BLAST.
Merkle et al.
[109]
2007 228 Suspected or known CAD
referred to XA
XA>50 % 75 93 86
XA>70 % 67 96 72
Gebker et al.
[110]
2008 101 Suspected or known CAD
referred to XA
XA≥50 % 69 90 71 3 T.
Kitagawa et al.
[111]
2008 50 Suspected or known CAD
referred to XA
XA≥50 % 72 92 57 Perfusion-CMR vs
comprehensive CMR.
Increased sens but not
global accuracy.
Klein et al.
[112]
2008 51 Suspected CAD
referred to XA
XA>50 % 49 88 89 Perfusion-CMR vs
comprehensive CMR.
Meyer et al.
[113]
2008 60 Suspected or known CAD
referred to XA
XA≥70 % 60 89 79 3 T vs 1.5 T comparison.
Pingitore et al.
[114]
2008 93 Suspected or known CAD
referred to XA
XA>50 % 71 92 67 Dypiridamole as stressor.
Plein et al.
[115]
2008 51 Suspected or known CAD
referred to XA
XA>50 % 69 89 44 Kt-SENSE.
Plein et al.
[116]
2008 33 Suspected or known CAD
referred to XA
XA>50 % 39 92 80 3 T vs 1.5 T comparison.
Kt-SENSE.
Schwitter et al.
[38]
2008 228 P referred for XA
and/or SPECT
XA≥50 % 76 85 67 Multicenter study. Optimal
Gd dose (visual) =
0.1–0.15 mmol/kg.
Bernhardt et al.
[117]
2009 823 Suspected or known CAD
referred to XA
XA≥70 % 38 88 83
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Table 1 (continued)
Author Year n Inclusion Reference
Standard
CAD
(%)
Sens
(%)
Spec
(%)
Comments
Klein et al. [118] 2009 78 P after bypass surgery XA>50 % 69 67 88
Krittayaphong
et al. [119]
2009 66 P referred for XA XA≥50 % 58 90 79 Comparison of MPR
with visual stress-rest
CMR-MPI and stress
CMR-MPI.
Arnold et al. [120] 2010 62 Suspected or known CAD
referred to XA
XA≥50 % 66 90 81 Comparison with adenosine
myocardial contrast
echocardiography.
Donati et al. [121] 2010 47 Suspected or known CAD
referred to XA
XA>50 % 70 91 100 Combined protocol
with CTA.
Klumpp et al. [122] 2010 57 Suspected or known CAD
referred to XA
XA>70 % 72 98 88 3 T. Evaluation of MPR.
Stolzmann et al. [123] 2011 65 Suspected CAD and
intermediate risk
XA>50 % 60 78 88
De Mello et al. [124] 2011 54 Patients referred to
CMR-MPI
and XA (retrospect)
XA≥70 % 69 92* 84* Dypiridamole as stressor.
Retrospective study with a
clear verification bias.
Gebker et al. [125] 2012 78 Suspected or known CAD
referred to XA
XA≥70 % 69 92 83 Dobutamine-stress
perfusion-CMR.
Greenwood
et al. [37••]
2012 628 Suspected or known CAD XA≥70 % 39 87 83 Largest CMR-MPI vs
SPECT comparison.
Schwitter et al.
[40••]
2012 425 Suspected or known CAD XA≥50 % 49 67 61 Multicenter study.
Nandalur et al. [28] 2007 1183 57 91 81 Meta-analysis.
Hamon [34] 2010 2456 57 89 80 Meta-analysis.
Jaarsma [35] 2012 2841 59 89 76 Meta-analysis.
De Jong [36] 2012 2970 54 91 80 Meta-analysis
FFR Rieber et al. [44] 2006 43 Suspected or known CAD
referred for XA
FFR≤0.75 31* 88* 90* Evaluation of MPR
Costa et al.
[42]
2007 30 Suspected CAD FFR≤0.75 32** 93** 57** Evaluation of MPR
Futamatsu et al. [126] 2007 30 Suspected CAD referred
for XA
FFR≤0.75 32** 93** 57** Evaluation of MPR
Watkins et al. [45] 2009 101 Suspected CAD, referred
for XA
FFR≤0.75 77 95 91 Clinical validation
Kirschbaum
et al. [127]
2011 50 Suspected CAD + Normal
EF referred for XA
FFR<0.80 43* 97* 60* Evaluation of MPR
Lockie et al.
[49]
2011 42 Suspected or known CAD FFR<0.75 42* 82* 94* 3 T
Bettencourt et al.
[46]
2012 103 Suspected CAD FFR≤0.80 44 89 88 Clinical validation
Bernhardt et al. [50] 2012 34 Suspected or known CAD FFR≤0.80 62 90 100 Evaluation of MPR:
Comparison of 1.5 vs 3 T.
(results shown for 3 T)
Jogiya et al. [48] 2012 53 P referred for XA FFR<0.75 64 91 90 3 T - Dinamic 3D
Whole-heart CMR_MPI
Manka et al. [47] 2012 129 Suspected or known CAD FFR<0.75 58 90 82 Bi-centric study. 1.5 T 3D
Whole-heart CMR-MPI.
Assessment of MIB
*Per-vessel analysis.
**Per-segment analysis
CAD prevalence of coronary artery disease, according with the reference-standard, CMR-MPI cardiac magnetic resonance myocardial perfusion
imaging, CTA computed tomography coronary angiography, DSMR dobutamine stress magnetic resonance; EF = Ejection fraction, FFR fractional
flow reserve, MIB myocardial ischemic burden, MPR myocardial perfusion reserve, Sens sensitivity, Spec specificity, SPECT single photon
computed tomography, XA X-ray invasive coronary angiography
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significant CAD have been tested in increasingly larger pa-
tient populations.
The first meta-analysis of CMR-MPI studies was pub-
lished in 2007, and involved a total population of 1183
patients, with a CAD prevalence of 57 % [28]. On a per-
patient level, sensitivity and specificity for detection of
stenosis >70 % (>50 % Left-main) were 91 % and 81 %,
respectively. Another meta-analysis published by Hamon et
al in 2010, involved a total population of 2456 patients, and
revealed a per-patient sensitivity and specificity of 89 % and
80 %, respectively [34]. Adenosine perfusion studies
showed better sensitivity when compared with dipyridamole
(90 % vs 86 %), and there was also a trend for better
specificity (81 % vs 77 %, P=0.065). The authors concluded
that CMR-MPI is highly sensitive in detecting CAD but
remained only moderately specific. Recently, Jaarsma et al
compared the diagnostic accuracy of SPECT, CMR-MPI,
and PET for the diagnosis of obstructive CAD as assessed
by XA ≥50 % diameter stenosis [35]. Patient-based analysis
demonstrated a pooled sensitivity of 89 % and specificity of
76 % for CMR-MPI which was similar to PET but superior
to SPECT. In the most recent meta-analysis, de Jong et al
compared the diagnostic performance of different myocar-
dial perfusion imaging methods, namely CMR, SPECT, and
Echocardiography, having conventional XA as the
reference-standard [36]. Pooled CMR studies, yielded a total
of 2970 patients and suggested that CMR performs better
and saves more patients from additional invasive tests than
the other 2 techniques under comparison.
In a recent paper by Greenwood et al a comprehensive
CMR-MPI protocol was superior to SPECT for detection of
CAD as assessed by XA [37••]. In this 752-patients single-
center study, the largest study published so far involving
CMR and SPECT, CMR achieved a sensitivity and speci-
ficity of 86 % and 83 %, while SPECT resulted in 66 %
(P<0.0001), and 83 %, respectively.
Finally, 2 multicenter studies comparing isolated CMR-
MPI with SPECT (MR-IMPACT I and II) confirmed CMR-
MPI as an accurate method for ischemia detection in
patients with suspected or known CAD. MR-IMPACT I
involved 234 patients at 18 centers and compared the results
of CMR-MPI with SPECT, having QCA ≥50 % as
reference-standard [38]. The results of this dose-finding
study confirmed the high diagnostic accuracy of CMR-
MPI and prompted the design of a second trial aiming to
directly compare CMR-MPI and SPECT for detection of
CAD, using a similar reference-standard (but this time with
the inclusion of previous myocardial infarction but no sig-
nificant stenosis on XA as a CAD equivalent). In the MR-
IMPACT II trial, 533 patients were enrolled in 33 centers.
The primary endpoint of CMR non-inferiority vs SPECT
was achieved for sensitivity but not specificity when using
the perfusion data only, without information from LGE.
CMR-MPI had higher sensitivity (75 % vs 59 %, P=0.03)
and lower specificity (59 % vs 72 %, P=0.03) [39••]. Global
CMR-MPI diagnostic performance was superior to SPECT
for the entire population (465 patients) and in all pre-
specified sub-groups such as patients with gated- and non-
gated-SPECT, patients without prior myocardial infarction,
patients with multi-vessel disease, both in men as well as
women [40••]. Furthermore, CMR-MPI superiority was
confirmed against both exercise and pharmacological stress
SPECT [40••]. Importantly, these results were found using
just the CMR-MPI component of the CMR protocol for the
direct comparison against SPECT. In clinical practice, how-
ever, the functional evaluation of myocardial contractility
and evaluation of myocardial fibrosis/scar are routinely
performed as part of a comprehensive CMR-MPI protocol.
Therefore, an even better performance of CMR might be
expected when these components are integrated in a com-
prehensive evaluation.
Validation Against Invasive Fractional Flow Reserve
CMR-MPI has been validated against coronary FFR for
discrimination of the hemodynamic significance of interme-
diate stenosis [41–44]. After the DEFER [11] and FAME
[12] trials, in which FFR proved its ability to correctly guide
management in patients with CAD, FFR has emerged as an
invasive functional reference-standard against which other
tests should compare. However, only recently, FFR was
used as a standard for the evaluation of CMR-MPI perfor-
mance in the clinical assessment of patients with suspected
CAD [45, 46]. In a population of 101 patients with sus-
pected angina, Watkins et al reported an excellent per-
patient sensitivity (95 %) and specificity (91 %) for detec-
tion of FFR ≤0.75, stating that CMR-MPI performance
seems to be even higher than previously reported [45].
Bettencourt et al confirmed these findings, reporting a per-
patient sensitivity and specificity of 93 % and 87 % respec-
tively, using the same FFR threshold as reference and values
of 89 % and 88 % using an FFR threshold of 0.80 which is
most commonly used in current clinical practice [46]. Both
studies showed better results in vessel- and patient- based
analysis when the functional standard (FFR) was used as
opposed to QCA, suggesting that the accuracy of CMR-MPI
performance is underestimated when compared with an
anatomical reference-standard.
Further developments are continuously being reported in
the field of CMR-MPI. Whole-heart 3D dynamic perfusion
allows determination of the myocardial ischemic burden
holding the promise for better noninvasive therapeutic guid-
ance and risk stratification. Recent publications report a very
high accuracy against FFR, both in 1.5 T and 3 T [47, 48].
We may expect further developments in CMR-MPI with
generalization of 3 T scanners: CMR-MPI may take
106 Curr Cardiovasc Imaging Rep (2013) 6:102–116
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advantage of the higher fields and faster gradients at 3 T,
improving temporal and spatial resolution. Both visual eval-
uation and MPR analysis seem to benefit from the use of
these higher-fields, as recently reported [49, 50]. A current
study (MR-INFORM) is comparing the outcomes of
patients with stable coronary artery disease when guided
by CMR-MPI in comparison to invasive angiography plus
FFR [51].
Multidetector Computed Tomography (MDCT)
CTA is the established noninvasive reference-standard for
assessment of coronary anatomy. It is particularly useful for
the exclusion of CAD in patients with intermediate to low
pre-test probability, largely due to its high NPV [52–56].
Normal results can accurately rule out the presence of he-
modynamically significant lesions in patients with sus-
pected CAD and have shown a good prognostic value
[57–59]. However, 1 major limitation of this technique is
that it cannot provide information on the hemodynamic
consequences of a detected lesion [60]. Comparative studies
between CTA and functional tests have revealed a substan-
tial discrepancy between the presence of a stenosis on
MDCT and myocardial ischemia [61, 62]. Since the pres-
ence and extent of ischemia is important in determining
management, detection of “significant” CAD using CTA
generally involves additional studies to confirm the find-
ings, as the degree of stenosis is often overestimated and its
physiologic significance remains uncertain [63, 64]. Fur-
thermore, diagnostic accuracy is severely limited by calcifi-
cation, having a limited value in patients with higher pre-test
probability. In these cases, it is generally preferable to use
functional tests, able to assess the presence of ischemia [64].
To overcome this limitation, the feasibility of MDCT
myocardial perfusion imaging (CTP) in combination
with CTA has been tested and its application as a way
to measure the functional significance of a detected lesion is
being investigated [65].
Similarly to CMR,MDCT has the potential for be used as a
comprehensive exam, including the anatomical detail provid-
ed by CTA and the functional information achieved with CTP
and late-enhancement, aiming to improveMDCTaccuracy for
the diagnosis of functionally significant CAD [66, 67]. The
iodinated contrast agents used in MDCT have similar kinetics
to gadolinium-chelates used in CMR [68]. Thus, imaging
performed immediately after contrast administration may
show areas of hypoenhancement corresponding to perfusion
defects (delayed wash-in of contrast) and images acquired 5 to
10 minutes after contrast administration may show regional
hyperenhancement, corresponding to areas of myocardial scar
(delayed wash-out of contrast and increased distribution vol-
ume) [69].
In the context of discrimination of functionally signifi-
cant from functionally irrelevant CAD the isolated value of
CTA is diminished, as the target population is no longer an
intermediate/low pretest-probability group but rather the
intermediate/high pretest-probability patients or even
patients with known CAD. Under this perspective, the re-
cently described functional tests using MDCT, namely
stress-rest CTP, and CT-derived estimation of fractional
flow reserve (CT-FFR) emerge as promising tools that
may change our approach for functional assessment of
CAD. This article will review the recent literature on this
exciting topic.
Myocardial CT Perfusion (CTP)
The ability to assess myocardial perfusion using CT tech-
nology was first studied around 1980 [70]. Only recently,
however, MDCT technology allowed reliable visualization
of myocardial perfusion. Depending on the scanner system,
different protocols can be applied to assess myocardial
perfusion [69, 71]. First explorative studies used a dynamic
imaging approach in which attenuation differences are dy-
namically detected over time during the entire infusion of
contrast media [69]. A major drawback of this protocol is
that it requires prolonged acquisition time and increased
radiation exposure. Nevertheless the fast hardware and soft-
ware development of recent years, allowed faster and larger
coverages with increasingly lower radiation exposure, mak-
ing this approach feasible in human patients [72]. The recent
introduction of 256- and 320-detectors MDCT systems has
enabled volumetric scanning, covering the entire heart with-
in a single rotation [73, 74]. Using a dynamic imaging
approach, myocardial perfusion imaging of the entire heart
may be performed in a single rotation, resulting in full
cardiac coverage with homogenous attenuation of the
myocardium.
A second approach is ECG gated helical scanning. This
protocol may be used in all ≥64-slice MDCT systems and
achieves full cardiac coverage by scanning the entire heart
in multiple heart-beats. During image acquisition, retrospec-
tive ECG-gating allows reconstructions of the entire heart
during any phase of the cardiac cycle. Since data are ac-
quired during several heart-beats, attenuation and misalign-
ment artifacts may occur. Furthermore, only semi-quantitative
evaluation is possible [71].
Validation Against Invasive X-ray Coronary Angiography/
Quantitative Coronary Angiography
Preliminary studies have shown the potential of CTP for
ischemia detection in both animal and humans and a rea-
sonable accuracy for detecting CAD as assessed by XA [69,
71]. Kurata et al were the first group to describe the use of
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adenosine stress-rest CTP in a small cohort of 12 patients,
using a 16-slice scanner. CTP and SPECT had an agreement
of 82 % in the evaluation of perfusion defects. Nine patients
also underwent XA but no data was reported concerning
CTP sensitivity and specificity for detection XA-defined
CAD [75]. Further studies followed using different
approaches and scanners [18, 19, 76–86] (Table 2).
George et al validated a semi-quantitative approach tak-
ing advantage of the high spatial resolution achieved with
MDCT: the transmural perfusion ratio (subepicardium/su-
bendocardium attenuation values) combined with CTA, ac-
curately predicted stenoses causing ischemia as assessed by
QCA + SPECT [77]. The feasibility of performing a com-
prehensive MDCT examination incorporating coronary im-
aging, stress-rest myocardial perfusion, and delayed-
enhancement imaging in humans has also been shown. In
2009, Blankstein et al published a comprehensive dual-
source-CT (DSCT) protocol aiming to evaluate CTA,
stress-rest CTP, and scar [78]. In this study, involving 34
patients with previous SPECT and XA, the adenosine stress-
rest MDCT protocol identified stress-induced myocardial
ischemia with similar diagnostic accuracy and radiation
exposure (12.7 mSv) compared with SPECT. Prospective
ECG-triggering was implemented, substantially reducing
radiation for the rest-scan, while the stress-CTP scan was
acquired using retrospective helicoidal scanning [78].
The same group later confirmed that CTP + CTA inte-
grated protocol improved DSCT accuracy for detection
of stenosis ≥50 % in 35 angina patients, having a sensitivity
and specificity of 91 % in per-vessel analysis [79]. Similar
results were reported by Cury et al in 36 patients with previous
positive SPECT, using dipyridamole stress-rest CTP in a
64-slice scanner. Despite the verification bias, the authors
concluded that the anatomical and functional information
provided by a combined CT protocol could allow identifica-
tion of false-positive results by SPECT [81].
Our group designed the largest CTP study published so
far [83]. The incremental diagnostic value of a comprehen-
sive stress-rest MDCT protocol applying restrictive dose-
reducing strategies on a 64-slice CTwas tested in 90 patients
with suspected CAD [83]. Integration of CTA and CTP
improved global accuracy for detection of stenosis ≥70 %,
with a sensitivity of 95 % and specificity of 94 %. Effective
radiation of 5.1 mSv for the entire MDCT protocol was
clearly lower than previously reported using this generation
of scanners. The study proved that stress-rest CTP with low
radiation exposure is feasible in widely available 64-slice
CT scanners and improves MDCT discrimination of CAD
significance.
Recently, So et al described a new quantitative dynamic
CTP technique for measuring Myocardial Perfusion Reserve
(MPR) and Volume Reserve (MVR) and studied their rela-
tionship with coronary stenosis in 26 patients with known
CAD [87]. Combination of MPR and MVR was a better
predictor of ≥50 % stenosis on XA than isolated MPR or
MVR. Wang et al studied the feasibility of a combined
adenosine-stress dynamic CTP and CTA protocol using
128-DSCT for detecting myocardial ischemia [85]. In this
30-patient study, integration of CTP with CTA improved the
diagnostic accuracy for detection of functionally significant
CAD as defined by QCA + SPECT. Ko et al studied 45
patients with known CAD using DSCT CTA and adenosine-
stress dual-energy CTP [86]. Once more, combination of
CTA and CTP improved diagnostic accuracy for the detec-
tion of stenosis ≥50 % on XA [86]. Per-vessel sensitivity
and specificity achieved 93 % and 86 %, respectively.
Very recently, the results of the first multicenter trial
involving stress-CTP (CORE-320) were presented in the
2012 European Congress of Cardiology. This trial enrolled
381 patients clinically referred to XA from 16 centers of
8 different countries. In this population with suspected or
known CAD, the integration of CTA and CTP increased the
global performance of MDCT from an AUC of 0.81 to 0.87
(P<0.001), having >50 % stenosis in a territory with posi-
tive SPECT as reference. Furthermore, there were no signif-
icant differences between the combination of CTA and CTP
vs XA + SPECT for the prediction of revascularization at
30 days. These results were not published until the date of
current manuscript.
Validation Against Invasive Fractional Flow Reserve
Only 2 recent studies have validated CTP against FFR assess-
ment. Bamberg et al used a dynamic CTP protocol in 33
patients, of whom 22 had FFR ≤0.75 or stenosis >85 % on
XA [72]. The use of estimated myocardial blood flow (MBF)
to determine the significance of lesions depicted with CTA,
reclassified 43 % of those into “not hemodynamically rele-
vant”, significantly increasing PPV [72]. The authors conclud-
ed that dynamic CT-derived estimates of MBF provide
incremental diagnostic value for the detection of functionally
significant CAD.
In 42 patients considered for revascularization, with at
least 1 stenosis ≥50 % on XA, a 320-detector CTP + CTA
combined protocol was evaluated, having FFR ≤0.80 as the
reference-standard [88]. This approach identified patients
with hemodynamically significant stenoses with 87 % sen-
sitivity and 95 % specificity. Global accuracy (90 %) was
significantly improved using functional and morphologic
integration [89].
CT-Derived Fractional Flow Reserve (CT-FFR)
One of the most astonishing developments in recent years in
the field of cardiovascular CT is the emergence of a method
108 Curr Cardiovasc Imaging Rep (2013) 6:102–116
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to estimate the FFR of any point of the coronary tree
based on a conventional rest CTA acquisition. As it relies
solely in the acquisition of an ordinary CTA scan, CT-FFR
does not require additional contrast administration or radiation
exposure.
CT-derived FFR (CT-FFR) is based on computational
fluid dynamics and requires modern computing power for
its calculation. A detailed analysis of coronary anatomy, as
well as knowledge or estimation of physiological condi-
tions, like mean aortic pressure (derived from measurement
of blood pressure), resting coronary flow and coronary
microcirculatory resistance is needed. In the absence of
acute myocardial ischemia, the method assumes that resting
coronary blood flow is proportional to myocardial mass and
that coronary microcirculatory resistance is non-linearly
inversely proportional to the size of the epicardial vessel.
Finally, the reaction of the microvasculature to adenosine is
assumed to be maximal hyperaemia. Viscosity and density
of blood are related to haematocrit values and, from there,
velocity and pressure of blood in the coronaries is calculated
[90].
A pair of studies validated the use of this technique
against invasive FFR ≤0.80 as reference-standard. In the
DISCOVER-FLOW [91•] study, 103 stable angina patients
referred for clinically indicated XA + FFR underwent CTA,
which identified at least 1 stenosis ≥50 % in a major coro-
nary artery [91•]. CT-FFR reduced the number of false
positives, resulting in a higher PPV (85 % vs 58 %), without
a decrease in NPV (81 % vs 80 %) in per-patient analysis
[91•]. Accuracy of CT-FFR was higher than isolated CTA
independently of the image quality, heart-rate, signal-to-
noise ratio, coronary calcification, motion and contrast
opacification [92].
In the DeFACTO [93•] multicenter trial, CT-FFR was
performed in 252 patients having invasive FFR ≤0.80 as
reference-standard. CT-FFR was associated with an im-
proved diagnostic accuracy compared with isolated CTA
but the pre-specified primary end-point (improvement in
per-patient diagnostic accuracy such that the lower bound-
ary of the 95 % confidence interval exceeded 70 %) was not
reached. One of the major advantages of this study is that,
for the first time, CTA was tested against a functional
invasive standard and not an anatomical standard. Therefore
– and due to the inclusion of patients with intermediate to
high pretest likelihood – the reported accuracy (64 %) was
much lower than previously published, with a sensitivity of
84 % and specificity of 42 %. These results highlight the
importance of defining the correct gold-standard for com-
parison of techniques. Current scientific evidence points out
that functional and not morphologic standards should be
used for the diagnosis of significant CAD and decision
management [94]. Previously reported CTA performances
should therefore be interpreted under this new perspective of
functionally significant CAD. One main limitation of this
study, which is generalizable to all the studies involving CT-
FFR assessment to date, is the “black-box” policy concerning
the methodology for CT-FFR estimation. As stated by Patel in
his editorial to the paper, “future studies will need to have
local sites rather than core laboratories performing, analyzing,
and interpreting the images to provide a sense of real-world
function” [95].
Conclusions
Evidence shows that the clinical significance of CAD
should be assessed using functional methods. In this con-
text, CMR-MPI is positioned as a noninvasive, ionizing
radiation-free technique that has been widely validated in
the clinical setting. MDCT has been classically used as a
purely anatomical method, especially indicated for docu-
mentation or exclusion of CAD. In recent years, research
is being undertaken aiming to improve the ability of MDCT
to discriminate the functional significance of CAD. Stress-
rest CTP is currently the most promising technique and has
proven to correlate with CMR. Another interesting concept
has recently emerged and promises to revolutionize this
field: the development of CT-derived FFR estimations using
CTA scans. Both techniques are currently being validated
and bring the promise of better MDCT performance in this
context.
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Background: Cardiac magnetic resonance myocardial perfusion imaging (CMR-MPI) is considered a state of the
art non-invasive modality for the detection of reversible ischemia. Recent studies have shown its utility in the
diagnosis of coronary artery disease (CAD) and superiority over other established techniques. However, only a
few studies compared CMR-MPI against the invasive standard including fractionalﬂow reserve (FFR) and clinical
validation in non-specialized centers is scarce. The aim of this study was to validate CMR-MPI in a real-world
clinical environment and to test its diagnostic accuracy in symptomatic patients with suspected CAD versus
FFR as the reference standard of functionally signiﬁcant disease.
Methods and results: 103 symptomatic consecutive patients (62±8.0 years, 66%males) with suspected CAD and
intermediate or high probability of disease underwent sequential CMR and invasive coronary angiography (XA).
The CMR protocol included stress-rest adenosine perfusion, SSFP cine imaging and late-enhancement imaging.
Functionally signiﬁcant CAD was deﬁned as occlusive/sub-occlusive stenoses on XA or non-occlusive stenoses
with a FFR measurement of b0.80 in vessels >2 mm. On a patient-based model, CMR-MPI had sensitivity, spec-
iﬁcity, positive and negative predictive values of 89%, 88%, 85%, and 91%, respectively, with a global accuracy of
88%. On a vessel-based analysis, these values were 80%, 93%, 79% and 94%, respectively, with a global accuracy of
90%.
Conclusions: CMR-MPI had a very high accuracy for detection of functionally signiﬁcant CAD as assessed by FFR
in patients with intermediate to high pretest probability.
© 2012 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Coronary artery disease (CAD) is one of themajor causes of morbid-
ity andmortality inwestern countries [1]. Since CAD is treatable, efforts
must focus on prevention and detection of the early stages of disease,
avoiding progression to irreversible damage (myocardial infarction
and heart failure) [2,3]. Therefore, it is essential to develop reliable
non-invasive methods, capable to correctly identify the presence of
CAD and to guidemanagement [4]. Nuclear Imaging and Stress Echocar-
diography are most established for the diagnosis of myocardial ische-
mia. However, these techniques are limited by low spatial resolution
and/or exposure to ionizing radiation [5]. Single-photon emission com-
puterized tomography (SPECT) is limited by attenuation artifacts
contributing to false positive and balanced ischemia may lead to false
negative results in the presence of multivessel disease. In recent years,
cardiac magnetic resonance myocardial perfusion imaging (CMR-MPI)
has evolved into a robust technique and is starting to challenge previ-
ously establishedmethods [6]. CMR-MPI integrates anatomic and func-
tional information in a single exam, with high spatial and temporal
resolution [7] without exposing the patient to harmful radiation [8,9].
It compares favorably to SPECT, positron emission tomography, and in-
vasive coronary angiography (XA) [10–12]. However, the majority of
these studies have been conducted in highly specialized CMR centers
and/or academic research facilities. Therefore, onemay argue that diag-
nostic accuracy may not be the same in routine clinical practice of
non-academic hospitals. In fact, the discrepant results between the
single-center “CE-MARC” trial [13] – showing CMR-MPI superiority
over SPECT – and the “MR-IMPACT II” multicenter clinical trial [14] –
reporting non-inferiority – highlight the importance of this discussion.
Furthermore, most studies tested CMR-MPI against an anatomical
standard as quantitative coronary angiography (QCA) as assessed by
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XA, which may underestimate the performance of this functional test.
Only a few studies compared CMR-MPI against the functional
reference-standard, fractional ﬂow reserve (FFR), reporting excellent
accuracy for the diagnosis of functionally signiﬁcant CAD [15,16].
We thought to evaluate the diagnostic performance of CMR-MPI for
ischemia detection in the clinical setting of a tertiary non-academic car-
diology center, using invasive FFR as the reference standard.
2. Methods
2.1. Population
During a 22-month period (February 2010 to November 2011) we prospectively
screened 176 consecutive patients referred by general physicians to our hospital outpatient
cardiology clinic due to clinical suspicion of CAD. Inclusion criteria of the study were:
age>40 years, symptoms compatible with CAD and ≥2 risk factors and/or a
positive/inconclusive treadmill test. Exclusion criteria included unstable clinical
status, previous myocardial infarction, previous coronary artery bypass grafting, pre-
vious percutaneous coronary intervention, valvular heart disease, pregnancy, atrial
ﬁbrillation, renal insufﬁciency (creatinine clearance≤60 ml/min) and standard con-
traindications to CMR, adenosine, and gadolinium. A total of 139 eligible patients,
were tested for exclusion criteria. Fig. 1 summarizes the study ﬂow and reasons for
exclusions.
The ﬁnal population consisted of 103 individuals (average age 62±8.0 years, 66%
males) with an intermediate or high pre-test probability for CAD according to the modi-
ﬁed Diamond–Forrester score [17]. Patient characteristics are summarized in Table 1.
The study protocolwas approved by the local research ethics committee and complies
with the declaration of Helsinki. Written informed consent was obtained from all
participants.
2.2. Study design
All the subjects that composed the ﬁnal study population underwent the same
protocol, as summarized in Fig. 1.
All patients gave written informed consent. Patient demographics (including symp-
toms, previous clinical history, known risk factors, previous examinations and medica-
tion) were obtained from a standardized health questionnaire and referral letters.
Physical examination (including measurement of abdominal circumference, height,
weight, resting heart rate and blood pressure) was performed.
Fig. 1. Study ﬂow-chart and reasons for exclusions.
Table 1
Population characteristics.
Number of patients (n) 103
Male sex 68 (66%)
Age (yrs) 62±8.0
Body-mass index (kg/m2) 28.0±4.47
Symptoms 103 (100%)
Typical angina 26 (25%)
Atypical angina 50 (49%)
Chest pain 22 (21%)
Dyspnoea on exertion/fatigue 5 (5%)
Hypercholesterolemia 82 (80%)
Hypertension 61 (73%)
Diabetes mellitus 40 (39%)
Positive smoking history 34 (33%)
Current smoker 14 (14%)
Ex-smoker 20 (19%)
Family history of premature CAD 21 (20%)
≥2 CRF 87 (85%)
Systolic blood pressure (mm Hg) 149±25.2
Diastolic blood pressure (mm Hg) 78±11.1
Abdominal circumference (cm) 98±10.3
Modiﬁed Diamond–Forrester score 14.2±2.6
On regular medication 92 (89%)
Aspirin or clopidogrel 55 (53%)
Statin 67 (65%)
ACEi or A2 receptor blockers 54 (52%)
β-Blocker 34 (33%)
Any stenosis>40% 53 (51%)
Any signiﬁcant stenosis (FFRb0.75) 42 (41%)
Single-vessel disease 23 (22%)
Double-vessel disease 12 (12%)
Triple-vessel disease 7 (7%)
Left main disease 5 (5%)
Values are n (%) or mean±SD unless otherwise stated. ACEi = angiotensin converting
enzyme inhibitor. A2 = angiotensin 2.
766 N. Bettencourt et al. / International Journal of Cardiology 168 (2013) 765–773
 85 
Patients underwent CMR-MPI one week before XA. At the time of XA, FFR was
measured in all major patent epicardial coronary arteries with a visually estimated ste-
nosis diameter of above 40%.
CMR results were not provided to the CMR readers or to the interventional cardi-
ologists, in order to allow a blinded study design and to avoid inﬂuencing the clinical
management and XA interpretation.
2.3. Patient preparation
Patients were sequentially referred for CMR and XA. Patients were instructed to re-
frain from smoking, coffee, tea, aminophylline, beta-blockers, calcium-channel antago-
nists and nitrates for 24 h before both procedures.
2.4. CMR protocol
Before scanning, one 18-gauge venous cannula for gadolinium administration was
inserted on a right antecubital vein and one 18–22-gauge line for adenosine infusion
was placed on a left antecubital vein. ECG and noninvasive blood pressure monitoring
were established. A 1.5 T Siemens Symphony TIM, Siemens, Erlangen, Germany with a
6-channel anterior chest coil combined with a 6-channel spinal coil within the gantry
table was used.
After scout images, 3 short-axis slices (basal, mid-ventricular and apical)
were planned. Maximal hyperemia was achieved with intravenous adenosine
(140 μg.kg−1.min−1) infusion for 5 min. Within the last 2 min of infusion, a bolus
of gadobutrol (Gadovist, Bayer HealthCare Pharmaceuticals, Berlin, Germany), was
injected at a rate of 4 mL/s with a power injector (MedRad Europe, Maastricht, Neth-
erlands) using the dedicated right antecubital vein 18-gauge access. The gadolinium
dose used was 0.07 mmol/kg. The 3 short-axis slices were imaged during the ﬁrst
pass of the bolus of gadolinium using a gradient echo pulse sequence with a single
saturation pre-pulse per R–R interval shared over the three slices. Typical sequence
parameters were: echo time, 1.18 ms; repetition time, 192 ms; inversion time,
110 ms; ﬂip angle, 12°; slice thickness, 10 mm; ﬁeld of view, 290–460 mm; matrix,
192×128 mm; in-plane spatial resolution, 1.5–2.4 mm [2]; bandwidth, 789 Hz per
pixel. Patients were asked to hold their breath on full expiration for the duration of
the ﬁrst pass of the gadolinium bolus. The duration of the scan varied according to
the patient's heart rate and was continued for 50 cardiac cycles. During adenosine in-
fusion, patient symptoms, heart rate, blood pressure, and electrocardiogram were
monitored. Adenosine infusion was discontinued immediately after the stress CMR
perfusion acquisition. After a pause ≥2 min, long- and short-axis cine images were
obtained using a steady-state free precession sequence with retrospective gating during
an end-expiratory breath hold. Short-axis coverage of the entire cardiac volume was
performed, to allow volumetric and functional analyses. Ten minutes after the ﬁrst gado-
linium injection, perfusion imaging was repeated at rest, using the same parameters used
for the stress acquisition. Additional gadolinium (0.06 mmol/kg) was then administered,
in order to achieve a total of 0.2 mmol/kg for late gadolinium-enhancement imaging. For
the latter, a phase-sensitive inversion-recovery sequence was used≥10 min after the last
administration of contrast. Fig. 2 represents the simpliﬁed scheme of CMR protocol.
2.5. CMR analysis
Two experienced (level III SCMR) independent readers (A.C. and A.S., 7 and
5 years of training, respectively), who were blinded to all patient clinical information
and to previous test results analyzed all CMR images. In cases of disagreement between
observers, a third blinded level III reader (N.B., 5 years of training) adjudicated.
Perfusion defects were deﬁned as subendocardial or transmural visually dark myo-
cardial areas when compared with remote healthy myocardium, persisting for at least
10 frames. In case of circumferential perfusion defects the epi- to endocardial wash-in
dynamic of the contrast was also evaluated. The stress and rest perfusion scans were
viewed simultaneously, and areas of hypoperfusion were assigned to the ventricular
segments, using the standard American College of Cardiology/American Heart Associa-
tion 17-segment model, excluding the apex [18]. Each of the 16 segments was classi-
ﬁed based on the presence and transmurality of perfusion defects using a 4-point
scoring system (from normal/no defect to transmural defect). Readers were also
asked to identify the potential vessel (s) involved [18]. Perfusion defects were then
classiﬁed as caused by ischemia or scar — integrating the information obtained from
functional analysis, perfusion, and late gadolinium enhancement imaging. Image qual-
ity and degree of conﬁdence were classiﬁed independently using four-class scales:
from poor to excellent and from very unconﬁdent to very conﬁdent, respectively.
2.6. X-ray coronary angiography and FFR assessment
XA was performed according to standard techniques by experienced cardiologists.
Vascular access was obtained through a femoral or radial approach with Seldinger tech-
nique using 5 to 7 French catheters. The operators were unaware of the CMR results and
were asked to analyze all the coronary segments assigning the visually perceived stenoses,
to one of two groups (≤40% and >40% diameter stenosis). In case of a stenosis severity
above 40% a pressure wire (Pressure Wire Certus, St Jude Medical, St Paul, MN, USA)
was used to determine the FFR under steady-state hyperemia induced by adenosine infu-
sion (140 μg/kg/min during 3–6 min) and recorded on RadiAnalyzer (Jude Medical, St
Paul, MN, USA). This procedure was repeated for all the coronary arteries and major
branches with visually perceived moderate to severe stenoses. Arteries were recorded
as having signiﬁcant ﬂow-limiting disease if they had an FFR valueb0.80, if they were oc-
cluded or subtotally occluded, or if there was angiographically severe left main stem dis-
ease. This functionally signiﬁcant CAD was deﬁned as the reference standard against
which CMR-MPI was compared.
2.7. QCA analysis
QCA was performed with automated edge detection software, which calibrates using
the coronary guide catheter as its reference diameter (Siemens Leonardo XP, IC3D v
1.6.8.83A, Paieon, Siemens AG, Berlin and Munich, Germany). Two independent readers,
blinded to patient details, pressure wire and CMR results marked the region of interest
within a coronary artery that they thoughtwas themost severe region of coronary arterial
disease. From these results, the percent diameter stenosis was calculated. Since there was
not a signiﬁcant difference between these two measurements (mean bias 0.40 [95% CI−
0.95–1.76]; r=0.95), their average was used for analysis.
2.8. Assignment of CMR perfusion segments to the corresponding vascular territory
To ensure correct association of the 16myocardial segmentswith the correct vascular
territory, angiographic visualization of vessel dominancewas used to decide if the inferior
and inferoseptal territories were supplied by the right coronary artery or the left circum-
ﬂex. For the distal segment of the inferior wall, an eventual LAD supply was also consid-
ered. Additionally, the basal and mid anterolateral segments were assigned to the left
circumﬂex or left anterior descending vessel depending on whether obtuse marginal or
diagonal branches were responsible for the blood supply of those territories [18].
2.9. Statistical analysis
Functionally signiﬁcant CAD was deﬁned on patient- and vessel- basis.
The diagnostic performance of CMR-MPI for the detection of functionally signiﬁcant
CAD was compared against FFR as the reference standard. Sensitivity, speciﬁcity, PPV,
NPV and overall accuracy were estimated having FFRb0.80 as a gold standard indicating
the true disease status. In order to allow comparisons with other studies, another FFR
cut-off value (FFRb0.75) and an anatomic standard using QCA (diameter stenoses≥70%)
were also tested. To test if scar detection could furthermore improve CMR-MPI
Fig. 2. Simpliﬁed scheme of CMR protocol.
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performance for detection of CAD, another protocol was tested in which patients/
territories with detected scar were classiﬁed as positives for CAD, independently of the
perfusion results (CMR-MPI+Scar). Ninety-ﬁve percent conﬁdence intervals were calcu-
lated based on the binominal distribution. CMR-MPI intra-observer and inter-observer
agreements were tested. The Cohen's kappa statistic was used to assess agreement. All
data were tested for normality using the Kolmogorov–Smirnov test and are described as
means and standarddeviations for continuous variables and as percentages for categorical
variables. Differences in continuous variableswere assessed using Student paired t tests. A
p value b0.05was considered signiﬁcant. Data analysiswas performed using SPSS analysis
software (Release 17, SPSS Inc., Chicago, Illinois).
3. Results
All the 103 patients completed the study protocol without adverse
effects. All CMR scans were performed within 9±8 days before XA.
3.1. CMR scans
The technical quality of all the ﬁnal population CMR scans was
thought to be adequate for visual diagnostic purposes. Based on both
observers, image quality was classiﬁed as poor in 2 (2%) patients, mod-
erate in 21 (20%), good in 57 (55%) and excellent in 23 (22%) patients.
Conﬁdence in the diagnosis varied from “very unconﬁdent” in 2 pa-
tients (2%) and “unconﬁdent” in 6 (6%) to “conﬁdent” or “very conﬁ-
dent” in 62 (60%) and 33 (32%), respectively.
Forty-seven (46%) of the 103 patients and 76 (25%) of the 309
vascular territories had perfusion abnormalities suggestive of ische-
mia during stress (examples in Fig. 3). There were 32 (10%) defects
in the left anterior descending coronary artery territory, 19 (6%) in
the left circumﬂex/obtuse marginal artery territory, and 25 (8%) in
the right coronary artery territory. In 6 patients a pattern of slow cir-
cumferential wash-in centripetal perfusion (from the epicardium to
the endocardium) was described and interpreted by CMR readers as
probable microvascular disease (Fig. 4).
Agreement between observers was assessed on the identiﬁcation of
abnormal perfusion per patient, which produced a kappa of 0.58, indi-
cating substantial agreement. Both observers agreed on the exact pat-
tern of perfusion in 64 scans (62%), and the third observer adjudicated
on the remaining 39 cases (34%) — where the per-vessel analysis
differed.
Myocardial LGE was visualized in 25 patients. In 17 of those cases
the LGE pattern was suggestive of ischemic etiology (Fig. 5). In 8 pa-
tients, however, an intramural or subepicardial pattern was
detected. Inter-observer agreement for ischemic scar detection was
good (kappa=0.72).
3.2. QCA results
QCA was performed on all 140 coronary arteries (68 patients) with
visually perceived stenoses on XA. QCA detected stenoses ≥70% in 65
vessels (42 patients). There were also 5 cases in which QCA conﬁrmed
≥50% stenoses of the left main stem; as these patients also had other
vessels with high-grade (≥70%) stenoses, a total of 42 patients were
considered positive for relevant CAD using this anatomical threshold.
3.3. FFR results
Fifty-three patientswith visually perceived diameter stenosis higher
than 40% were considered for FFR assessment. Arteries without any
Fig. 3. Cases illustrating CMR-MPI and angiographic ﬁndings in patients with functionally signiﬁcant CAD. A. A 61 year old woman with diabetes, dyslipidemia and hypertension
with typical chest pain. Reversible hypoperfusion during stress imaging involving different coronary artery territories was interpreted by the CMR readers as probable
three-vessel CAD. During coronary catheterization anatomically signiﬁcant stenosis (≥70%) was detected in LAD, RCA and Obtuse Marginal (arrowheads) but FFR conﬁrmed func-
tionally signiﬁcant stenoses in only 2 of those vessels (FFR=0.77 in LAD, 0.6 in RCA and 0.81 in obtuse marginal). B. A 73 year old diabetic, dyslipidemic and hypertensive male with
family history of CAD presenting with atypical angina. A reversible dark area of hypoperfusion was detected in the mid and apical segments of the anterior and septal wall, as well as
in the distal segment of the inferior wall. Readers correctly identiﬁed LAD as having functionally signiﬁcant CAD (FFR=0.65) but incorrectly assumed additional stenoses of the RCA
due to the involvement of the inferior wall. However, as can be seen in XA (*), this area was also supplied by the long LAD, surrounding the ventricular apex. C. A 68 year old
ex-smoker male with hypertension and dyslipidemia presenting with atypical chest pain. Localized and reversible perfusion defect during stress perfusion restricted to the inferior
wall was correctly identiﬁed as signiﬁcant RCA disease. RCA was found to be functionally occluded at the ostium (arrowhead) during XA.
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identiﬁable plaque (n=181) or with mild disease (stenosis visually
perceived as ≤40%) (n=31) had no FFR measurements. Vessels with
a luminal diameter b2 mm (n=10) were also excluded from this
analysis.
There were 20 completely occluded arteries and 11 sub-totally oc-
cluded arteries in which FFR could not be measured. Additionally, in 9
vessels – with long areas of severe, heavily calciﬁed, and complex dis-
ease associated with tortuous anatomy, and/or low TIMI ﬂow after
intra-coronary nitrates – FFR assessment was considered to be of unac-
ceptable risk to the patient; therefore, in accordance to the study proto-
col, it was not performed. Furthermore, in the 5 patients with left main
stem disease (QCA≥50%) FFR was not performed in any vessel of the
left coronary artery. All these lesions where FFR could not be measured
due to anatomy or disease complexity were considered positive for the
purpose of the comparison with CMR-MPI.
A total of 37 diseased, non-occluded vessels, were evaluated using
FFR invasive assessment. Of those, 25 (67%) had an FFRb0.80. Mean
FFR was 0.80±0.12 (0.54–1.00).
According to the described protocol 75 arteries (24%) were consid-
ered positives for functionally signiﬁcant CAD (including occluded/
sub-occluded arteries and non-occluded vessels with a FFRb0.80).
Single-vessel disease was seen in 24 (23%) patients; 13 (13%) had
double-vessel disease, and 8 (8%) had triple-vessel disease.
3.4. Patient- and vessel-based analysis
Diagnostic patient- and vessel-based performances using FFRb0.80
as reference standard are summarized in Table 2. Table 3 represents
the same analysis using FFRb0.75 as reference. Ability to detect
relevant CAD as assessed by QCA (≥70% stenosis) is summarized in
Table 4.
Of the 47 patients with a perfusion defect on their CMR scan, 40 (85%)
had a FFRb0.80 in at least 1 coronary artery (7 false-positives); of the 56
patientswithnoperfusion defects onCMR, 5were false-negative patients.
Using this FFR threshold, CMR-MPI had sensitivity of 89%, speciﬁcity of
88% and global accuracy of 88%. As could be expected, the use of an ana-
tomic standard as reference (QCA≥70%)was associatedwith a decreased
performance of themethod, with sensitivity of 88% and speciﬁcity of 84%,
achieving a global accuracy of 85%. Integration of scar detected in LGE into
the CMRanalysis algorithmdid not improve overall accuracy or any of the
components of CMR diagnostic performance.
Microvascular disease patternwas described in 6 patients. Those pa-
tients were correctly identiﬁed as having no signiﬁcant epicardial CAD.
In 2 additional cases, microvascular disease was also considered in the
differential diagnosis of multi-vessel disease. In those cases, CMR was
taken as positive for CAD and no epicardial CAD was found on XA
(false-positives) (Fig. 4).
For vessel-based analysis, areas of perfusion defects in CMR-MPI
were identiﬁed using the 16 myocardial segments. Each of these myo-
cardial segmentswas assigned to one of the 3 “main vessels” (Right cor-
onary artery, Left anterior descending artery and Circumﬂex artery). A
total of 309 vessels (103 patients×3) were used in this analysis. Vessel
dominance and branch distribution obtained from angiography were
used to ensure a correct association of the detected defect with the vas-
cular territory, as previously described.
In vessel-based analysis CMR-MPI had a sensitivity of 80%, speciﬁcity
of 93% and global accuracy of 90%. Oncemore, when anatomy is used as
reference standard performance is lower: sensitivity of 78%, speciﬁcity
of 90% and global accuracy of 87%. Similarly to the per-patient analysis,
integration of scar-detection in the interpretation algorithmdid not im-
prove overall performance in per-patient analysis—whatever the refer-
ence standard used.
Fig. 4. Cases illustrating CMR-MPI and angiographic ﬁndings in patients with probable microvascular disease and no obstructive epicardial CAD. A. A 64 year old hypertensive and
dyslipidemic male with typical chest pain. An almost circular dark pattern during stress CMR-MPI was interpreted by the CMR blinded observers as possible microvascular disease
but multivessel disease could not be excluded according to their judgment (taken as false-positive as per-protocol). B. This pattern was also suggested by CMR-readers in this hy-
pertensive and dyslipidemic 73 year old women. However, as an alternative diagnosis of 2-vessel-disease (LCX and LAD) was also considered and no stenoses were found on XA,
this case was reported as false-positive. C. A 58 year old woman with diabetes, hypertension and dyslipidemia with doubtful chest pain. The CMR pattern of hypoperfusion was
considered typical for microvascular disease and, therefore, CMR-MPI was reported as negative (true negative).
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4. Discussion
The main ﬁnding of our study is that CMR-MPI has very good accu-
racy for the detection of functionally signiﬁcant CAD in symptomatic
patients with intermediate or high pre-test probability. Our results
show the high sensitivity and speciﬁcity of CMR stress perfusion, both
in patient- and in vessel-based analysis. These results were obtained
in a real world clinical cardiology setting, using standard, widely
available acquisition sequences and a common 1.5 Tesla clinical CMR
scanner. Importantly we were able to conﬁrm the excellent perfor-
mance of CMR stress perfusion thatwas previously reported fromhighly
specialized centers [13,19,20].
As reference standard for CAD, we used invasive XA with pressure
wire-derived fractional ﬂow reserve (FFR) assessment. The vast major-
ity of studies published so far tested CMR-MPI for the diagnosis of CAD
using quantitative XA (QCA) or visual assessment of the degree of
Table 2
Patient-based and vessel-based analysis of CMR-MPI in predicting functionally signiﬁcant CAD (FFRb0.80).
CAD (%) n TP TN FP FN k Sensit. (%) Specif. (%) PPV (%) NPV (%) +LR −LR Accu. (%)
Patient-based
CMR-MPI 43.7 103 40 51 7 5 0.76 89 (79–95) 88 (80–93) 85 (76–91) 91 (83–96) 7.37 0.13 88 (80–94)
CMR-MPI+scar 43.7 103 40 50 8 5 0.75 89 (79–95) 86 (78–91) 83 (74–89) 91 (83–96) 6.44 0.13 87 (79–93)
Vessel-based
CMR-MPI 24.3 309 60 218 16 15 0.73 80 (72–86) 93 (91–95) 79 (71–85) 94 (91–96) 11.70 0.21 90 (86–93)
CMR-MPI+scar 24.3 309 62 215 19 13 0.73 83 (74–89) 92 (89–94) 77 (69–82) 94 (92–96) 10.18 0.19 90 (86–93)
RCA
CMR-MPI 20.4 103 19 76 6 2 0.78 90 (72–98) 93 (88–95) 76 (61–83) 97 (93–100) 12.37 0.10 92 (85–95)
CMR-MPI+scar 20.4 103 20 75 7 1 0.78 95 (78–100) 91 (87–93) 74 (61–78) 99 (94–100) 11.16 0.05 92 (85–94)
LAD
CMR-MPI 33.0 103 26 63 6 8 0.69 76 (63–85) 91 (85–96) 81 (67–91) 89 (82–93) 8.79 0.26 86 (78–92)
CMR-MPI+scar 33.0 103 26 63 6 8 0.69 76 (63–85) 91 (85–96) 81 (67–91) 89 (82–93) 8.79 0.26 86 (78–92)
LCX
CMR-MPI 19.4 103 15 79 4 5 0.72 75 (56–87) 95 (91–98) 79 (59–92) 94 (90–97) 15.56 0.26 91 (84–96)
CMR-MPI+scar 19.4 103 16 77 6 4 0.70 80 (60–92) 93 (88–96) 73 (55–84) 95 (90–98) 11.07 0.22 90 (83–95)
Accu. = accuracy; CAD = Coronary artery disease; CMR-MPI = cardiac magnetic resonance myocardial perfusion imaging; FN = false-negative; FP = false-positive; k = kappa
value; PPV = positive predictive value; NPV = negative predictive value; Sensit. = sensitivity; Specif. = speciﬁcity; TN = true-negative; TP = true-positive; +LR = positive like-
lihood ratio; −LR = negative likelihood ratio.
Fig. 5. Cases illustrating CMR-LGE, and angiographic ﬁndings in patients with ischemic scar. A. A 67 year old woman with hypercholesterolemia and familiar history of CAD.
CMR-LGE identiﬁed transmural scar in the basal segments of the inferior and inferolateral left ventricular wall (arrows). Sub-occluded LCX and functionally occluded RCA were
found on XA (arrowheads). B. A 71 year old hypertensive woman with hypercholesterolemia and typical chest pain. Despite the subendocardial scar found on CMR-LGE in the
mid-basal segments of the inferolateral ventricular wall (arrows), no signiﬁcant stenosis was found on XA (myocardial infarction with normal coronary arteries). C. A 72 year
old hypertensive woman with atypical angina. Subendocardial ischemic scar was detected in the inferior wall and distal septum (arrows). Functionally occluded RCA was found
on XA (arrowheads).
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stenoses as the reference standard. However, this approach is limited
since isolated anatomic evaluation cannot accurately predict the func-
tional signiﬁcance of a coronary stenosis; there is compelling evidence
that patients should be guided by the physiological importance of a ste-
nosis rather than luminal assessment [21]. FFR has recently emerged as
a highly successful invasive tool to provide this essential information
and is currently considered the invasive reference standard for
assessing the functional signiﬁcance of an epicardial coronary artery
stenosis and therefore represents a better comparator for the assess-
ment of ischemia [22–24]. It is independent of heart rate, blood pres-
sure, and left ventricular contractility and takes into account the
contribution of collateral ﬂow to myocardial perfusion [25]. Only a
few studies compared CMR-MPI performance against FFR in patients
with clinically suspected CAD [15,19]. Watkins et al. validated visual
analysis of CMR-MPI against FFR, reporting an excellent per-vessel sen-
sitivity (91%) and speciﬁcity (94%) for detection of functionally signiﬁ-
cant CAD, using a FFR cut-off value of 0.75 as reference. In our study,
based in prognostic studies recently published, a different FFR cut-off
value (0.80) was used as reference standard. The 0.80 threshold proved
its utility in the management of patients referred for XA and is increas-
ingly used as the invasive reference in clinical practice [23,24]. Interest-
ingly, however, the use of a FFR reference of 0.75 would improve the
overall performance of CMR-MPI in our study with an increase in sensi-
tivity to 93% which is similar to the results presented by Watkins et al.
Taken together, both studies show a very good performance of
CMR-MPI for the diagnosis of functionally signiﬁcant CAD. CMR-MPI
performed better both in vessel-based and in patient-based analysis
when the functional standard (FFR) is used as opposed to QCA (diame-
ter stenosis≥70%).
CMRprovides comprehensive assessment of perfusion, function and
detailed scar imaging without radiation exposure and is increasingly
used for clinical decision making [4,26–28]. In our study ischemic scar
was detected in a signiﬁcant proportion of patients. Interestingly, the
integration of that ﬁnding into the diagnostic protocol did not improve
CMR-MPI global performance for detection of functionally signiﬁcant
CAD; this occurred because the majority of patients with ischemic scar
Table 3
Patient-based and vessel-based analysis of CMR-MPI in predicting functionally signiﬁcant CAD (FFRb0.75).
CAD (%) n TP TN FP FN k Sensit. (%) Specif. (%) PPV (%) NPV (%) +LR −LR Accu. (%)
Patient-based
CMR-MPI 40.8 103 39 53 8 3 0.78 93 (83–98) 87 (80–90) 83 (74–88) 95 (87–99) 7.08 0.08 89 (81–94)
CMR-MPI+scar 40.8 103 39 52 9 3 0.76 93 (83–98) 85 (78–89) 81 (72–86) 95 (87–99) 6.29 0.08 88 (80–93)
Vessel-based
CMR-MPI 22.3 309 58 222 18 11 0.74 84 (75–91) 93 (90–94) 76 (68–82) 95 (93–97) 11.21 0.17 91 (87–94)
CMR-MPI+scar 22.3 309 60 219 21 9 0.74 87 (78–93) 91 (89–93) 74 (68–79) 96 (93–98) 9.94 0.14 90 (86–93)
RCA
CMR-MPI 19.4 103 19 77 6 1 0.80 95 (77–100) 93 (88–94) 76 (62–80) 99 (94–100) 13.14 0.05 93 (86–95)
CMR-MPI+scar 19.4 103 20 76 7 0 0.81 100 (83–100) 92 (88–92) 74 (62–74) 100 (96–100) 11.86 0.00 93 (87–93)
LAD
CMR-MPI 29.1 103 24 65 8 6 0.68 80 (65–90) 89 (83–93) 75 (61–85) 92 (85–96) 7.30 0.22 86 (78–92)
CMR-MPI+scar 29.1 103 24 65 8 6 0.68 80 (65–90) 89 (83–93) 75 (61–85) 92 (85–96) 7.30 0.22 86 (78–92)
LCX
CMR-MPI 18.4 103 15 80 4 4 0.74 79 (59–91) 95 (91–98) 79 (59–91) 95 (91–98) 16.58 0.22 92 (85–97)
CMR-MPI+scar 18.4 103 16 78 6 3 0.73 84 (64–95) 93 (88–95) 73 (55–82) 96 (92–99) 11.79 0.17 91 (84–95)
Accu. = accuracy; CAD = coronary artery disease; CMR-MPI = cardiac magnetic resonance myocardial perfusion imaging; FN = false-negative; FP = false-positive; k = kappa
value; PPV = positive predictive value; NPV = negative predictive value; Sensit. = sensitivity; Specif. = speciﬁcity; TN = true-negative; TP = true-positive; +LR = positive like-
lihood ratio; −LR = negative likelihood ratio.
Table 4
Patient-based and vessel-based analysis of CMR-MPI in predicting degree of stenoses by QCA (≥70%).
CAD (%) n TP TN FP FN k Sensit. (%) Specif. (%) PPV (%) NPV (%) +LR −LR Accu. (%)
Patient-based
CMR-MPI 40.8 103 37 51 10 5 0.70 88 (77–95) 84 (76–88) 79 (69–85) 91 (83–96) 5.37 0.14 85 (76–91)
CMR-MPI+scar 40.8 103 37 50 11 5 0.69 88 (77–95) 82 (74–87) 77 (67–83) 91 (82–96) 4.89 0.15 85 (75–90)
Vessel-based
CMR-MPI 21.0 309 51 219 25 14 0.87 78 (69–86) 90 (87–92) 67 (59–74) 94 (91–96) 7.66 0.24 87 (83–91)
CMR-MPI+scar 21.0 309 53 216 28 12 0.64 82 (72–89) 89 (86–91) 65 (58–71) 95 (92–97) 7.11 0.21 87 (83–90)
RCA
CMR-MPI 21.4 103 18 74 7 4 0.70 82 (63–93) 91 (86–95) 72 (56–82) 95 (90–98) 9.47 0.20 89 (81–94)
CMR-MPI+Scar 21.4 103 19 73 8 3 0.71 86 (68–91) 90 (85–93) 70 (55–78) 96 (91–99) 8.74 0.15 89 (82–94)
LAD
CMR-MPI 24.3 103 23 69 9 2 0.74 92 (76–99) 88 (83–91) 72 (59–77) 97 (92–100) 7.97 0.09 89 (82–93)
CMR-MPI+scar 24.3 103 23 69 9 2 0.74 92 (76–99) 88 (83–91) 72 (59–77) 97 (92–100) 7.97 0.09 89 (82–93)
LCX
CMR-MPI 17.5 103 10 76 9 8 0.44 56 (34–74) 89 (85–93) 53 (32–70) 90 (86–94) 5.25 0.50 83 (76–90)
CMR-MPI+scar 17.5 103 11 74 11 7 0.44 61 (39–80) 87 (82–91) 50 (32–65) 91 (86–96) 4.72 0.45 83 (75–89)
Accu. = accuracy; CAD = coronary artery disease; CMR-MPI = cardiac magnetic resonance myocardial perfusion imaging; QCA = quantitative coronary angiography; FN =
false-negative; FP = false-positive; k = kappa value; PPV = positive predictive value; NPV = negative predictive value; Sensit. = sensitivity; Specif. = speciﬁcity; TN =
true-negative; TP = true-positive; +LR = positive likelihood ratio; −LR = negative likelihood ratio.
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also had additional reversible defects compatible with ischemia (al-
ready detected as positives) and because some patients had ischemic
scar with normal coronary arteries (previously undetected myocardial
infarction with normal coronary arteries; see Fig. 5). The absence of ad-
ditional value for diagnostic performance of scar detection found in our
study does not diminish the value of an integrated protocol including
stress-rest perfusion and LGE for scar detection as the latter has proved
a signiﬁcant prognostic impact even when small areas of scar were
detected in patients with unrecognized previous ischemic events [29].
In current clinical practice myocardial ischemia assessment is
often performed using SPECT. CMR-MPI is potentially superior to
this nuclear technique in terms of diagnostic performance — mainly
due to its superior spatial resolution. However, while SPECT is well
established, clinically implemented, and widely available, CMR-MPI
had been restricted to specialized academic centers and only recent-
ly increased its availability and emerged as a clinical tool. Two recent
clinical trials compared these techniques for the diagnosis of CAD using
XA as reference standard [13,14]. Both studies demonstrated good accu-
racy for CMR-MPI to detect CAD and showed that CMR-MPI is, at least,
non-inferior to SPECT. In the “CE-MARC” single-center study, Green-
wood et al. were able to show superiority of CMR-MPI over SPECT in a
population of 752 patients with suspected angina— based on a superior
sensitivity and no differences in speciﬁcity [13]. In the multi-center and
multivendor “MR-IMPACT II” trial, Schwitter et al. proved the primary
end-point of non-inferiority of CMR vs. SPECT for detection of CAD in
a population of 533 patients: in this study the sensitivity of CMR-MPI
was superior to SPECT, while its speciﬁcity was inferior [14]. Both trials
clearly showed that CMR-MPI is a good alternative to SPECT to detect is-
chemia. However, the discrepancies in CMR diagnostic performance
reported could be interpreted as evidence that in a real-world clinical
scenario, the CMR potential superiority for ischemia detection may
not translate directly into signiﬁcant improvements in non-invasive di-
agnosis of CAD. This has to be integratedwith other advantages and dis-
advantages of each method, namely radiation exposure, information
obtained, patient comfort, availability, exam duration and price.
In our study, the entire comprehensive CMR-MPI scan, including
right and left ventricular function and volumes assessment, stress
and rest perfusion analysis and scar imaging was achieved in 30 to
35 min. As our and other studies have shown, this comprehensive
CMR-MPI protocol is readily available in standard CMR scanners and
provides excellent assessment of CAD. Scanner availability may be,
at the moment, a major limitation for CMR-MPI expansion, as mag-
netic resonance magnets are intensively used for other clinical indica-
tions. However, as the vast majority of CMR facilities may be easily
upgraded in order to perform good CMR-MPI scans – and as long as
adequate training is provided – current clinical standards of ischemia
detection may be signiﬁcantly improved with a broader utilization of
CMR-MPI.
4.1. Study limitations
In this single-center study, only patients without known CAD and
with an intermediate or high pre-test probability were included. A
small percentage of patients had to be excluded because of contraindi-
cations, such as renal dysfunction or arrhythmia. Important limitations
of CMR are claustrophobia, as well as CMR-incompatible devices like
pacemakers and implanted deﬁbrillators. In our study, these causes
were responsible for exclusions in a small percentage of cases (5/139
(3.6%) and 0 patients, respectively). However, in other populations –
namely in those with known CAD – the proportion of patients with
implanted devices that cannot be tested using CMR may be signiﬁcant.
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Introduction: Cardiac magnetic resonance myocardial perfusion imaging (CMR-MPI) is considered a state-
of-the-art non-invasive modality for ischemia detection but its additive value in a multiple-test strategy
in patients with suspected coronary artery disease (CAD) is not fully validated. We aimed to evaluate
CMR-MPI integration with exercise treadmill test (ETT) for the diagnostic workup of patients with
suspected CAD, having invasive fractional ﬂow reserve (FFR) as reference standard.
Methods: In this prospective single-center study, patients with suspected CAD underwent sequential ETT,
CMR-MPI and X-ray invasive coronary angiography (XA). Signiﬁcant CAD was deﬁned by the presence of
stenosis N40% with FFR ≤0.8 in vessels N2 mm or ≥90% stenosis/occlusion.
Results: 80 symptomatic patients (68%male, 61 ± 8 years) were enrolled. Compared to ETT, CMR-MPI showed
similar sensitivity (81%) and higher speciﬁcity (93 vs. 58%, p b 0.001) for CAD detection (prevalence = 46%)
translating into better diagnostic performance (AUC 0.87 vs. 0.70; p = 0.002). CMR-MPI improved accuracy in-
dependently of ETT in all patients with high pre-test probability and in intermediate-probability patients but
those with a clearly positive-ETT (symptoms + ST-shift), in whom ETT correctly identiﬁed CAD. In the low-
probability group CMR-MPI was useful as a gatekeeper for XA after a positive-ETT. The best integrating protocol
achieved a global accuracy of 89% (AUC 0.88) and was clearly superior to an approach based solely in ETT (AUC
0.70, p b 0.001), yet similar to isolated CMR-MPI (AUC 0.87, p = ns).
Conclusions: CMR-MPI has high sensitivity and speciﬁcity for CAD detection and may be combined with ETT in a
diagnostic workﬂow aiming to increase accuracy and reduce the number of unnecessary catheterizations.
© 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Coronary artery disease (CAD) remains one of the leading causes of
morbidity and mortality [1]. Clinical suspicion of CAD is a common
cause to refer patients to cardiology and medical history and physical
examinations alone may not be sufﬁcient to detect or exclude CAD
with a high certainty. Subsidiary tests are often needed to conﬁrm the
diagnosis of CAD and assess its functional consequences and the most
appropriate treatment option.
Choosing the best diagnostic test should be driven by patient's
pretest probability of CAD (based on age, gender and typicality of
symptoms) and the accuracy, risks, limitations and costs of available
techniques [3]. Patients deemed to have a high likelihood of CAD can
be directly referred to X-ray invasive coronary angiography (XA) if
symptomatic despite maximal medical therapy, but otherwise beneﬁt
from non-invasive risk stratiﬁcation mainly for prognostic information.
For patients with low likelihood of CAD, the most appropriate non-
invasive diagnostic strategy remains uncertain. The intermediate pretest
population is the group most commonly encountered in the outpatient
clinical setting and most likely to beneﬁt from non-invasive diagnostic
and prognostic testing [3]. A multiple-test strategy has several
advantages over direct referral to catheterization, namely: lower
exposure to ionizing radiation; identiﬁcation of patients who will
actually beneﬁt from revascularization, avoiding decision based
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solely on visual assessment of CAD [4–7]; reduce the need for unneces-
sary invasive investigation and, ultimately, costs. Because of high avail-
ability and low costs, an exercise treadmill testing (ETT) is the most
commonly used test to conﬁrm the cardiac nature of the symptoms
and to provide objective evidence of inducible ischemia. However,
its accuracy is limited, especially in women [8]. Cardiac magnetic reso-
nance (CMR) provides high spatial and temporal resolution images of
myocardial perfusion [9], myocardial function, and scar having proved
utility in the guidance of patients with CAD [10,11]. Adenosine
stress-rest CMR myocardial perfusion imaging (CMR-MPI) has been
favorably compared with other established techniques [12–15]
and proved to have an excellent accuracy for the detection of CAD
when compared to the functional invasive gold-standard, fractional
ﬂow reserve (FFR) [16,17]. However, CMR availability is still limited
and associated costs are relatively elevated. There are numerous re-
ports and meta-analyses of the performance of ETT for the diagnosis
of coronary disease [18–22]. Using exercise ST-depression N0.1 mV
or 1 mm to deﬁne a positive test, the reported sensitivity and speci-
ﬁcity for the detection of signiﬁcant coronary disease range between
23–100% (mean 68%) and 17–100% (mean 77%), respectively [3].
In contemporary meta-analyses, the reported sensitivity and speci-
ﬁcity of vasodilator stress-induced CMR range between 89–91% and
76–81%, on a patient-based analysis [14,23,24].
The main purpose of this study was to compare the diagnostic
accuracy of ETT and CMR-MPI for the detection of signiﬁcant CAD,
using invasive FFR as the reference standard, in a group of symptom-
atic patients referred to our cardiology outpatient clinic. Secondly,
we aimed to identify the best protocol for the diagnosis of CAD
having ETT and CMR-MPI as available non-invasive tests.
2. Methods
2.1. Study design
During a 22-month period (February 2010 to November 2011) we prospective-
ly screened 176 consecutive patients referred by general physicians to our hospital
outpatient cardiology clinic due to clinical suspicion of CAD. Inclusion criteria of the
study were: age N40 years, symptoms compatible with CAD and at least one of
cardiovascular risk factor. Exclusion criteria were: previous myocardial infarction,
previous percutaneous coronary intervention or coronary artery bypass grafting,
unstable CAD, valvular heart disease, pregnancy, renal insufﬁciency (creatinine
clearance ≤60 mL/min) and standard contraindications to CMR, contrast media,
adenosine, and gadolinium. A total of 121 patients were eligible for enrollment.
The pre-test probability for obstructive CAD was estimated using the Diamond
and Forrester classiﬁcation [2], regarding b15% as low, 15–85% as intermediate,
and N85% as high probability. All patients were referred for a sequential protocol
of 3 exams including an ETT, CMR-MPI and XA, within a period of no more than
4 weeks. Before each of these procedures, patients were instructed to refrain
from smoking, coffee, tea, aminophylline, beta-blockers, calcium-channel antago-
nists and nitrates for 24 h. Written informed consent was obtained from all partic-
ipants and the study protocol was approved by the ethical committee of our
institution.
2.2. ETT protocol
Treadmill exercise tolerance testingwasperformedusing the standardBruce protocol.
Candidates for ETTwere capable of performing at leastmoderate physical functioning and
had no disabling comorbidity (including frailty, marked obesity, chronic obstructive
pulmonary disease, or orthopedic limitations). The following data was recorded: resting
heart rate (HR) and blood pressure, peak exercise stress heart rate, exercise duration,
achievement of 85% of age predicted HR and total workload (Metabolic Equivalents,
METS), reason for test termination, reproduction of clinical symptoms, degree of ST
segment shift, presence of arrhythmia and heart rate recovery (HRR) at 1 min. The ETT
was dichotomously classiﬁed in two categories: 1. Suggestive of CAD: reproduction of
clinical symptoms during effort and/or ST-segment elevation or horizontal or down-
sloping ST-segment depression [≥1 mm (0.1 mV) for ≥60–80 ms after the end of the
QRS complex], and2.Not suggestive of CAD: inconclusive or absence of symptoms/abnormal
ST response. In addition each of these two categories was subdivided into two sub-
categories, resulting in four potential outcomes: clearly positive ETT (symptoms plus ST
shift), borderline positive ETT (isolated symptoms or ST shift), inconclusive ETT (85% of
maximumHR or 6METS not achieved in the absence of symptoms or ST shift) and negative
ETT (no symptoms and no ST shift).
2.3. Stress perfusion CMR protocol
CMR-MPI was performed on a 1.5 T scanner (Symphony, Siemens, Erlangen, Germany)
with a 6-channel anterior chest coil and spinal coils within the gantry table. Maximal
hyperemia was achieved with intravenous adenosine (140 μg/kg/min) infusion for
5 min. After scout images, 3 short-axis slices (basal, mid-ventricular and apical)
were planned. Within the last 2 min of infusion, a bolus of Gadobutrol (dose
0.07 mmol/kg) (Gadovist, Bayer HealthCare Pharmaceuticals, Berlin, Germany),
was injected at a rate of 4 mL/s with a power injector (MedRad Europe, Maastricht,
Netherlands). The 3 short-axis slices were imaged during the ﬁrst pass of the bolus
of gadolinium using a gradient echo pulse sequence with a single saturation pre-pulse per
R–R interval shared over the three slices. Typical sequence parameters were: echo time,
1.18 ms; repetition time, 192 ms; inversion time, 110 ms; ﬂip angle, 12°; slice thickness,
10 mm; ﬁeld of view, 290–460 mm; matrix, 192 × 128 mm; in-plane spatial resolution,
1.5–2.4 mm2; bandwidth, 789 Hz per pixel. Patients were asked to hold their breath on
full expiration for the duration of the ﬁrst pass of the gadolinium bolus. The duration of
the scan varied according to the patient's heart rate andwas continued for 50 cardiac cycles.
During adenosine infusion, patient symptoms, heart rate, blood pressure, and electrocardio-
gram were monitored. Adenosine infusion was discontinued immediately after the stress
CMR perfusion acquisition. After a pause of ≥2 min, long- and short-axis cine images
were obtained using a steady-state free precession sequence with retrospective gating
during an end-expiratory breath hold. Short-axis coverage of the entire cardiac volume
was performed to allow volumetric and functional analyses. Ten minutes after the ﬁrst
gadolinium injection, perfusion imaging was repeated at rest, using the same parameters
used for the stress acquisition. Additional gadolinium (0.06 mmol/kg) was then adminis-
tered in order to achieve a total of 0.2 mmol/kg for late gadolinium-enhancement imaging.
Afterwards, a phase-sensitive inversion-recovery sequence was performed ≥10 min after
the last administration of contrast. The exact same sequence parameters were used for all
patient scans during the course of the study. In addition, the ﬁeld of view remained constant
for all perfusion scans. Detailed methodology of CMR-MPI performance and interpretation
was previously described elsewhere [17].
Studies were analyzed on per-patient level using the standard American College of
Cardiology/American Heart Association 17-segment model [25]. Two experienced (level
III SCMR) independent readers (A.C. and A.S., 7 and 5 years of training, respectively),
who were blinded to all patient clinical information and to previous test results analyzed
all CMR images. In cases of disagreement between observers, a third blinded level III read-
er (N.B., 5 years of training) adjudicated. CMR-MPI intra-observer and inter-observer
agreements were tested. The Cohen's kappa statistic was used to assess agreement.
2.4. X-ray coronary angiography and FFR assessment
All X-ray angiograms were performed according to standard techniques. The inter-
ventional cardiologists involved in this procedure were unaware of the CMR-MPI and
ETT results and were asked to analyze all the coronary segments and to characterize all
visually perceived stenosis, assigning them to one of two groups according to
stenosis severity (≤40% and N40%). When stenosis N40% was visually perceived,
FFR was assessed using a pressure wire (Pressure Wire Certus, St Jude Medical, St
Paul, MN, USA) under steady-state hyperemia – obtained with adenosine infusion
(140 μg/kg/min) over 3–6 min – and recorded on RadiAnalyzer (St Jude Medical, St Paul,
MN, USA). Arteries were recorded as having signiﬁcant ﬂow-limiting disease if they had ste-
nosis ≥90% (≥50% in left main stem), or had an FFR measurement ≤0.80. This signiﬁcant
CADwasdeﬁned as the reference standard againstwhichETT andCMR-MPIwere compared.
3. Statistical methods
Sensitivity, speciﬁcity, positive predictive value (PPV) and negative
predictive value (NPV) were estimated for ETT and CMR-MPI having
XA (FFR assessment) as the gold standard indicating the true disease
status. The diagnostic performance of each test for the detection of sig-
niﬁcant CAD was assessed with receiver operating characteristic (ROC)
curve analysis and the respective areas under the ROC curves (AUC or C-
statistics) reported with 95% conﬁdence intervals (CI). Multiple hypo-
thetical protocols were tested according to ETT ﬁnal report and
according to patient pretest probability of CAD and compared using
ROC curves (Table 1). In case of similar diagnostic performances, in
terms of AUC, the authors used a pre-speciﬁed strategy of preferring
protocols based on lower invasiveness and costs (that is ETT preferable
to CMR-MPI, and CMR-MPI preferable to direct XA). The McNemar test
was used to calculate differences between proportions (i.e., accuracy,
sensitivity and speciﬁcity) obtained from paired observations. AUCs
were compared using the method of DeLong et al. [26]. A p value
b0.05 was considered signiﬁcant.
Data analysis was performed using SPSS analysis software (Release
19, SPSS Inc, Chicago, Illinois) and MedCalc analysis software (Version
12.3.0, MedCalc Software, Belgium).
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4. Results
A total of 121 patients were recruited, of whom 41 patients
were excluded, including 24 patients who did not perform ETT
(non-interpretable baseline ECG or inability to exercise); 13 pa-
tients who did not performed CMR (direct XA or claustrophobia)
and 4 patients who refused invasive testing. A schematic design of
study population is represented in Fig. 1. Baseline characteristics
Table 1
Hypothetical tested protocols according to exercise treadmill test report and according to patient pretest probability of coronary artery disease.
Tested Protocols
ETT A B C D E G H I J K L
Clearly positive CMR–MPI CMR–MPI CMR–MPI XA XA XA XA XA XA XA XA
Borderline positive CMR–MPI CMR–MPI CMR–MPI XA CMR–MPI CMR–MPI XA XA XA XA XA
Inconclusive CMR–MPI CMR–MPI STOP CMR–MPI CMR–MPI STOP CMR–MPI XA XA STOP XA
Negative CMR–MPI STOP STOP CMR–MPI CMR–MPI STOP STOP CMR–MPI STOP STOP XA 
A
U
C 
(9
5%
 C
I)
ALL PATIENTS (n=80) 0.87
(0.78–0.96)
0.83
(0.73–0.93)
0.80
(0.70–0.91)
0.76
(0.66–0.87)
0.89
(0.80–0.97)
0.82
(0.72–0.92)
0.72
(0.61–0.84)
0.69
(0.58–0.81)
0.65
(0.53–0.77)
0.70
(0.58–0.81)
–
CAD prevalence=46.2%
TP TN 30 40 27 40 25 40 35 25 32 39 29 39 27 39 32 25 35 24 32 24 30 25 37 0
FN FP 7 3 10 3 12 3 2 18 5 4 8 4 10 4 5 18 2 19 5 19 7 18 0 43
PPV NPV 90.9 85.1 90.0 80.0 89.3 76.9 66.0 92.6 88.9 88.6 87.9 83.0 87.1 79.6 64.0 83.3 64.8 92.3 62.7 82.8 62.5 78.1 46.2 –
HIGH PRETEST PROBABILITY 
(n=20) 0.81
(0.59–1.0)
0.77
(0.55–1.0)
0.70
(0.46–0.95)
0.63
(0.34–0.92)
0.76
(0.51–1.0)
0.66
(0.39–0.92)
0.59
(0.31–0.88)
0.63
(0.34–0.92)
0.59
(0.31–0.88)
0.52
(0.24–0.81) –
CAD prevalence=70%
TP TN 11 5 10 5 8 5 13 2 12 4 11 4 9 4 12 2 13 2 12 2 10 2 14 0
FN FP 3 1 4 1 6 1 1 4 2 2 3 2 5 2 2 4 1 4 2 4 4 4 0 6
PPV NPV 91.7 62.5 90.9 55.6 88.9 45.4 76.5 66.7 85.7 66.7 84.6 57.1 81.8 44.4 75.0 50.0 76.5 66.7 75.0 50.0 71.4 33.3 70.0 –
INTERMEDIATE PRETEST 
PROBABILITY (n=50) 0.86
(0.74–0.98)
0.81
(0.67–0.95)
0.81
(0.67–0.95)
0.76
(0.63–0.90)
0.89
(0.78–0.99)
0.84
(0.71–0.97)
0.71
(0.56–0.86)
0.68
(0.54–0.83)
0.63
(0.48–0.79)
0.71
(0.56–0.86) –
CAD prevalence=38%
TP TN 15 29 13 29 13 29 18 18 16 29 14 29 14 29 16 18 18 13 16 13 16 18 19 0
FN FP 4 2 6 2 6 2 1 13 3 2 5 2 5 2 3 13 1 18 3 18 3 13 0 31
PPV NPV 88.2 87.9 86.7 82.8 86.7 82.8 58.1 94.7 88.9 90.6 87.5 85.3 87.5 85.3 55.2 85.7 50.0 92.8 47.0 81.2 55.2 85.7 38.0 –
LOW PRETEST PROBABILITY
(n=10) 1.0
(0.69–1.0)
1.0
(0.69–1.0)
1.0
(0.69–1.0)
0.92
(0.72–1.0)
1.0
(0.69–1.0)
F
XA
CMR–MPI
CMR–MPI
STOP
0.84
(0.75–0.94)
0.73
(0.47–0.98)
0.84
(0.71–0.97)
1.0
(0.69–1.0)
1.0
(0.69–1.0)
0.92
(0.72–1.0)
0.83
(0.57–1.0)
0.83
(0.57–1.0)
0.92
(0.72–1.0) –
CAD prevalence=40%
TP TN 4 6 4 6 4 6 4 5 4 6 4 6 4 6 4 5 4 4 4 4 4 5 4 0
FN FP 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 2 0 2 0 1 0 6
PPV NPV 100 100 100 100 100 100 100 80.0 100 100 100 100 100 100 100 80.0 100 66.7 100 66.7 100 80.0 40.0 –
XAmeans direct referral to coronary angiography. All patients referred to CMR-MPI would undergo XA in case of CMR-MPI positive for ischemia; in case of negative CMR-MPI would stop
further testing. STOP means no further diagnostic investigation. In protocol L, referral to XA was assumed for all patients irrespective of non-invasive test results or patient pretest
probability of CAD.
AUC = area under the receiver–operator characteristic curve; CAD = coronary artery disease; CMR-MPI = cardiac magnetic resonance myocardial perfusion imaging; ETT = exercise
treadmill test; FN = false negative; FP = false positive; PPV = positive predictive value; NPV = negative predictive value; STOP = no further testing; TP = true positive; TN = true
negative; XA = X-ray invasive coronary angiography.
Screening
176 patients referred for assessment of CAD
121 eligible patients
97 patients performed ETT
84 patients performed ETT and CMR-MPI
80 patients performed ETT, CMR-MPI and XA
4 XA not performed
4 patients refuse catheterization
13 CMR-MPI not performed
9 patients undergo direct XA
4 patients unable to undergo CMR due to
claustrophobia not stated during screening
24 ETT not performed
17 patients unable to exercise
7 patients with non-interpretable baseline ECG
Fig. 1. A schematic design of the study population. Legend: CMR-MPI = cardiac magnetic resonance myocardial perfusion imaging; ETT = exercise treadmill test; XA = X-ray invasive
coronary angiography.
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of the 80 enrolled patients are shown in Table 2. Pre-test probabil-
ity of CAD was high in 25.0% of patients, intermediate in 62.5% and
low in 12.5% of patients. The overall prevalence of protocol-deﬁned
signiﬁcant CAD was 46.2% (37 patients).
4.1. ETT and CMR-MPI performance
The average treadmill exercise duration performed was 7.2 ±
2.1 min (the mean total workload in METS of 7.8 ± 2.0) and one
ﬁfth of patients presented both exertional chest pain and electro-
cardiographic ST segment shift ≥1.0 mm. In the clinical reports,
ETT was classiﬁed as suggestive of CAD in 60% of cases (48 patients),
including a clearly positive ETT in 16 patients (20%) and a borderline
positive ETT in 32 patients (40%). ETT was not suggestive of CAD in 40%
of cases (32 patients), including an inconclusive ETT in 8 patients (10%)
and a negative ETT in 24 patients (30%).
First-pass perfusion CMR during adenosine stress disclosed nor-
mal myocardial perfusion in 47 patients (58.8%). A perfusion defect
suggestive of myocardial ischemia was observed in 33 patients
(41.2%). Agreement between observers was assessed on the identi-
ﬁcation of abnormal perfusion per patient, which produced a kappa
of 0.56, indicating substantial agreement. Both observers agreed on
the exact pattern of perfusion in 57 scans (71.2%) and the third
observer adjudicated on the remaining 23 cases (28.8%) where
the per-vessel analysis differed.
On a vessel level, hypo-enhancement during ﬁrst-pass perfusion
CMR was linked to only one-vessel territory in 18 patients (54.5%)
being left anterior descending artery in 10 cases, left circumﬂex
artery in 1 case and right coronary artery in 7 cases. Two-vessel pattern
of hypo-perfusion was suggested in 10 patients (30.3%) and three-
vessel diseasewas reported in 5 patients (15.2%). Amicrovascular disease
pattern of hypo-perfusion was apparent in 6 patients.
Performance measurements of ETT and CMR-MPI, including ROC
curve analysis, are shown in Table 3.
4.2. Comparison of ETT and CMR-MPI performances
Compared to ETT, CMR-MPI showed better speciﬁcity (93.0 vs. 58.1%,
p = 0.001) and positive predictive value (90.9 vs. 62.5%, p = 0.009). No
signiﬁcant differences were found in terms of sensitivity and negative
predictive value.
Data analyses according to gender showed no signiﬁcant differences
between men and women in terms of diagnostic performance of
the tests (AUCs of 0.69 vs. 0.68 for ETT and AUCs of 0.86 vs. 0.91 for
CMR-MPI in male and female patients, respectively).
A strategy of referral to XA according only to CMR-MPI report
(protocol A, Table 1) yielded greater performance than a strategy of
referral to XA driven by ETT results only (protocol K, Table 1) (AUC
0.87 vs. 0.70, p = 0.002). CMR-MPI out-performed ETT among patients
with high pretest probability of CAD [AUC 0.81 (0.59–1.0) vs. AUC 0.52
(0.24–0.81), p = 0.04] and among patients with intermediate pretest
probability of CAD [AUC 0.86 (0.74–0.98) vs. 0.71 (0.56–0.86), p =
0.042]. Diagnostic performance of the two tests was similar for patients
with low pretest probability of CAD [AUC 1.0 (0.69–1.0) for CMR-MPI
vs. 0.92 (0.72–1.0) for ETT, p = 0.317].
Direct referral to XA (irrespective of non-invasive test results or
patient pretest probability of CAD) presented lower diagnostic accuracy
Table 2
Baseline characteristics of the study population.
Patient characteristics N = 80
Male 54 (68%)
Age (years), mean ± SD 61 ± 8
Risk factors
Diabetes 35 (44%)
Hypertension 58 (72%)
Dyslipidemia 61 (76%)
Current smoking 8 (10%)
Obesity (BMI ≥ 30) 21 (26%)
Family history of CAD 16 (20%)
Clinical presentation
Typical angina 21 (26%)
Dubious or atypical chest pain 52 (65%)
Dyspnea 3 (4%)
Chest pain and dyspnea 3 (4%)
Pretest likelihood of CAD
Low 10 (12%)
Intermediate 50 (62%)
High 20 (25%)
Signiﬁcant CAD (FFR measurement) 37 (46%)
One-vessel disease 18 (22%)
Two vessel disease 13 (16%)
Three-vessel disease 6 (8%)
Results are shown as percentage terms (%) unless stated otherwise.
BMI, body mass index; CAD, coronary artery disease; FFR, fractional ﬂow reserve.
Table 3
Performance measures of ETT and CMR-MPI in the overall study population and according to patient pretest probability of coronary artery disease.
Sensitivity (95% CI) Speciﬁcity (95% CI) PPV (95% CI) NPV (95% CI) Accuracy (95% CI) AUC (95% CI)
All patients (n = 80)
ETT 81.1% 58.1% 62.5% 78.2% 68.7% 0.70
TP = 30 FP = 18 TN = 25 FN = 7 (64.8–92.0) (42.1–73.0) (47.1–76.1) (60.1–90.7) (57.9–77.8) (0.58–0.81)
CMR-MPI 81.1% 93.0% 90.9% 85.1% 87.5% 0.87
TP = 30 FP = 3 TN = 40 FN = 7 (64.8–92.0) (80.9–98.5) (75.3–98.1) (71.7–93.8) (78.5–93.0) (0.78–0.96)
High pretest probability (n = 20)
ETT 71.4% 33.3% 47.9% 57.6% 60.0% 0.52
TP = 10 FP = 4 TN = 2 FN = 4 (41.9–91.4) (5.3–77.3) (20.5–76.3) (16.2–92.0) (38.4–78.2) (0.24–0.81)
CMR-MPI 78.6% 83.3% 80.2% 81.9% 80.0% 0.81
TP = 11 FP = 1 TN = 5 FN = 3 (49.2–95.1) (36.1–97.2) (42.4–97.9) (46.4–98.1) (58.1–91.8) (0.59–1.0)
Intermediate pretest probability (n = 50)
ETT 84.2% 58.1% 63.3% 81.1% 68.0% 0.71
TP = 16 FP = 13 TN = 18 FN = 3 (60.4–96.4) (39.1–75.4) (43.8–80.0) (56.8–95.1) (54.1–79.2) (0.56–0.86)
CMR-MPI 78.9% 93.5% 91.3% 83.8% 88.0% 0.86
TP = 15 FP = 2 TN = 29 FN = 4 (54.4–93.8) (78.5–99.2) (69.3–99.2) (65.8–94.6) (76.1–94.3) (0.74–0.98)
Low pretest probability (n = 10)
ETT 100% 83.3% 83.7% 100% 90.0% 0.92
TP = 4 FP = 1 TN = 5 FN = 0 (40.2–100) (36.1–97.2) (31.5–99.8) (39.8–100) (58.7–97.7) (0.72–1.0)
CMR-MPI 100% 100% 100% 100% 100.0% 1.0
TP = 4 FP = 0 TN = 6 FN = 0 (40.2–100) (54.1–100) (39.8–100) (47.8–100) (76.1–100) (0.69–1.0)
AUC = area under the receiver–operator characteristic curve; CI = conﬁdence intervals; CMR-MPI = cardiac magnetic resonance myocardial perfusion imaging; ETT = exercise
treadmill test; FN = false negative; FP = false positive; PPV = positive predictive value; NPV = negative predictive value; TP = true positive; TN = true negative.
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for signiﬁcant CAD (protocol L — Table 1, accuracy of 46.2%) than
selecting patients for invasive stratiﬁcation according to ETT report
(protocol K, 68.7%, p = 0.003) or according to CMR-MPI ﬁndings
(protocol A, 87.5%, p b 0.001).
4.3. Integrated protocols including pretest probability of CAD, ETT and
CMR-MPI
4.3.1. CMR-MPI performance according to ETT result (Table 1)
In the global population, performing CMR-MPI prior to XA in
patients with a clearly positive ETT (protocol A, AUC 0.87) did not
improve diagnostic performance for CAD detection over direct XA
referral (protocol E, AUC 0.89), p = ns. Of the 16 patients with a
clearly positive ETT (symptoms plus ST shift), 13 patients (81.2%)
presented signiﬁcant CAD on XA. In this group, CMR-MPI excluded
ischemia in only 1 of the 3 patients without CAD. Referring to
CMR-MPI prior to XA in patients with borderline positive ETT
(symptoms or ST shift) improved diagnostic performance (protocols E
vs. D, p = 0.004). In patients with an inconclusive ETT, the addition of
CMR-MPI also improved diagnostic performance as compared to
direct XA (protocols D vs. I, p = 0.009). Interestingly, in patients with
a negative ETT, CMR-MPI performance showed some advantage over
no further testing (protocols E vs. F, p = 0.075).
Accordingly, the best protocol integrating ETT and CMR-MPI for CAD
detection, irrespective of patient pretest probability of CAD, was
protocol E (AUC of 0.89; 95% CI 0.80–0.97), in which CMR-MPI was
performed in all patients but those with a clearly positive ETT, to
whom direct referral to XA was assumed. Of the 64 patients with a
borderline positive, inconclusive or negative ETT, 40 patients (62.5%)
presented no signiﬁcant functional CAD on XA and 24 patients (37.5%)
had signiﬁcant disease — diagnostic accuracy of 65.6% (TP = 17,
FP = 15, TN = 25, FN = 7). In the same group, diagnostic accuracy
of CMR-MPI reached 90.6%, reducing the false positive and negative
cases to 5 patients and 1 patient, respectively. This means that addition-
al testing with stress imaging should be offered after a borderline
positive, inconclusive or negative ETT. In Fig. 2, we present four repre-
sentative cases showing true positive results of both tests (case A) and
the additive value of CMR-MPI over ETT (cases B–D).
4.3.2. CMR-MPI performance according to pre-test probability of CAD
(Table 1)
Hypothetical protocols based on patient pretest probability of CAD
were tested and the results are shown in Table 1.
For patients with high pretest probability of CAD, a strategy of
direct referral to XA was less accurate than selecting patients for
invasive stratiﬁcation according to CMR-MPI report (protocol L
accuracy 70.0% vs. protocol A 80.0%, p = 0.73). Protocol K (AUC
0.52) based solely on ETT performance showed worst performance
than protocol A (AUC 0.81), based on CMR-MPI only, p = 0.04.
CMR-MPI was particularly useful to redeﬁne the need for invasive in-
vestigation among patients with ETT suggestive of CAD (protocol A,
AUC 0.81 vs. protocol D, AUC 0.63, p = ns), reducing the rate of
false positives. In this group, ETT is useless to select patients either
to CMR-MPI or to XA. Protocol A was the best performing protocol
(AUC 0.81, highest PPV) for patients with high pretest probability
of CAD, in which CMR-MPI was performed prior to XA in all patients,
irrespective of the ETT report.
For patients with intermediate pretest probability of CAD, a strat-
egy of referral to XA based on only CMR-MPI result (protocol A accu-
racy 88.0%) was signiﬁcantly more accurate than a strategy based on
only ETT report (protocol K, 68.0%, p = 0.03) and a strategy of direct
referral to XA (protocol L 38.0%, b0.001). In this group, CMR-MPI
prior to XA was particularly useful to redeﬁne the need for invasive
investigation in patients with borderline positive ETT (protocols E
vs. D, p = 0.028), inconclusive ETT (protocols D vs. I, p = 0.016)
and negative ETT (protocols I vs. L, p b 0.001). For patients with a
clinically and electrically positive ETT, CMR-MPI didn't improve
the diagnostic performance of ETT (protocols E vs. A, p = ns). The
best performing protocol for patients with intermediate likelihood
of CAD was protocol E (AUC 0.89), in which CMR-MPI was assumed
for all patients prior to XA, except for those with a positive ETT who
would undergo direct XA.
For patients with low probability of CAD and a negative ETT,
assuming no further investigation was as accurate as performing
CMR-MPI (protocol J vs. protocol I, AUC 0.83 for both, p = ns). Also
for patients with an inconclusive ETT, no further testing strategy
(protocol K, AUC 0.92) showed similar performance than referring
to CMR-MPI (protocol H, AUC 0.92), p = ns, and greater performance
than sending to direct XA (protocol J, AUC 0.83), p = ns. In this
group, no false negative results were reported for any protocol. Pa-
tients with a borderline positive ETT would beneﬁt from CMR-MPI
prior to XA (protocol G, AUC 1.0) instead of direct referral to XA (pro-
tocol K, AUC 0.92), p = ns, excluding the false positive result report-
ed. For patients with positive ETT, no false positive results were
reported when direct referral to XA was assumed (protocols E vs.
protocol A, AUC 1.0 for both, p = ns). However, only one patient of
this group presented a clearly positive ETT and assuming direct re-
ferral to XA based on only one case report wouldn't be wise. Accord-
ingly, protocol C was chosen as the best performing protocol (AUC
1.0) for patients with low pretest probability of CAD.
Based on the above results, in our population, the best performing
algorithm for the management of patients with suspected CAD,
according to patient pretest probability of CAD, is presented in
Fig. 3. This protocol achieved a global accuracy of 89% (AUC = 0.88,
95% CI 0.80–0.97) and was clearly superior to an approach based solely
in ETT (protocol K, AUC 0.70, p b 0.001), yet similar to isolated CMR-
MPI (protocol A, AUC 0.87, p = ns). Interestingly, its diagnostic
performance did not signiﬁcantly differ from an approach of performing
ETT to all patients, referring to XA the clearly positives and submitting
to CMR-MPI all the others (protocol E, AUC = 0.89), p = ns. The
algorithm based on pretest probability, however, implies lower costs
since some patients only perform CMR-MPI and no ETT and a few others
may be exempted from further testing after a negative ETT.
5. Discussion
In our population with a high prevalence of CAD (46.2%), ETT
presented a higher level of sensitivity (81.1%) and a lower level of
speciﬁcity (58.1%) than previously reported [18]. Sensitivity and
speciﬁcity are inversely related, affected by the population tested
(namely pretest probability and CAD prevalence [22]) and deter-
mined by the methodology used, including the choice of a cut point
or discriminant value [8]. Our interpretation of the ETT included
symptomatic response, exercise capacity, hemodynamic response,
and ECG response as recommend in guidelines [8]. We followed the
most commonly used deﬁnition for a positive ETT that is ≥1 mm of
horizontal or downsloping ST-segment depression or elevation for
N60 to 80 ms after the end of the QRS complex, especially when
the ECG changes are accompanied by chest pain suggestive of angina
[27]. If the discriminant value used was set high (ST depression
≥2 mm) to ensure that nearly all normal subjects would have a nor-
mal test, giving the test a high speciﬁcity (95.3%), then a substantial
number of those with the disease would appear to be normal, reduc-
ing the test sensitivity (48.6%). The low level of speciﬁcity of ETT in
our population may also be explained by the inclusion of borderline
positive reports (symptoms or ST shift during effort) in the group of ETT
suggestive of CAD, raising the rate of false positives from 3 to 18 cases
(accordingly reducing speciﬁcity from 93.0 to 58.1%). However, if only
clearly positive ETT reports were to be considered as positive tests,
the sensitivity of ETT would diminish to 35.1%. The diagnostic perfor-
mance of ETT in our study was also driven by the high prevalence of
CAD in our population, increasing the chance of establishing a diagnosis.
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Indeed, previous published studies with similar prevalence of CAD and
protocol of exercise testing used, reported identical diagnostic perfor-
mance of ETT [28,29].
Compared to ETT, CMR-MPI showed similar sensitivity and nega-
tive predictive value, but signiﬁcantly better speciﬁcity and positive
predictive value. CMR-MPI in addition to ETT provided better diag-
nostic accuracy than ETT or CMR-MPI alone. In subgroup analysis,
the incremental value of CMR-MPI in CAD detection was especially
relevant in patients without a clearly positive ETT, including cases
of borderline positive, inconclusive or negative ETT. In this context,
a multitest strategy combining both CMR-MPI and ETT would be
advantageous in order to correctly select those patients who would
beneﬁt from invasive investigation. Patients presenting an undoubtful
positive ETT (both symptoms and ST shift) would beneﬁt from direct
referral to XA, avoiding CMR-MPI performance, which is needless in
this group in terms of diagnostic accuracy of CAD.
In daily practice, current guidelines [3] recommend that manage-
ment of patients with suspected CAD should be based on the estimate
of CAD likelihood of each patient. Our results based on patient
pretest probability of CAD, support the strategy of initial CMR-MPI
Fig. 2.Adenosine stress perfusion CMR images (basal, mid and distal left ventricular short axis slices in panels 1–3) and coronary angiograms (panel 4) of four patientswith suspected CAD
presenting with different ETT reports. Legend: Case A: A 67-year old woman presenting with typical chest pain and a clearly positive ETT (limiting angina and horizontal ST-segment
depression of 2 mm), underwent CMR-MPI that showed diffuse hypoperfusion pattern, suggestive of multivessel disease (panels A1–A3). Signiﬁcant CAD was reported: occluded mid-left
anterior descending (LAD) artery; diffusely diseased ﬁrst obtusemarginal (OM) coronary artery (panel A4); and signiﬁcantmid-right coronary artery (RCA) stenosis (75%). Patient underwent
successful coronary artery bypass graft (CABG) surgery with complete target vessel revascularization. Case B: A 47-year old male with atypical chest pain (intermediate pretest probability)
performed a borderline positive ETT (ST shift during effort but no symptoms). In CMR-MPI, reversible subendocardial hypoperfusion was reported in the septum, anterior and distal
inferoseptal walls (panels B1–B3). Proximal LAD occlusion is shown in panel B4 (arrow head) and CABGwas decided. Case C: CMR-MPI of a 58-year oldmale with intermediate pretest prob-
ability of CAD and an inconclusive ETT (70% of age predictedHR achievedwith no symptoms or ST shift) showing subendocardial hypoperfusion involving the septumand inferiorwall (panels
C1–C3). In XA (panel C4), signiﬁcant LAD artery disease (95% stenosis) was noticed and coronary angioplastywith a drug-eluting stent was performed. Case D: A 61-year-oldwoman present-
ing with typical chest pain (high pretest probability of CAD) and a negative ETT (no angina and no ST shift during effort). Diffuse subendocardial hypoperfusion in CMR-MPI was reported
(panels D1–D3). In XA (panel D4) functional signiﬁcant stenosis in the proximal LAD artery (FFR 0.77) and in the distal RCA (FFR 0.60) was detected. A functional moderate stenosis
was also described in the ﬁrst OM coronary artery (FFR 0.81). Patient underwent successful CABG with complete target vessel revascularization. CMR = cardiac magnetic resonance;
CMR-MPI = cardiac magnetic resonance myocardial perfusion imaging; ETT = exercise treadmill test; XA = X-ray invasive coronary angiography; CAD = coronary artery disease.
4165E. Pereira et al. / International Journal of Cardiology 168 (2013) 4160–
 99 
in all patients with high pretest probability of CAD, rather than direct
referral to XA or starting with ETT, as the ﬁrst testing strategy. As
previously stated [30], the ETT does not offer additional information
for the diagnosis in patients with high pretest probability of CAD,
although it may add prognostic information.
ETT for initial diagnostic assessment of patients with suspected
CAD is a class I recommendation in patients with intermediate pretest
probability of CAD as deﬁned by age, sex, and symptoms [8,27],
unless unable to exercise or display ECG changes which make ECG
non-evaluable (level of evidence B). In our study, an initial ETT
indeed provided valuable diagnostic information in this group.
Patients with a clearly clinically and electrically positive ETT would
beneﬁt from direct referral to XA, avoiding CMR-MPI. Patients with
any other ETT result (borderline positive, inconclusive or negative
ETT) would beneﬁt from CMR-MPI prior to XA to improve the diag-
nostic accuracy for detecting obstructive CAD.
For patients with low pretest probability of CAD, the use of ETT to
diagnose or exclude coronary disease was assigned to a class IIb indica-
tion in the ACC/AHA guidelines [8] and has been expressly discouraged
in the most recent NICE guidelines [31], in which cardiac tomography
(CT) calcium scoring ﬁgures as the ﬁrst-line diagnostic investigation
for this group of patients. In our study, ETT presented a high NPV
(100%) for patients with low pretest probability of CAD. In this group,
an ETT not suggestive of CAD (including an inconclusive or negative
ETT) provided adequate reassurance of the absence of CAD. Instead,
patients with low pretest probability of CAD but high risk ﬁndings on
ETT (symptoms and/or ST shift) beneﬁt from further investigation
with CMR-MPI. Based on our data, despite the reduced number of
patients with low pretest probability of CAD included in our study,
ETT could actually be useful as a gatekeeper for patients with low
pretest probability of CAD, preventing unnecessary invasive investiga-
tion, avoiding exposure to ionizing radiation and limiting the costs.
In conclusion, patients with suspected coronary artery disease and a
high pretest probability of CAD before any diagnostic testing, beneﬁt
fromundergoing CMR-MPI for CAD detection rather than being referred
directly for XA and independent of ETT results. A diagnostic strategy
combining ETT and CMR-MPI for CAD detection is needed for the evalu-
ation of patients with low to intermediate pretest probability of CAD. In
these groups of patients, ETT is a good initial test for the evaluation of
patients who are able to exercise and have a normal baseline ECG.
This safe and inexpensive test can be used to correctly select those pa-
tients with intermediate pretest probability of CAD who beneﬁt from
direct referral to XA (symptoms plus ST shift with effort). ETT is also re-
liable to exclude CAD in patients with low pretest probability of CAD in
case of an inconclusive or negative ETT report. Further testing with
CMR-MPI is recommended in patients with intermediate pretest proba-
bility of CAD without a clearly positive ETT and in patients with low
pretest probability of CAD presenting a clinically and/or electrically
positive ETT, in order to improve the diagnostic accuracy for CAD
detection and enhancing risk assessment.
6. Limitations
We acknowledge that this study has multiple limitations that
may decrease the generalizability of our ﬁndings. In this single-cen-
ter study, sample size was limited by the available funds and center
capacity. Patients weremainly referred to our center from the gener-
al health care practitioner due to symptoms compatible with CAD
and with at least one cardiovascular risk factor (and without
known CAD). No selection bias was evident since only symptoms
and risk factors were used to select patients. Nevertheless, it is ad-
missible that general physicians would be more prone to refer to car-
diology patients with previous positive exercise tests than patients
with the same symptoms and a negative test. Also, our statements
may not be applicable to all patients presenting with chest pain. Ad-
ditionally, in daily practice, the number of low risk patients is likely
to be higher and with lower incidence of CAD.
The results presented herein do not take into account the cost ef-
fectiveness of the different test modalities and the technical, training
and resource implications of the different tests, as well as patient and
clinician preferences. Nevertheless, in most studies, stress imaging is
estimated to provide a beneﬁt over ETT at a reasonable cost, a result
driven primarily by more frequent angiography and adverse cardio-
vascular events for those with negative ETT [32–34].
A small percentage of patients had to be excluded because of
contraindications, such as renal dysfunction or arrhythmia. As
such, these results may not apply to other groups of patients re-
ferred for stress testing. FFR was only measured in vessels with in-
termediate stenosis on visual assessment. Stenosis b50% was assumed
as irrelevant and stenosis≥90%was considered functionally signiﬁcant.
While this was performed to avoid potential iatrogenic complications,
and reﬂects current clinical practice in many centers, an eventual bias
may exist.
Patient with
suspected CAD
Pretest probability of
CAD
High CMR-MPI XA
Intermediate
ETT clinically and
electrically positive XA
Any other ETT result CMR-MPI XA
Low
ETT sugestive of CAD
(ST shift or symptoms) CMR-MPI XA
ETT not suggestive of
CAD STOP
Fig. 3. Best performing protocol for CAD diagnosis in tested population combining patient pretest probability of CAD, ETT and CMR-MPI (AUC = 0.88, 95% CI 0.80–0.97). Legend: CMR-MPI
prior to XA should be offered in all patients with high pretest likelihood of CAD; in this group ETT is a usefulness exam. In patients with intermediate likelihood of CAD, ETT is a good initial
test to identify patients who should be directly referred to XA (symptoms plus ST shift with effort); all the other ETT results should bemanaged according to CMR. In patients with low pretest
probability, an initial ETT not suggestive of CAD reliably excludes CAD; the presence of symptoms or ST shift with effort precludes the need for further investigationwith CMR-MPI prior to XA.
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7. Conclusions
CMR-MPI has similar sensitivity and higher speciﬁcity for CAD
detection compared with ETT. CMR-MPI can be used in a diagnostic
workﬂow aiming to increase accuracy and reduce the number of
unnecessary catheterizations, particularly in patients with interme-
diate to high pretest probability of CAD. ETT performed well in the
low pretest probability patients and seems to be still a valuable
option to exclude CAD in this group of patients.
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coronary artery disease
Nuno Bettencourt, MDa,*, Jo~ao Rochaa, Nuno Ferreira, MDa, Gustavo Pires-Morais, MDa,
M!onica Carvalhoa, Daniel Leitea, Bruno Melica, MDa, Lino Santos, MDa,
Alberto Rodrigues, MDa, Pedro Braga, MDa, Madalena Teixeira, MDa, Lino Sim~oes, MDa,
Adelino Leite-Moreira, MD, PhDb, Silva Cardoso, MD, PhDb, Eike Nagel, MD, PhDc,
Vasco Gama, MDa
aDepartment of Cardiology, Centro Hospitalar de Gaia/Espinho, EPE, Rua Conceic¸~ao Fernandes, 4434–502 Vila Nova de
Gaia, Portugal; bFaculty of Medicine, University of Porto, Portugal and cKings College, London, UK
KEYWORDS:
Adenosine;
Angiography;
Coronary disease;
MDCT;
Perfusion;
Stress;
Tomography
BACKGROUND: Preliminary studies have shown the potential of myocardial computed tomography
perfusion (CTP) analysis for ischemia detection in both animals and humans.
OBJECTIVE: To provide validation data on stress-rest CTP protocols as additive tools to improve the
accuracy of multidetector computed tomography (MDCT) for coronary artery disease (CAD) in symp-
tomatic patients.
METHODS: Ninety symptomatic patients with suspected CAD (62 6 8 years, 66% males) under-
went both MDCT and invasive coronary angiography (XA). The MDCT protocol included a prospec-
tive calcium score acquisition, a helical acquisition with retrospective gating during infusion of
adenosine (140 mg/kg/min) and a prospective scan for computed tomography angiography (CTA) at
rest (total effective radiation dose: 5.1 6 0.8 mSv). Significant and higher-grade CADs were defined
by the presence ofR50% orR70% stenosis in at least one coronary artery, as evaluated by quantita-
tive coronary angiography (QCA) using XA images.
RESULTS: On a patient-based model, CTA sensitivity, specificity, and positive (PPV) and negative
predictive values (NPV) to detect R50% or R70% stenosis were 98%, 71%, 80%, and 97% (global
accuracy 86%) and 100%, 60%, 64%, and 100% (accuracy 77%), respectively. An integrative approach
of CTA and CTP results had the best performance for detection of CAD with sensitivity of 83%, spec-
ificity of 98%, PPVof 98%, and NPVof 84% (accuracy 84%) for detection of 50% stenosis and 97%,
90%, 88%, and 98% (accuracy 93%), respectively, for the 70% threshold. The integration of results had
the best overall performance in all scenarios but was particularly advantageous in the prediction of
higher-grade CAD, with an area under the curve of 0.93, compared with 0.80 for isolated CTA
and 0.82 for CTP and in patients with severe calcifications (sensitivity 92%, specificity 87%, overall
accuracy of 90%).
Conflict of interest: The authors report no conflicts of interest.
* Corresponding author.
E-mail address: bettencourt.n@gmail.com
Submitted August 8, 2011. Accepted for publication October 19, 2011.
1934-5925/$ - see front matter ! 2011 Society of Cardiovascular Computed Tomography. All rights reserved.
doi:10.1016/j.jcct.2011.10.002
Journal of Cardiovascular Computed Tomography (2011) 5, 392–405
 102 
CONCLUSIONS: The integration of functional and morphological data using CTA and CTP im-
proved MDCT accuracy for detection of clinically relevant CAD at both thresholds of 50% and
70% in this intermediate to high pretest probability population.
! 2011 Society of Cardiovascular Computed Tomography. All rights reserved.
Introduction
Multislice computed tomography (MDCT) is an effec-
tive method for the exclusion of coronary artery disease
(CAD) in patients with intermediate to low pretest proba-
bility, largely owing to its high negative predictive value
(NPV).1–5 One major limitation of this technique, however,
is its low specificity and positive predictive value (PPV).6
The detection of significant CAD using MDCT generally
involves additional studies to confirm the findings, as the
degree of stenosis is often overestimated.6–9 Furthermore,
its diagnostic accuracy is severely limited by calcification,
having a limited value in patients with higher pretest prob-
ability. In these cases, it is generally preferable to use func-
tional tests, able to assess the presence of myocardial
ischemia.9 Recently, MDCT stress perfusion was described
as capable of detecting inducible perfusion defects, by
examining the differences in contrast distribution between
normal and hypoperfused myocardium.10–12 The ability to
integrate detailed morphological data from MDCT coro-
nary angiography (CTA) together with functional informa-
tion provided by MDCT myocardial perfusion imaging
(CTP13) in a single examination may be beneficial and
may improve overall accuracy of MDCT for the diagnosis
of clinically relevant CAD.14,15
Preliminary studies have shown the potential of myo-
cardial CTP for ischemia detection in both animals and
humans and a reasonable accuracy for detecting significant
CAD as assessed by invasive coronary angiography
(XA).10–12,16–19 One recent study assessed the incremental
value of perfusion imaging over CTA for the detection of
obstructive CAD in high-risk populations.20 All the studies
published so far, however, included patients selected from
imaging and/or catheterization lists and/or patients with
known CAD. Therefore, a myocardial CTP stress-rest pro-
tocol has never been fully validated in a clinical scenario as
an additive tool to improve MDCT ability to detect signif-
icant stenoses in symptomatic patients with suspected
CAD.
The aim of this study was to evaluate the diagnostic
accuracy of an integrated protocol of MDCT including
CTA and stress-rest myocardial CTP. The study also
intended to test if, in patients with intermediate-to-high
pretest probability, the addition of CTP to a prospective
CTA examination would improve overall diagnostic accur-
acy for the detection of significant CAD, using invasive
quantitative coronary angiography (QCA) as the reference
standard.
Methods
Population
During a 17-month period (February 2010 to June 2011)
we prospectively screened 156 consecutive patients referred
by general physicians to our hospital outpatient cardiology
clinic because of clinical suspicion of CAD. Inclusion
criteria of the study were age older than 40 years, symptoms
compatible with CAD, and at least one of the following: 2 or
more risk factors or a positive/inconclusive treadmill test. A
total of 111 eligible patients were tested for exclusion
criteria. Figure 1 summarizes the study flow and reasons
for exclusions.
The final population consisted of 90 individuals (average
age 62 6 8 years, 66% males) with suspected CAD, who
were clinically stable at the time of the evaluation and had no
prior history of CAD. All patients had an intermediate or
high pretest probability according to the modified Diamond-
Forrester score.21 Patient characteristics are presented in
Table 1. The study was approved by the local ethics commit-
tee and complies with the declaration of Helsinki. Written
informed consent was obtained from all participants.
Study design
All the 90 subjects that composed the final study
population underwent the same protocol, as summarized
in Figure 1. After informed consent, clinical information
(including symptoms, previous clinical history, known
risk factors, previous examinations, and medications) was
obtained from a standardized health questionnaire and re-
ferral letters. Physical examination (including measurement
of abdominal circumference, height, weight, sitting heart
rate, and blood pressure) was performed.
Patient preparation
Patients were sequentially referred for MDCT and inva-
sive coronary angiography and were instructed to refrain
from smoking, coffee, tea, aminophyline, beta-blockers, and
nitrates in the 24 hours preceding each exam. On a right
antecubital vein, an 18-gauge intravenous line was inserted
for contrast medium administration, as usually performed in
a standard coronary MDCT acquisition.22–24 One additional
18- to 22-gauge peripheral intravenous line was inserted for
adenosine infusion in a left antecubital vein. No pretest med-
ication was administered.
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MDCT scan protocol
All scans were performed using the same MDCT scanner
(Somatom Sensation 64, Siemens Medical Solutions, For-
chheim, Germany). MDCT scan details are summarized in
Table 2. The integrated MDCT protocol included 3 sequen-
tial acquisitions: one prospectively triggered acquisition
without contrast for coronary calcification evaluation, one
retrospectively gated acquisition during the first-passage of
contrast medium under adenosine infusion (140 mg/kg/
min) and, after a break of at least 10 minutes, a rest prospec-
tively triggered contrasted MDCT acquisition. Figure 2
represents the simplified scheme of MDCT protocol.
Calcium score
After scout images, patients underwent a low-dose
prospective scan (tube voltage 120 kV; tube current 190
mAs) to assess coronary artery calcification, using estab-
lished protocols.22,23
Adenosine stress MDCT perfusion acquisition
Immediately after the calcium score acquisition, adeno-
sine was started at a rate of 140 mg/kg/min. A retrospectively
gated scan with tube current modulation was obtained 3
minutes ormore after the beginning of adenosine infusion. To
decrease radiation exposure, all acquisitions were performed
with a tube voltage of 100 kV and tube current modulation
(with full tube current applied only at 60%–65% of the RR
interval). Collimation was 64.0! 0.6 mm and maximal tube
current was based on the patient’s body habitus (BMI): 600
mA from 20 to 30 kg/m2, 800 if BMI R30 kg/m2 and 400
if BMI%20 kg/m2. Depending on the scan time, a bolus of
50 to 110 mL of contrast (Ultravist, Iopromide 370 mg/mL,
Bayer Healthcare, Leverkusen, Germany) was injected at
4.5 mL/s via a power injector, followed by a 20-mL saline
‘‘chaser,’’ using the dedicated right antecubital vein
18-gauge access catheter. A bolus-tracking technique was
used, with a region of interest placed into the ascending aorta,
set to detect a predefined threshold of 150 HU and a fixed
Figure 1 Study flow-chart and reasons for exclusions.
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delay of 4 seconds. During adenosine infusion, patient symp-
toms, heart rate, blood pressure, and electrocardiogram were
monitored. The pharmacologic infusion was discontinued
immediately after the stress MDCT acquisition.
Rest MDCT acquisition
A break, with the patient lying in the same table position,
was then undertaken. In those patients whose heart rate was
still exceeding 65 beats per minute 3 minutes after the
suspension of the adenosine infusion (n 5 37, 41%), intra-
venous metoprolol (8.1 6 4.10 mg; minimum 5, maximum
20 mg) was administered in bolus of 2.5 to 5.0 mg. After
optimization of heart rate (targeted to%60 beats perminute),
and a minimum of 10 minutes after the last acquisition, a test
bolus was performed as an auxiliary tool to decide the best
rest acquisition timing after contrast injection. Flow rate for
the 20 mL of contrast test bolus and for the rest image
acquisition was similar to the stress scan (4.5 mL/s) and was
followed by a 20-mL flush of saline. Image acquisition
timing for the rest scan was determined by adding 4 seconds
to the time of peak contrast enhancement in the ascending
aorta. All patients received 0.5 mg of sublingual nitroglyc-
erine 5 minutes before the third acquisition. To reduce
radiation exposure, rest MDCT used prospective triggering
(Sequential Scanning, Siemens Medical Systems) at 65% of
the RR interval. Rest MDCT used a fixed tube voltage of
100 kVand tube current of 110mA. The typical contrast dose
for this portion of the examinationwas 84.06 11.5mL (50 to
110 mL) of iopromide delivered at a rate of 4.5 mL/s.
MDCT imaging processing and analysis
Image reconstruction of the calcium score acquisition was
performed using an effective slice thickness of 3 mm. Coro-
nary calcification was reported as the mean Agatston score
and was calculated using a detection threshold of 130 HU
using semiautomated software (Syngo Calcium Scoring,
Siemens Medical Solutions) as previously described.22,23
CTA
For CTA analysis, both acquisitions (retrospective ac-
quisition under adenosine and prospective rest acquisition)
were used. From the stress acquisition, a multiphase set of
10 retrospective reconstructions of the RR interval, ranging
from 5% to 95% of the RR interval plus an additional 60%
phase was reconstructed using a standard medium-soft
cardiac filter (Siemens B25f), anonymized, and sent to a
postprocessing workstation (Aquarius WorkStation, Tera-
Recon Inc, San Mateo, CA). If necessary, additional phases
were reconstructed. From the rest acquisition, a single-
phase (65%) volumetric reconstruction was obtained, using
the same filter and slice thickness.
Two cardiologists with level III experience in MDCT
(N.B., 7 years of experience, and N.F., 2 years of experience),
blinded to clinical data, Agatston score, and QCA results,
evaluated the sets of reconstructed images. Axial-source
images, multiplanar reformations, and thin-slab maximum
intensity projections (1–5 mm) were used for detection of
stenoses using the 17-segment modified American Heart
Association classification.25 Each segment was graded as fol-
lows: 1, normal; 2, nonsignificant stenosis (,50%); 3, stenosis
ranging from 50% to 70%; 4, higher-grade stenosis (R70%);
or 5, uninterpretable (significant stenoses are impossible to
exclude but not definitively present), usually owing to signifi-
cant calcification or artifact. Subjective image quality (poor,
moderate, good) was noted for each acquisition dataset.
Table 1 Population characteristics
No. of patients 90
Male sex 59 (66%)
Age, y 62 6 8.0 (41–79)
Body mass index, kg/m2 27.9 6 4.88 (19.9–45.2)
Symptoms 90 (100%)
Typical angina 18 (20%)
Atypical angina 45 (50%)
Chest pain 20 (22%)
Dyspnea on exertion/Fatigue 7 (8%)
Hypercholesterolemia 70 (78%)
Hypertension 66 (73%)
Diabetes mellitus 33 (37%)
Smoking history 31 (34%)
Family history of CAD 20 (22%)
R 2 Cardiac risk factors 76 (82%)
Agatston Score (median, min-max) 283 (0–5879)
CAD R50% 48 (53%)
1-vessel CAD 21 (23%)
2-vessel CAD 14 (16%)
3-vessel CAD 13 (14%)
CAD R70% 37 (41%)
1-vessel CAD 20 (22%)
2-vessel CAD 13 (14%)
3-vessel CAD 5 (6%)
CAD, coronary artery disease; min, minimum; max, maximum.
Values are n (%) or mean 6 SD (95% confidence interval).
Table 2 MDCT scan details
Days from CT to XA 5.1 6 5.99 (1–31)
Use of metoprolol 37 (41%)
Metoprolol EV, mg 8.1 6 4.10 (5–20)
Total volume of contrast used, mL 183 6 14.5 (120–215)
Stress scan, mL 80 6 7.1 (50–110)
Rest scan, mL 84 6 11.5 (50–110)
Effective radiation, total, mSv 5.5 6 0.74 (3.5–8.1)
Effective radiation stress, mSv 3.4 6 0.58 (2.4–5.6)
Effective radiation rest, mSv 0.8 6 0.33 (0.7–1.8)
Effective radiation CAC, mSv 0.5 6 0.30 (0.3–2.2)
CT, computed tomography; CAC, coronary artery calcification; XA,
coronary angiography.
Values are n (%) or mean 6 SD (95% confidence interval).
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Interobserver disagreements were resolved by consensus in a
joint session. Uninterpretable or nonevaluable segments
were assumed as positive for the study purpose and thus all
segments were used for analysis in an ‘‘intent-to-diagnose’’
manner.
Myocardial CTP
For myocardial CTP analysis, multiphase reconstructions
from the retrospective stress acquisition and a single-phase
(65%) reconstruction from the rest acquisition were obtained
using exactly the same parameters used for the CTA analysis
but with an extrasmooth filter (Siemens B10f). The same
postprocessing dedicated workstation was used.
The same readers, blinded for CTA and QCA results,
analyzed these blinded images at a different time period of
the study. For each dataset, standard reference lines were
used to create true short-axis and long-axis (2, 3, and 4
chambers) planes using 10-mm-thick multiplanar reformat
images. Using standard planes, semiquantitative per-
segment analysis was performed using the standard Amer-
ican College of Cardiology/American Heart Association
17-segmentmodel.26 This analysis was typically initiated us-
ing average intensity projections and set, by protocol, to nar-
row window and level settings (W300, L150). The reading
physician was allowed to adjust these display settings (after
an initial exploratory reading), and to change projections
(using, for instance, minimum intensity projections), as
needed. Stress images were typically analyzed as cine
images, using the multiphasic reconstruction. Physicians
were encouraged to analyze the multiphase cine first and
then to change between individual phases, as needed. This
approach had the advantage to allow simultaneous integra-
tion of perfusion informationwith regional wall motion anal-
ysis and helped to discriminate real perfusion defects from
artifacts, as the latter tend to change position from systole
to diastole. A side-by-side analysis of stress and rest
images was performed when hypo-intense areas compatible
with perfusion defects were identified in any of the volumet-
ric reconstructions (Fig. 3). This comparison was used to
differentiate inducible ischemia from artifacts or scar.
Hypo-intense areas detected in multiple phases during stress
and absent at rest were classified as inducible perfusion
defects. Hypo-intense areas present at both stress and rest
were interpreted as scar (classified as positives for CAD) if
compatible with a coronary artery territory distribution and
involving predominantly the subendocardium. Defects pre-
sent at rest but not during stress were classified as artifacts.
Each of the 17 segments was classified based on the
presence and transmural extent of perfusion defects (suben-
docardial vs transmural). Readerswere asked to determine if a
myocardial perfusion defect was present and, in case of a
positive finding, to identify the potential vessel(s) involved,
integrating the informationperceived fromboth perfusion and
contractility analysis. Image quality and degree of confidence
were classified independently using 4-class scales: from poor
to excellent and from very unconfident to very confident,
respectively. Similar to CTA analysis, interobserver disagree-
ments were resolved by consensus in a joint session.
During the entire period of patients’ participation in the
study, MDCT (calcium score, CTA, and CTP) results were
withheld to avoid influencing clinical management and XA
interpretation.
X-ray coronary angiography
XA was performed according to standard techniques by
experienced cardiologists. Vascular access was obtained
through a femoral or radial approach with Seldinger
technique using 5- to 7-Fr catheters. The interventional
cardiologists involved in this procedure were unaware of
the MDCT results and were asked to analyze all the
coronary segments and to identify all the visually perceived
stenoses. All the detected stenoses were then quantified
using QCA (Siemens Leonardo XP, IC3D v 1.6.8.83A,
Paieon, Siemens AG, Berlin and Munich, Germany) by 2
independent readers (B.M. and L.S., both with 7 years of
experience), blinded to the MDCT results. Because there
was not a significant difference between these 2 measure-
ments (r 5 0.95), their average was used for analysis.
Radiation exposure
Effective radiation dose exposure for each component of
the stress-rest integrated perfusion protocol was calculated
by the method proposed by the European Working Group
for Guidelines on Quality Criteria in CT. The effective
radiation dose was calculated by the product of the chest
Figure 2 Simplified scheme of MDCT protocol.
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Figure 3 Case illustrating CT perfusion analysis. (A) Short-axis thick-MPR reconstructions at basal, midventricular, and apical slices (from
left to right) during first passage of contrast under adenosine stress in different phases of the cardiac cycle (25%, 55%, and 85%, from top to
bottom). Hypo-intensity in the anterior and septal wall is noticed in the stress images during the entire cardiac cycle. Location of each slice is
represented in the end of each row, in long axis view (right column). (B) Short-axis thick-MPR reconstructions at basal, midventricular, and
apical slices (from left to right) during stress (upper row) and rest (lower row). The defect is present during stress but not in rest images. A
misalignment artifact is visible in the rest images; this type of artifact is more frequent in the prospective scan and does not usually preclude
identification of perfusion defects. (C) CTA angiography showing calcified and noncalcified plaques (left, maximal intensity projection; right,
curved multiplanar reconstruction). (D) Significant stenosis of LAD was confirmed in x-ray coronary angiography.
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coefficient (0.014) and the dose-length product (DLP)
obtained during each scan.27
Statistical analysis
Three different approaches using the MDCT data were
tested for the prediction of CAD as assessed by QCA using 2
different cutoffs for the definition of CAD (50% and 70%
stenoses). The first approach consisted in the use of CTA
results alone; the second approach was based solely in CTP
results. Finally, an integrated protocol applied CTA analysis
results in all cases but for those segments classified as
uninterpretable or nonevaluable (significant stenoses could
not be excluded but were not definitively present); for these
situations CTP results were used. Basically, the integrated
protocol was composed of CTA results in all segments where
the CTA diagnosis was clear and of CTP results when CTA
analysis was doubtful (as previously stated, these segments
were classified as positives in the isolated CTA analysis).
The diagnostic performance of CTA alone, CTP alone, and
the integrated protocol for the detection of significant
(R50%) or higher-grade stenosis (R70% or 50% in LM)
was evaluated against QCA as the reference standard.
Agreement between these different approaches and inva-
sive QCA was estimated at vessel-based and patient-based
levels. Sensitivity, specificity, PPV,NPV, andoverall accuracy
were estimated for each of the 3 approaches as tests and QCA
as a gold standard indicating the true disease status. Ninety-
five percent confidence intervals were calculated based on the
binominal distribution. As previously stated, ‘‘nonevaluable’’
coronary segments in CTAwere coded as being positive for
CAD. Intermodality agreements between each of the MDCT
protocols and invasive QCAwere expressed as kappa values.
Separate analyses were carried out by Coronary Artery
Calcification (CAC) categories according to the Agatston
Calcium Score (CaSc) and in obese (BMI R30 kg/m2)
versus nonobese patients.
Myocardial CTP intraobserver and interobserver agree-
ments were tested and expressed as kappa values. All data are
described as means and standard deviations for continuous
variables and as percentages for categorical variables. A
P value,0.05 was considered significant. All analyses used
SPSS analysis software (Release 17, SPSS Inc, Chicago, IL).
Results
All 90 patients completed the integrated MDCT protocol
and invasive XAwithout adverse effects. One patient did not
complete the rest acquisition because of equipment failure
but was kept in the study because images obtained during
stress were sufficient for confident CTA and CTP diagnosis.
In all the others, it was possible to obtain images for calcium
scoring, CTA, stress, and rest perfusion. Image quality was
classified as moderate/good in 82% for CTA (87% in
nonobese vs 73% in obese, nonsignificant [NS]) and 89%
for CTP (92% vs 81%, NS). Good reproducibility of CTP
analysis was found, with good intraobserver (kappa 5
0.56) and interobserver agreement (kappa 5 0.48). The ef-
fective radiation of the entire protocol was 5.5 6 0.7 mSv
(3.5 to 8.1 mSv). Mean heart rates were 776 17 (minimum
44; maximum 118) beats per minute during the stress acqui-
sition and 63 6 7 (minimum 49; maximum 81) beats per
minute during rest. Invasive QCA confirmed CAD (R50%
stenoses) in 48 (53%) patients. StenosesR70% (or 50% in
LM) were present in 37 (41%) patients.
Patient-based analysis
Diagnostic patient-based performances are summarized
in Tables 3 and 4. Isolated CTA analysis had a very high
sensitivity for detection of significant (98%) or higher-
grade (100%) CAD. As expected, however, specificity
and PPV were low (71% and 80% for stenoses R50%,
and 67% and 69% for stenosesR70%, respectively). If un-
interpretable/nonevaluable segments were excluded from
these analyses, however, isolated CTA would have a very
high global accuracy of 97% for the detection of CAD, us-
ing both the defined cutoffs (sensitivity: 96%/100%, speci-
ficity: 97%/95% for detection of stenosisR50% orR70%,
respectively). CTP, conversely, had higher specificity
(100% and 98%, according to the 50% or 70% cutoff, re-
spectively), at a cost of lower sensitivity (54% and 66%,
respectively).
The integration of data from CTP analysis when CTA
did not exclude but could not absolutely confirm the
presence of CAD (integrated protocol) changed these
values to a sensitivity of 83%, specificity of 98%, PPV of
98%, and NPV of 84% for significant CAD detection, and
sensitivity of 95%, specificity of 94%, PPV of 92%, and
NPV of 96% when the 70% cutoff is considered. The
overall accuracy for significant CAD detection was 86% for
CTA, 76% for CTP and 90% for the integrated protocol.
For detection of stenoses R70%, accuracy was 81% for
CTA, 84% for CTP, and 94% for the integrated protocol.
Integration of the perfusion analysis results was shown
to be beneficial in all Agatston score classes (,10, 10–399,
400–999, and R1000) but was particularly advantageous
for the diagnosis of higher-grade stenoses (R70%) in
patients with higher scores (sensitivity of 92%, specificity
of 93%, overall accuracy of 93%), mainly owing to the low
specificity of CTA (40%). In these patients with severely
calcified coronary arteries, CTA is limited, and the addic-
tion of perfusion may help in discriminating patients with
severely obstructing CAD. The same could be said about
obese patients: despite being useful in all patients, the
additive value of the integrative analysis was particularly
notorious in patients with BMI R30 kg/m2 (global accur-
acy of 85% and 88% for detection ofR50% orR70% ste-
noses, respectively).
The receiver operating characteristic analysis for the
prediction of CAD (as assessed by QCA) is represented in
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Figure 4. Areas under the curve (AUC) for significant CAD
detection were 0.85 (95% confidence interval [CI] 0.76–
0.94) for CTA alone, 0.77 (95% CI 0.67–0.87) for CTP
alone and 0.91 (95% CI 0.84–0.97) for the integrated pro-
tocol. The integration of results had the best overall perfor-
mance in all scenarios but was particularly advantageous in
the prediction of higher-grade CAD, with an AUC of 0.93
(95% CI 0.86–0.99), compared with 0.80 (95% CI 0.71–
0.89) for isolated CTA and 0.82 (0.72–0.92) for CTP.
Vessel-based analysis
Diagnostic vessel-based performances are summarized in
Tables 5 and 6. For vessel-based analysis, each coronary seg-
ment was assigned to one of the 4 ‘‘main vessels’’ (right coro-
nary artery, left main, left anterior descending artery, and
circumflex artery). A total of 360 vessels (90 patients ! 4)
were used for analysis. Of these, 96 had at least one segment
inwhich it was not possible to definitely diagnose or to exclude
a significant stenosis. In those segments, the integrative ap-
proach followed CTP results for the vessel territory (22 were
positive and 74 were negative for inducible perfusion defects).
Areas of perfusion defects in CTP were identified using
the 17 myocardial segments and initially assigned to one or
more of these vessels, according to the CTP readers,
considering the usual distribution of the coronary territo-
ries, as previously described. In a later stage, vessel
dominance obtained from angiography was used to decide
which vessel supplied the inferior and inferoseptal seg-
ments and if the anterolateral wall was supplied by LAD
(through a diagonal branch or circumflex through an obtuse
marginal artery). Based on this knowledge, the initial
assignment done by the reader could be changed to ensure
a correct association of the signalized defect with the
correct vascular territory. LM was considered when both
LAD and LCX territories were involved: these 3 vessels
were then signalized as positives.
Invasive QCA confirmed stenosis R 50% in 89 vessels
(25%) and stenosis R 70% in 62 vessels (17%). When
compared with isolated CTA, integration of CTP results
increased accuracy in vessel-based analysis (88% vs 83%
for the 50% cutoff and 91 vs 79% for the 70% cutoff). This
was observed for the global analysis and for each coronary
artery individually. As noted also in patient-based analysis,
this improved performance was achieved because of an
increase in specificity at a cost of a slightly decreased
sensitivity.
Discussion
In this prospective study, we report the incremental
value of myocardial CTP as an adjunctive tool to CTA for
the diagnosis of significant CAD in patients with
intermediate-to-high pretest probability. The main finding
of our investigation is that an integrated protocol of CTA
and myocardial CTP improves MDCT accuracy for detec-
tion of significant and higher-grade coronary stenoses, as
assessed by QCA, and performs better than CTA alone in
this population. Of notice, these results were obtained using
standard acquisition protocols that are available in all
current clinical MDCT scanners, and not only in the
Figure 4 Receiver-operating characteristic (ROC) curves. Isolated CTA, isolated CTP, and integrated protocol as predictors of significant
(A) or higher-grade (B) CAD. Integrated protocol had the best diagnostic performance in both analyses.
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last-generation scanners with higher temporal resolution
and higher number of detectors.
An additional contribution of this study is the limitation of
tube voltage to a maximum of 100 kVand implementation of
strict tube current modulation in all stress scans. The mean
radiation dose used for the entire protocol is much lower than
reported in similar previous studies, using both 64-MDCTand
DSCT, which means that low-dose perfusion protocols might
be ready for use in clinical practice, without a significant
increase of radiation exposure, even in obese patients.
For the first time, an integrated protocol of stress-rest
perfusion and CTA was tested in a population of sympto-
matic patients with suspected CAD and no previously
documented CAD. Different from most previous studies,
the protocol was not optimized for isolated perfusion anal-
ysis but for an integrative approach of CTA plus CTP, taking
advantage of the volumetric acquisitions allowed by MDCT.
Therefore, the acquired images were used not only to
evaluate perfusion feasibility and diagnostic accuracy but
also to access CTA. The study was designed to test if the
addition of stress-rest perfusion analysis would increase
diagnostic accuracy of a standard prospective MDCT pro-
tocol in patients with intermediate to high pretest probability.
Compared with previous published studies, CTP analy-
sis had a lower rate of false positives and, therefore, higher
specificity. We believe that the simultaneous visualization
of perfusion and contraction using multiphase cine images
may have contributed to these results. In contrast to prior
studies, this integration may have allowed a better
discrimination of true findings from artifacts. The potential
drawback is a decreased sensitivity, as inducible contrac-
tion abnormalities appear later in the ischemic cascade.
Because CTA is highly sensitive, however, it is reasonable
to keep CTP as specific as possible, taking advantage of the
potential integration of results.
Interestingly, the addition of a functional test such as CTP
improved the diagnostic accuracy of MDCT, even when the
comparison standard was kept entirely morphologic (degree
of stenosis as assessed by invasive QCA). As could be
expected, integration of perfusion results in global MDCT
analysis was particularly useful in the diagnosis of higher-
grade stenosis (R70%), as these are more frequently
responsible for perfusion deficits. Despite the wide range
of degrees of stenoses that may cause ischemia, it seems of
undeniable relevance the improved specificity allowed by
the use of this integrative approach in the detection of these
particularly relevant stenotic lesions. The ability to have, in
the same examination, different types of information con-
cerning CAD makes stress-rest perfusion MDCT protocols
very attractive, especially in higher risk populations: if the
concern is still to keep a high sensitivity, wemay follow CTA
results; however, if a more specific test is needed to
differentiate degrees and severity of CAD, integration of
perfusion analysis may add value to MDCT.
One particular case is that of extremely calcified arteries.
It is well known the limitations that heavy calcification of
the coronary arteries poses to CTA. In this group of
patients, we are usually interested in discriminating the
Table 5 Vessel-based analysis of CTA, CTP, and integrative protocol in predicting significant CAD (stenosis R 50%)
CAD
(%) n TP TN FP FN k Sensit. (%) Specif. (%) PPV (%) NPV (%) 1LR 2LR Accu. (%)
CTA alone 24.7 360 81 217 54 8 0.61 91 (84–96) 80 (78–82) 60 (55–63) 96 (94–98) 4.57 0.11 83 (79–85)
CTP alone 24.7 360 32 260 11 57 0.39 36 (29–41) 96 (94–98) 74 (60–86) 82 (80–84) 8.86 0.67 81 (78–84)
Integ Prot 24.7 360 54 263 8 35 0.64 61 (54–65) 97 (95–99) 87 (77–94) 88 (86–90) 20.55 0.41 88 (85–90)
RCA
CTA alone 30.0 90 24 46 17 3 0.54 89 (73–97) 73 (66–77) 59 (48–64) 94 (85–98) 3.29 0.15 78 (68–83)
CTP alone 30.0 90 9 61 2 18 0.36 33 (20–39) 97 (91–99) 82 (50–97) 77 (73–79) 10.50 0.69 78 (70–81)
Integ Prot 30.0 90 14 61 2 13 0.55 52 (38–58) 97 (91–99) 88 (64–98) 82 (77–85) 16.33 0.50 83 (75–87)
LM
CTA alone 4.4 90 4 81 5 0 0.59 100 (42–100) 94 (92–94) 44 (19–44) 100 (97–100) 17.20 0.00 94 (89–94)
CTP alone 4.4 90 0 80 6 4 20.06 0 (0–56) 90 (93–96) 0 (0–37) 95 (95–97) 0.00 1.08 89 (89–94)
Integ Prot 4.4 90 3 84 2 1 0.65 75 (24–99) 98 (95–99) 60 (19–79) 99 (96–100) 32.25 0.26 97 (92–99)
LAD
CTA alone 40.0 90 34 37 17 2 0.59 94 (83–99) 69 (61–72) 67 (58–70) 95 (84–99) 3.00 0.08 79 (69–83)
CTP alone 40.0 90 17 53 1 19 0.50 47 (37–50) 98 (91–100) 94 (73–100) 74 (68–75) 25.50 0.54 78 (69–80)
Integ Prot 40.0 90 27 53 1 9 0.76 75 (64–78) 98 (91–100) 96 (83–100) 85 (79–87) 40.50 0.25 89 (80–91)
LCX
CTA alone 24.4 90 19 53 15 3 0.54 86 (67–96) 78 (72–81) 56 (44–62) 95 (87–99) 3.92 0.17 80 (71–85)
CTP alone 24.4 90 6 66 2 16 0.31 27 (14–35) 97 (93–100) 75 (37–96) 80 (77–82) 9.27 0.75 80 (73–84)
Integ Prot 24.4 90 10 65 3 12 0.48 45 (29–55) 96 (90–99) 77 (49–94) 84 (80–87) 10.30 0.57 83 (75–88)
Accu., accuracy; CAD, coronary artery disease; CTA, computed tomography angiography; CTP, computed tomography perfusion; FN, false-negative; FP,
false-positive; Integ Prot, integrated protocol; k, kappa value; LAD, left artery descendent; LCX, left circumflex artery; LM, left main; PPV, positive
predictive value; NPV, negative predictive value; RCA, right coronary artery; Sensit., sensitivity; Specif., specificity; TN, true-negative; TP, true-positive;
1LR, positive likelihood ratio; 2LR, negative likelihood ratio.
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presence of higher degrees of stenoses and visual analysis
of vessel lumen is significantly hampered by calcium.
Previous studies reported a low CTA accuracy in patients
with an Agatston calcium score higher than 400.1,28 There-
fore, some centers exclude these patients from CTA and
proceed to functional tests or invasive angiography. Our
study once more confirmed the reduced accuracy of CTA
with higher calcium scores, mainly owing to reduced spec-
ificity. Overall accuracy of the integrated protocol was also
comparatively lower in this group; however, the huge in-
crease of specificity shown when compared with isolated
CTA may justify the use of CTP in these patients.
According to our data, an MDCT protocol including an
initial acquisition for calcium score quantification could be
used to guide subsequent acquisitions: if no calcium or low
calcification is present, we could probably skip the stress
acquisition, focusing the aim of the MDCT study in a correct
luminal assessment, and placing all efforts in reducing heart
rate and acquisition artifacts; then, if needed (unevaluable
segments present), stress perfusion MDCT could still be
performed at a second time, taking advantage of the CTP
incremental value in this context. In most patients with
higher calcium scores (R400), an integrated protocol of
stress-rest perfusion would most probably represent an
added accuracy (mainly owing to a higher specificity) for
detection of significant/higher-grade CAD. Therefore, its
use immediately following the CAC acquisition would be
recommended, aiming to reduce false positives (that would
end being referred to further testing) and, eventually, to spare
unnecessary catheterizations or to guide treatment if an
invasive angiography is later performed.
If our findings can be confirmed in future studies, the use
of stress-rest perfusion protocols may extend MDCT indi-
cations to higher risk/higher pretest probability populations
presently restricted to other imaging approaches, based on
ischemia detection.
Study limitations
We acknowledge that this study has multiple limitations.
Only patients without known CAD and an intermediate to
high pretest probability were included. As such, these results
may not apply to other groups of patients referred for CTA.
Another limitation concerns the study design itself: to validate
a stress-rest MDCT integrated protocol, 2 contrasted scans
were performed separated by a few minutes. This approach
has the advantage of clinical applicability but is associated
with some drawbacks, mainly related to optimization of heart
rate for theCTA scan, and contrast redistribution. In our study,
stress scan was performed first, with no medication given,
aiming to optimize sensitivity in this crucial part of the
protocol. Rest scan was then performed after nitrates (and
beta-blockers, if applicable). At the time of the second scan,
an important contrast redistribution already occurred. This
has the advantage of minimizing residual intravascular con-
trast circulation, as indicated for perfusion analysis, but could
Table 6 Vessel-based analysis of CTA, CTP, and integrative protocol in predicting higher-grade CAD (stenosis R 70%)
CAD
(%) n TP TN FP FN k Sensit. (%) Specif. (%) PPV (%) NPV (%) 1LR 2LR Accu. (%)
CTA alone 17.2 360 60 242 56 2 0.58 97 (89–99) 81 (80–82) 52 (47–53) 99 (97–100) 5.15 0.04 84 (81–85)
CTP alone 17.2 360 30 285 13 32 0.50 48 (39–56) 96 (94–97) 70 (56–81) 90 (88–92) 11.09 0.54 88 (84–90)
Integ Prot 17.2 360 43 286 12 19 0.68 69 (60–77) 96 (94–98) 78 (67–87) 94 (92–95) 17.22 0.32 91 (88–94)
RCA
CTA alone 24.4 90 20 52 16 2 0.55 91 (72–98) 76 (71–79) 56 (44–60) 96 (88–99) 3.86 0.12 80 (71–84)
CTP alone 24.4 90 9 66 2 13 0.46 41 (25–48) 97 (92–100) 82 (50–97) 84 (79–86) 13.91 0.61 83 (76–87)
Integ Prot 24.4 90 11 65 3 11 0.52 50 (33–60) 96 (90–99) 79 (52–94) 86 (81–88) 11.33 0.52 84 (76–89)
LM
CTA alone 4.4 90 4 81 5 0 0.59 100 (42–100) 94 (92–94) 44 (19–44) 100 (97–100) 17.20 0.00 94 (89–94)
CTP alone 4.4 90 0 80 6 4 20.06 0 (0–56) 90 (93–96) 0 (0–37) 95 (95–97) 0.00 1.08 89 (89–94)
Integ Prot 4.4 90 3 84 2 1 0.65 75 (24–99) 98 (95–99) 60 (19–79) 99 (96–100) 32.25 0.26 97 (92–99)
LAD
CTA alone 27.8 90 25 47 18 0 0.59 100 (86–100) 72 (67–72) 58 (50–58) 100 (91–100) 3.61 0.00 80 (72–80)
CTP alone 27.8 90 17 64 1 8 0.73 68 (54–72) 98 (93–100) 94 (74–100) 89 (84–90) 44.20 0.33 90 (82–92)
Integ Prot 27.8 90 23 61 4 2 0.84 92 (77–99) 94 (88–96) 85 (72–91) 97 (91–99) 14.95 0.09 93 (85–97)
LCX
CTA alone 12.2 90 11 62 17 0 0.47 100 (70–100) 78 (74–79) 39 (28–39) 100 (95–100) 4.65 0.00 81 (74–81)
CTP alone 12.2 90 4 75 4 7 0.36 36 (14–59) 95 (92–98) 50 (19–80) 91 (88–94) 7.18 0.67 88 (82–93)
Integ Prot 12.2 90 6 76 3 5 0.55 55 (28–72) 96 (93–99) 67 (34–90) 94 (90–96) 14.36 0.47 91 (85–96)
Accu., accuracy; CAD, coronary artery disease; CTA, computed tomography angiography; CTP, computed tomography perfusion; FN, false-negative; FP,
false-positive; Integ Prot, integrated protocol; k, kappa value; LAD, left artery descendent; LCX, left circumflex artery; LM, left main; PPV, positive
predictive value; NPV, negative predictive value; RCA, right coronary artery; Sensit., sensitivity; Specif., specificity; TN, true-negative; TP, true-positive;
1LR, positive likelihood ratio; 2LR, negative likelihood ratio.
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lead to potential difficulties of stress-rest image interpretation
in the cases where myocardial scar is present. This should
have aminor impact on the study, however, in that (1) patients
with known previous myocardial infarction were excluded,
and (2) for the study purposes it is almost indifferent if CAD is
detected owing to a true stress-induced reversible defect or by
a previous ischemic subendocardial scar that is mistaken for
reversible ischemia. In addition, to facilitate comparisons of
stress and rest perfusion, rest images were acquired at the
same phase as those acquired with higher tube current output
during the stress scan (65%of the R-R interval). This diastolic
phasewas found to be appropriate for CTA analysis in thevast
majority of cases; however, it is admissible that in patients
with higher heart rates, the use of other phases (namely
systolic ones) could have some benefit in terms of image
quality and overall accuracy.
Furthermore, the ‘‘per-protocol’’ limitation of tube voltage
to 100 kV could have a potential negative impact in CTA
evaluation, especially in obese patients, artificially increasing
the additive value of the integrated analysis in this subgroup.
Nevertheless, no significant differences were reported in
terms of CTA image quality and diagnostic confidence when
obese and nonobese patients were compared.
Importantly, the definition of significant CAD as assessed
by QCA in our study was based solely on anatomic/
morphologic features of the coronary lumen. It is well known
that lumen visualization is not a good predictor of the
functional significance of a coronary stenosis.15,20,29 The
use of this anatomical gold standardmay emphasize thevalue
of CTA in detriment of the functional assessment obtained by
myocardial CTP. Therefore, the additive value of myocardial
CTP for detection of obstructive CAD may be even better
than what was shown in our study if a more physiological
measure is used as standard.
In addition, although a separate analysis of CTA and
myocardial CTP was done for the study purposes (trying to
differentiate the different inputs of these 2 components into
the final diagnosis), it should be noted that, despite the use
of a different filter for each of these analyses, the informa-
tion concerning both perfusion and coronary anatomy was
always present in the volume reconstructions used by each
reader. Therefore, even if an effort was made to describe
each finding separately, there may be some degree of
involuntary contamination (integration) of information
obtained from CTA in the perfusion analysis and vice-
versa. Nonetheless, we believe that this is not a major issue
in the validation of our study: in the clinical scenario the
same contamination/integration of information would hap-
pen and the interpretation of the examination would be
done by simultaneous visualization and interpretation of
myocardial perfusion and coronary anatomy.
Finally, given the rapid evolution of scanner hardware,
the diagnostic accuracy of newer scanners with more
detectors and higher temporal resolution might be different.
The higher temporal resolution achieved may translate in
fewer artifacts and improved perfusion visualization. We
feel, however, that one of the major contributions of our
work is to demonstrate that CTP is feasible with current
single-source 64 MDCT scanners, and that it may add
important information to be taken in consideration in
clinical management.
Conclusions
The integration of functional and morphological data
using CTA and CTP improved MDCT accuracy for detec-
tion of clinically relevant CAD in this intermediate to high
pretest probability population.
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Objectives This study sought to compare the diagnostic performance of a multidetector computed tomography (MDCT) inte-
grated protocol (IP) including coronary angiography (CTA) and stress-rest perfusion (CTP) with cardiac magnetic
resonance myocardial perfusion imaging (CMR-Perf) for detection of functionally significant coronary artery dis-
ease (CAD).
Background MDCT stress-rest perfusion methods were recently described as adjunctive tools to improve CTA accuracy for
detection of functionally significant CAD. However, only a few studies compared these MDCT-IP with other clini-
cally validated perfusion techniques like CMR-Perf. Furthermore, CTP has never been validated against the inva-
sive reference standard, fractional flow reserve (FFR), in patients with suspected CAD.
Methods 101 symptomatic patients with suspected CAD (62 ! 8.0 years, 67% males) and intermediate/high pre-test
probability underwent MDCT, CMR and invasive coronary angiography. Functionally significant CAD was defined
by the presence of occlusive/subocclusive stenoses or FFR measurements !0.80 in vessels "2mm.
Results On a patient-based model, the MDCT-IP had a sensitivity, specificity, positive and negative predictive values of 89%,
83%, 80% and 90%, respectively (global accuracy 85%). These results were closely related with those achieved by
CMR-Perf: 89%, 88%, 85% and 91%, respectively (global accuracy 88%). When comparing test accuracies using non-
inferiority analysis, differences greater than 11% in favour of CMR-Perf can be confidently excluded.
Conclusions MDCT protocols integrating CTA and stress-rest perfusion detect functionally significant CAD with similar accu-
racy as CMR-Perf. Both approaches yield a very good accuracy. Integration of CTP and CTA improves MDCT per-
formance for the detection of relevant CAD in intermediate to high pre-test probability populations. (J Am Coll
Cardiol 2013;61:1099–107) © 2013 by the American College of Cardiology Foundation
Multidetector computed tomography (MDCT) is the es-
tablished noninvasive reference standard for the assessment
of coronary artery anatomy. It is particularly useful for the
exclusion of coronary artery disease (CAD) in patients with
intermediate-to-low pre-test probability, largely because of
its high negative predictive value (NPV) (1,2). However, a
major limitation of this technique is its low specificity and
positive predictive value (PPV) (3). Decision on the signif-
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icance of MDCT-findings gen-
erally involves additional studies,
as the degree of stenosis is often
overestimated and the physio-
logic significance of many lesions
remains uncertain (4,5). Further-
more, its diagnostic accuracy is
severely limited by calcification,
reducing the value in patients with
higher pre-test probability. In those
cases, it is generally preferable to use
functional tests, capable of detecting
myocardial ischemia (6).
MDCT perfusion (CTP) has
been recently described as a poten-
tial tool for ischemia detection and
preliminary studies proved the in-
cremental value of integrating
CTP and CTA for the detection
of obstructive CAD as assessed by
invasive x-ray coronary angiogra-
phy (xA) in high-risk populations
(7,8). However, a comparison of
theseMDCT integrated protocols (MDCT-IP) with established
stress perfusion techniques like cardiovascular magnetic resonance
(CMR) myocardial perfusion imaging (Perf) (9–11) and frac-
tional flow reserve (FFR), considered the invasive standard for
assessing the functional significance of CAD (12) is missing.
The aim of this study was to compare the diagnostic
accuracy of a MDCT-IP (including CTA and stress-rest
myocardial CTP) with CMR-Perf for the detection of
functionally significant CAD, using FFR as the reference
standard.
Methods
Population. One-hundred-seventy-six consecutive pa-
tients referred to the cardiology outpatient clinic for assess-
ment of CAD were prospectively screened from January/
2010 to November/2011. Inclusion criteria were: age !40
years, symptoms compatible with CAD and !2 risk-factors
or a positive/inconclusive treadmill-test. Exclusion criteria
included clinical instability, known CAD, valvular heart
disease, atrial fibrillation, creatinine clearance "60 ml/min
and standard contraindications to CMR, contrast media
and adenosine. A total of 139 eligible patients were tested
for exclusion criteria. Figure 1 summarizes the study flow
and reasons for exclusions. The final population consisted of
101 individuals with an intermediate or high pre-test
probability (Table 1) (13). The local research ethics com-
mittee approved the study protocol and written informed
consent was obtained from all participants.
Study design. Patients were scheduled for CMR and
MDCT scans in the week before xA and were instructed to
refrain from smoking, coffee, tea, aminophylline, beta-
blockers, calcium antagonists and nitrates for 24-hours
before the tests. At the time of xA, FFR was measured in all
major patent coronary arteries with !40% diameter steno-
sis. CMR and MDCT results were fully blinded.
CMR protocol. CMR-Perf was performed using estab-
lished protocols on a 1.5-T Siemens Symphony (Siemens,
Erlangen, Germany) using a 12-channel receiver coil (14).
Three short-axis slices (basal, mid-ventricular, apical) per
heartbeat were imaged at apnoea during the first pass of a
gadolinium bolus (0.07 mmol/kg) using a gradient-echo
sequence during maximal hyperaemia (intravenous adeno-
sine 140 #g·kg"1·min"1) and at rest. Long- and short-axis
cinematic images were obtained using a steady-state free-
precession breath-hold sequence for volumetric and func-
tional analyses. Late-gadolinium-enhancement imaging
(LGE) using a 2D phase-sensitive inversion-recovery
breath-hold sequence was performed !10 min after the last
administration of contrast (11).
MDCT scan protocol. The MDCT stress-rest protocol
was performed as previously described, using a Somatom
Sensation 64 scanner (Siemens Medical Solutions, Forch-
heim, Germany) (15). No pre-test medication was
administered.
After calcium-scoring, a retrospectively gated scan during
the first-passage of contrast medium (iopromide, 80 ml, at
4.5 ml/s) during adenosine infusion (140 #g·kg"1·min"1
for 3 to 6 min) was obtained (tube voltage: 100 kV; tube
current modulation with full tube current [600 mAs] ap-
plied at 60% to 65% of the RR interval; collimation, 64 #
0.6 mm) using a bolus-tracking technique in the ascending
aorta (threshold: 150 HU; delay, 4 s). Adenosine infusion
was discontinued immediately after stress acquisition.
If the heart rate exceeded 65 beats/min at 3 min after
suspension of adenosine (n $ 44), fractionated boluses of
intravenous metoprolol (5 to 20 mg) were administered
targeting a heart rate "60 beats/min. All patients received
0.05 mg of sublingual nitroglycerine 5 min prior to the rest
scan. This scan was acquired 10 min after the stress scan,
using prospective triggering (65% of cardiac cycle interval;
100 kV; 110 mAs). Timing and contrast injection were
similar to the stress scan, using a test-bolus technique.
CMR analysis. Two blinded independent readers analysed
all CMR images. In cases of disagreement, a third reader
adjudicated. Perfusion defects were defined as subendocar-
dial or transmural dark areas compared to remote healthy
myocardium, persisting for at least 10 frames. Stress and rest
scans were viewed simultaneously, and areas of hypoperfu-
sion were assigned to the ventricular segments, using the
standard 17-segment model, excluding the apex (16). LGE
was analysed simultaneously and used to differentiate areas
of scar from induced ischemia. Regional wall motion or scar
alone was not regarded as a sign of ischemia/CAD. Only
areas with ischemia on perfusion imaging were regarded as
positive; patients with scar but no additional ischemia were
classified as negatives. Image quality and degree of confi-
dence were classified using four-class scales: from poor to
Abbreviations
and Acronyms
CAD ! coronary artery
disease
CMR ! cardiac magnetic
resonance
CTA ! computed
tomography angiography
CTP ! computed
tomography perfusion
FFR ! fractional flow
reserve
IP ! integrated Protocol
MDCT ! multidetector
computed Tomography
Perf ! myocardial perfusion
imaging
NPV ! negative predictive
value
PPV ! positive predictive
value
xA ! x-ray coronary
angiography
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excellent and from very unconfident to very confident,
respectively.
MDCT analysis. For CTA analysis both stress and rest
acquisitions were used. From the stress acquisition, a set of
10 (5% to 95%) plus 1 (60%) phases was reconstructed using
a standard soft frequency cardiac filter (Siemens-B25f), with
a slice-thickness of 0.6mm. From rest, a single-phase (65%)
reconstruction was obtained using the same slice thickness
and filter. Resulting datasets were anonymized, sent to a
post-processing workstation (Aquarius; TeraRecon Inc.,
San Mateo, California) and analyzed by two blinded readers
using the 17-segment modified AHA classification (17).
Each segment was graded according to stenoses: 1 !
normal; 2!"50%; 3! 50% to 70%; 4!!70%/occlusion;
5 ! uninterpretable.
For myocardial CTP analysis, similar reconstructions
were obtained using the same parameters but with a very
smooth frequency filter (Siemens-B10f). The same blinded
readers performed a visual analysis of these images at a
different time point of the study, according to the standard
17-segment model (16) using standard 10-mm-thick mul-
tiplanar reformat planes (short-axis, 2, 3, and 4 chambers).
This analysis was typically initiated using average intensity
projections and set to narrow window (W) and level (L)
settings (W300/L150), but the reading physician was al-
lowed to adjust settings and projections, as needed. Stress
images were typically analyzed as cinematic images, taking
advantage of the multiphasic reconstruction and integrating
perfusion with regional wall motion analysis. This approach
helped in the differentiation of perfusion defects from
artifacts, which tend to change position from systole to
diastole. A side-by-side comparison of stress and rest
images was also used to differentiate inducible ischemia
from artifacts or scar. The same criteria used for defining
functionally significant CAD in CMR-Perf analysis were
applied for CTP. Image quality and degree of confidence
were classified as described for CMR. Interobserver dis-
agreements were resolved by consensus.
MDCT radiation exposure estimation. Effective radiation
dose exposure was calculated by the method of the Euro-
Figure 1 Study Flow Chart and Reasons for Exclusions
Of the 176 screened patients, 139 met inclusion criteria; of those, 15 had exclusion criteria and 11 refused written informed consent. Twelve patients were excluded for
not completing the protocol as planned. The 101 patients composing the final population underwent cardiac magnetic resonance (CMR), multidetector computed tomo-
graphy (MDCT), and coronary catheterization with no adverse events. CAD ! coronary artery disease; EKG ! electrocardiogram; FFR ! fractional flow reserve.
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pean working group: product of the chest coefficient (0.014)
and the dose-length product (DLP) obtained during each
scan (18).
X-ray coronary angiography and FFR assessment. xA
was performed according to standard techniques. When
arteries with stenosis !40% were visually perceived, pres-
sure wire (Certus; St. Jude Medical, St. Paul, Minnesota)
was used to determine vessel FFR by using RadiAnalyzer
(St. Jude Medical, St. Paul, Minnesota) under steady-state
hyperemia (intravenous adenosine, 140 !g·kg"1·min"1, 3
to 6 min). Arteries were recorded as having significant CAD
if they had a FFR "0.80, if they were occluded/subtotally
occluded, or if there was severe left main (LM) disease
(!50%). This functionally significant CAD was defined as
the reference standard against which MDCT and CMR-
Perf were compared.
Assignment of perfusion segments to the corresponding
vascular territory. For vessel-based analysis, areas of per-
fusion defects in CTP and CMR were identified using the
16 myocardial segments. Each segment was assigned to one
of the 3 “main vessels”: right coronary artery (RCA), left
anterior descending (LAD), and circumflex (LCX). To
ensure correct association of the 16 myocardial segments
with the correct vascular territory, xA visualization of vessel
dominance was used to decide if the inferior and inferosep-
tal territories were supplied by the RCA or the LCX. For
the distal segment of the inferior wall, an eventual LAD
supply was also considered. Additionally, the basal and mid
anterolateral segments were assigned to the LCX or LAD
vessel depending on whether obtuse marginal or diagonal
branches were responsible for the blood supply of those
territories (16).
Statistical analysis. The diagnostic performances of
MDCT (CTA alone, CTP alone, MDCT-IP) and CMR
for the detection of functionally significant CAD were
compared against FFR as the reference standard. The
“unevaluable” segments/arteries in CTA were coded as
being positive for CAD when CTA alone was considered;
in the MDCT-IP, they were classified as negative or
positive, according to the CTP results of their territory (Fig. 2).
CTP performance in detecting reversible myocardial isch-
emia was also evaluated having CMR-Perf as the reference
standard.
All continuous variables were expressed as mean # SD,
whereas categorical variables were expressed as percentages.
The McNemar test was used to calculate differences be-
tween proportions (sensitivity, specificity and accuracy)
obtained from paired observations. Cohen’s kappa statistic
was used to assess intermodality and intra/interobserver
agreements. The area under the receiver-operator charac-
teristic curve (AUC $ C-statistic) was calculated and
compared for all diagnostic-testing strategies taking FFR as
gold-standard. Specific methods to test noninferiority for
paired binary data (19) and ROC curves (20) were used to
calculate the minimal noninferiority margin that we are able
to detect with the present sample size and to perform a
formal power analysis. Statistical analyses were performed
using MedCalc for Windows, version 12.3.0.0 (MedCalc
Software, Mariakerke, Belgium). A p value %0.05 was
considered statistically significant.
Results
All patients completed the study protocol without adverse
effects. CMR and MDCT scans were performed within 9#
8.2 days before xA.
CMR scans. Image quality was classified as poor in 2
patients, moderate in 20, good in 57, and excellent in 22.
Readers felt unconfident in the diagnosis of 8 patients,
confident in 60 and very confident in 33. Forty-six patients
and 70 of the 303 vascular territories had perfusion defects
suggestive of ischemia during stress (Fig. 3); 30 were in the
Population CharacteristicsTable 1 Population Characteristics
n 101
No. of males (% of total) 68 (67%)
Age, yrs (range) 62# 8.0 (41–79)
Body mass index, kg/m2 (range) 28.0# 4.45 (19.9–45.2)
Symptoms 101 (100%)
Typical angina 25 (25%)
Atypical angina 49 (49%)
Chest pain 22 (22%)
Dyspnea on exertion/ fatigue 5 (5%)
Hypercholesterolemia 80 (79%)
Hypertension 73 (72%)
Diabetes mellitus 39 (39%)
Positive smoking history 34 (34%)
Current smoker 14 (14%)
Ex-smoker 20 (20%)
Family history of premature CAD 21 (21%)
#2 CRF 85 (84%)
Systolic blood pressure (mm Hg) 147# 21.9 (99–184)
Diastolic blood pressure (mm Hg) 78# 10.8 (57–102)
Abdominal circumference in cm (range) 98# 10.3 (76–126)
Modified Diamond-Forrester score (range) 14.2# 2.7 (9–20)
On regular medication 90 (89%)
Aspirin or clopidogrel 54 (53%)
Statin 66 (65%)
ACEi or A2 receptor blockers 52 (51%)
Beta-blocker 68 (67%)
Agatston score (median-min-max) 291 (0–5879)
CAC " 10 19 (19%)
CAC 11–100 20 (20%)
CAC 101–400 17 (17%)
CAC 401–1,000 26 (26%)
CAC !1,000 19 (19%)
Any stenosis !40% 54 (53%)
Any significant stenosis (FFR " 0.80) 44 (44%)
Single-vessel disease 24 (24%)
Double-vessel disease 12 (12%)
Triple-vessel disease 8 (8%)
Left main disease 5 (5%)
Values are n (%) or mean # SD (95% CI) (%) unless otherwise stated.
ACEi $ angiotensin-converting enzyme inhibitor; A2 $ angiotensin 2.
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LAD territory, 15 in the LCX territory, and 25 in the RCA
territory. Sixteen patients had an ischemic pattern of LGE.
Intraobserver and interobserver agreements for CMR-Perf
in per-patient analysis produced a kappa of 0.71 and 0.57,
respectively (substantial agreement).
MDCT scans. Image quality was classified as poor in 9
patients, moderate in 39, good in 52 and excellent in 1.
Readers felt unconfident in 49 cases, confident in 47 and
very confident in 5. Mean radiation exposure of the entire
MDCT protocol was 5.0 ! 0.96 (3.7 to 8.9) mSv. Thirty-
three (33%) patients had at least 1 unevaluable segment –
usually because of the presence of extensive calcification.
Among the patients who had fully interpretable scans, 10
had no atherosclerotic disease, 25 had mild disease ("50%
stenosis), and 33 had stenosis!50%. When the unevaluable
segments were considered to represent significant disease,
65 patients were categorized as having significant CAD.
CTP inducible defects were identified in 34 patients and in
46 (15%) of the vascular territories; 190 segments had
adenosine-induced subendocardial (88%) or transmural
(12%) perfusion defects. CTP had good intraobserver
(kappa# 0.66) and interobserver agreement (kappa# 0.44)
in per-patient analysis.
FFR results. Fifty-four patients with visually perceived
diameter stenosis $40% were considered for FFR assess-
ment. Arteries without any identifiable plaque (n # 179) or
with mild ("40%) disease (n # 29) had no FFR measure-
ments. Vessels with a luminal diameter "2 mm (n # 10)
were also excluded. There were 19 completely occluded
arteries and 11 subtotally occluded arteries in which FFR
could not be measured but regarded as positive. Addi-
tionally, in 9 vessels with long sections of severe disease
and heavily calcified lesions associated with tortuous
anatomy and/or low TIMI-flow after intracoronary ni-
trates, FFR assessment was considered an unacceptable
risk and was not performed. Furthermore, in 5 patients
with LM disease FFR was not performed in any vessel of
the left coronary. Lesions in which FFR could not be
measured because of anatomy or disease complexity were
considered positive for the purpose of the comparison
with CMR-Perf and CTP. A total of 36 diseased,
unoccluded vessels (n # 27) were evaluated using FFR
assessment. Using this approach, 72 arteries were classi-
fied as positives. Single-vessel disease was seen in 24
patients; 12 had double-vessel disease and 8 had triple-
vessel disease.
Figure 2 MDCT Integrated Protocol Interpretative Algorithm
The MDCT integrated protocol (IP) was classified positive if a definitive luminal obstruction (!50%) was detected on computed tomography coronary angiography (CTA) or
if a perfusion defect was detected on computed tomography coronary perfusion (CTP) in a territory corresponding to a lesion of uncertain significance on CTA. The IP was
deemed negative if no stenosis$50% were detected on CTA or if no perfusion defects were found in areas supplied by vessels with uncertain findings on CTA. CAD #
coronary artery disease. MDCT # multidetector computed tomography.
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Figure 3 Five Cases Illustrating CMR-Perf, CTP, and Angiographic Findings in Patients With CAD
(A) Stress cardiac magnetic resonance perfusion (CMR-Perf) shows inducible ischemia in the septum and anterior wall (arrow shows dark area of hypoperfusion). Com-
puted tomography coronary perfusion (CTP) is concordant and x-ray invasive coronary angiography (xA) confirms a stenosis (arrowhead) in the LAD. (B) Both CMR-Perf
and CTP show a dark area of fixed hypoperfusion (arrows) in the inferior and inferoseptal wall, corresponding to an occluded right coronary artery as seen on xA.
(C) Both CMR-Perf and CTP were able to identify the reversible hypoperfusion (arrow) caused by a significant stenosis on the left circumflex artery. (D) Significant left
main disease as seen on xA (arrowhead) causing hypoperfusion on both left anterior descendent and left circumflex territories (arrows) on CMR-Perf and CTP. (E) Inter-
mediate (70%) stenosis in the mid left anterior descendent artery (arrowhead) causing functional ischemia detected by CMR-Perf and CTP (arrows) and confirmed using
fractional flow reserve (FFR ! 0.76).
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Patient-based analysis. Patient and vessel-based perfor-
mances are summarized in Table 2. Of the 46 patients with
a positive CMR-Perf scan, 39 had functionally significant
CAD in at least 1 vessel. Of the 55 patients with normal
CMR-Perf scans, 50 were true-negatives. CMR-Perf had
very good sensitivity (89%) and specificity (88%). PPV and
NPV were 85%, and 91%, respectively.
Isolated CTA analysis had an excellent sensitivity and
NPV (100%) for detection of functionally significant CAD.
However, specificity and PPV were low (61% and 67%,
respectively). CTP, conversely, had higher specificity (93%)
with lower sensitivity (68%; p ! 0.001 for both). The
integrated MDCT protocol that results from integration of
functional data from CTP with the anatomic data from
CTA when the later is not sufficient for a confident
diagnosis (Fig. 2) had a sensitivity of 89%, and specificity of
83%. This represents a significant increase of specificity
(p " 0.005) with a nonsignificant decreased sensitivity (p "
0.06). The overall accuracy for functional significant CAD
detection was 78% for CTA, 82% for CTP and 85% for the
MDCT integrated protocol.
C-statistics for detection of functionally significant CAD
were similar for CMR-Perf (AUC " 0.88, 95% CI:0.81 to
0.96) and MDCT-IP (AUC " 0.86, 95% CI:0.77 to 0.93;
p " 0.52). They had the same sensitivity (89%) and
nonsignificant differences in specificity (88% vs. 83%, p "
0.61). Isolated CTP (AUC " 0.81, 95% CI: 0.71 to 0.90)
tends to perform worse than CMR-Perf (p " 0.06), having
similar specificity (93% vs. 88%, p " 0.51) but significantly
inferior sensitivity (68% vs. 89%, p ! 0.005). CMR-Perf
had the best performance in discriminating functional
relevance of CAD in patients with stenosis #40% (AUC "
0.84, 95% CI: 0.72 to 0.93). Its performance in this
subgroup of 54 patients was superior to CTA (AUC "
0.60, 95% CI: 0.46 to 0.73; p " 0.03), but nonsignificantly
superior to CTP (AUC " 0.79, 95% CI: 0.66 to 0.89; p "
0.34). CTP was clearly superior to CTA in this setting (p"
0.02). When only the 67 patients with intermediate pre-test
probability were analysed similar results were found: inte-
gration of CTP with CTA significantly increased MDCT
specificity from 63 to 85% (p " 0.004) and accuracy was
similar for MDCT-IP and CMR-Perf (87% vs. 88%,
p " 1.0).
Vessel-based analysis. A total of 303 vessels (n " 101)
were analyzed. CMR-Perf had the best performance for
functionally significant CAD detection (AUC " 0.87, 95%
CI: 0.82 to 0.90), clearly outperforming CTP (AUC "
0.75, 95% CI: 0.70 to 0.85; p " 0.0003) but not CTA
(AUC " 0.81, 95% CI: 0.75 to 0.85) or MDCT-IP (AUC "
0.80, 95% CI: 0.75 to 0.85), despite the tendency found
(p " 0.08 for both). Furthermore, the MDCT-IP (p "
0.05) but not isolated CTA (p " 0.09) performed signifi-
cantly better than isolated CTP. When only vessels that
effectively received FFR assessment were considered for
analysis, a nonsignificant tendency favouring CMR-Perf
over the MDCT-IP was seen (AUC " 0.75 vs. 0.58,
respectively, p " 0.06). In this particular case, CTP and
CTA performances did not differ significantly (AUC "
0.65 for both, p " 0.99) with a clear advantage of CTA in
terms of sensitivity (95% vs. 42%, p " 0.002) and of CTP
in terms of specificity (88% vs. 35%, p " 0.004).
CTP using CMR-Perfusion as a reference standard.
CTP performance in detecting reversible myocardial isch-
emia having CMR-Perf as reference standard is presented
in Table 3. In per-patient analysis, isolated CTP had good
overall accuracy (82%) in identifying inducible perfusion
defects visualized on CMR-Perf, with a sensitivity of 67%
and specificity of 95%. PPV was 91% and NPV 78%.
Noninferiority analysis. Using either the C-statistic or the
accuracy analysis results for the noninferiority analysis, an
11% noninferiority limit would be needed to conclude for
the noninferiority of MDCT-IP in comparison with CMR-
Perf. For the present sample size, and for a nominal
significance level of 0.05, the 11% noninferiority limit was
estimated with a power of 81.8%. Thus, based on our
Comparison of Diagnostic Protocols in Predicting Functionally Significant CAD (FFR <0.80)Table 2 Comparison of Diagnostic Protocols in Predicting Functionally Significant CAD (FFR <0.80)
CAD (%) n TP TN FP FN k
% Sensit.
(95% CI)
% Specif.
(95% CI)
% PPV
(95% CI)
% NPV
(95% CI) !LR "LR
% Accu.
(95% CI)
Patient-based
CTA alone 43.6 101 44 35 22 0 0.58 100 (92 to 100) 61 (55 to 61) 67 (61 to 67) 100 (89 to 100) 2.59 0.00 78 (71 to 78)
CTP alone 43.6 101 30 53 4 14 0.62 68 (58 to 74) 93 (85 to 98) 88 (75 to 96) 79 (72 to 83) 9.72 0.34 82 (73 to 87)
MDCT Int to
Prot
43.6 101 39 47 10 5 0.70 89 (78 to 95) 83 (74 to 88) 80 (70 to 86) 90 (82 to 96) 5.05 0.14 85 (76 to 91)
CMR-Perf 43.6 101 39 50 7 5 0.76 89 (79 to 95) 88 (80 to 93) 85 (75 to 91) 91 (83 to 96) 7.22 0.13 88 (79 to 94)
Vessel-based
CTA alone 24.1 303 69 155 75 4 0.47 95 (87 to 98) 67 (65 to 69) 48 (44 to 50) 97 (94 to 99) 2.90 0.08 74 (70 to 76)
CTP alone 24.1 303 40 219 11 33 0.56 55 (46 to 61) 95 (93 to 97) 78 (66 to 88) 87 (84 to 89) 11.46 0.47 85 (81 to 89)
MDCT Int-Prot 24.1 303 52 206 24 21 0.60 71 (62 to 79) 90 (87 to 92) 68 (59 to 76) 91 (88 to 93) 6.83 0.32 85 (81 to 89)
CMR-Perf 24.1 303 58 215 15 15 0.73 79 (71 to 86) 93 (91 to 96) 79 (71 to 86) 93 (91 to 96) 12.18 0.22 90 (86 to 93)
Values for sensitivity, specificity, PPV, and NPV and accuracy are presented with 95% CI.
Accu. " accuracy; CAD " coronary artery disease; CTA " computed tomography angiography; CTP " computed tomography perfusion; CMR " cardiac magnetic resonance; FN " false-negative; FP "
false-positive; Int-Prot " integrated protocol; k " kappa value; MDCT " multidetector computed tomography; Perf " myocardial perfusion imaging; PPV " positive predictive value; NPV " negative
predictive value; Sensit. " sensitivity; Specif. " specificity; TN " true negative; TP " true positive; $LR " positive likelihood ratio; %LR " negative likelihood ratio.
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results, a difference !11% in favour of CMR-Perf com-
pared to MDCT-IP can be confidently excluded.
Discussion
This is the first study to directly compare CTP against
CMR-Perf using FFR as reference standard. Our main
findings are: 1) both CMR-Perf and MDCT-IP have an
excellent sensitivity and very good specificity for the detec-
tion of functionally significant CAD and their overall
performances are similar; 2) isolated CTP is globally inferior
to CMR-Perf for diagnosis of CAD but is very specific; and
3) addition of CTP to CTA increases MDCT global
accuracy for functionally significant CAD detection in
patients with intermediate to high pre-test probability,
mainly because of a significant increase in specificity. Thus,
a 64-MDCT morphologic and functional integrated proto-
col using standard available hardware and software may be
as effective as CMR-Perf standard protocols for detection of
functionally significant CAD.
Previous smaller studies compared CTP with SPECT or
CMR using QCA or visual estimation of stenosis severity as
the gold standard (21–23). Only one study compared CTP
against FFR in patients with known CAD (24). Evidence
shows that patients should be guided by the physiological
importance of a stenosis rather than luminal assessment and
FFR has emerged as the reference invasive tool to provide this
information (12).
Of note, in our study, both MDCT and CMR results were
obtained using standard acquisition protocols available in
current clinical MDCT and MR scanners. Tube voltage
limitation to a maximum of 100 kV, strict tube current
modulation in the stress scans and the use of prospective
scanning at rest resulted in a low radiation exposure (lower
than in previous 64-MDCT studies) (7,8,25). Based on our
results, low-dose perfusion protocols might be ready for rou-
tine use in clinical practice, without a significant increase of
radiation exposure, using standard 64-MDCT scanners: the
entire MDCT protocol, including Calcium-scoring, CTA and
CTP is completed with an effective radiation exposure that
represents less than one half of the exposure usually reported
for SPECT (21).
CMR-Perf results are in line with published studies and the
excellent accuracy of the method in symptomatic intermediate-
to-high risk patients is confirmed. Stress and rest perfusion
were simultaneously visualized with LGE images resulting in
very good accuracy for ischemia detection. Interestingly, inte-
gration of isolated ischemic scar detection as a marker of CAD
in the CMR-Perf interpretation algorithm did not improve
overall performance for functionally significant CAD detection
(data not shown). CMR has several advantages over MDCT
for the detection of myocardial ischemia: it does not expose
patients to ionizing radiation and provides dynamic real-time
imaging of myocardial perfusion over the first-passage of
contrast (26). MDCT perfusion is limited to the “one-shot”
opportunity to visualize differences of x-ray attenuation be-
tween the ischemic and remote myocardium. However, a
previous study evaluating myocardial blood flow quantification
showed that the difference in upslope between ischemic and
normal myocardium remains relatively constant for several
seconds during the entire arterial phase, after a minimum delay
of 12 s (27). Our imaging time point was chosen to be within
this constant wash-in phase. A potential advantage of CTP
over CMR is the ability to acquire high-resolution isotropic
3D “whole heart” datasets that allow for simultaneous coronary
anatomy and myocardial perfusion analysis. This may be of
particular interest for decision and management of revascular-
ization.
Isolated CTP results are also in line with previous studies.
However, a slightly lower sensitivity is noticed in our study.
This could be justified by scanner limitations in this low-
radiation 64-MDCT protocol. Simultaneously, a lower rate of
false positives is noticed, resulting in higher specificity. CTP
performed equally well in patients with or without ischemic
scar revealing that it is capable of detecting perfusion defects
that represent true ischemia and not only scar (data not
shown). Furthermore, CTP performance in discriminating
functionally relevant CAD in patients with stenosis!40% as
assessed by xA was clearly superior to CTA. We have recently
shown that the addition of CTP to CTA improves diagnostic
accuracy of MDCT as assessed by invasive QCA, mainly
because of an increased specificity in heavily calcified coronary
arteries (15). Not surprisingly, the use of a functional standard
in current study confirms this finding and highlights the
advantage of functional and anatomic integration.
CTP intra- and interobserver agreement was only mod-
erate and self-reported confidence was lower compared with
CMR. This is an expected finding, as CMR-Perf is a
well-validated, clinically implemented and better-established
technique. The use of a new technique, despite the similarities,
involves a certain degree of uncertainty and a learning curve
that may explain the results.
Study limitations. Several limitations may decrease gener-
alizability of findings: single-center study, exclusion of
patients with known CAD or low pre-test probability and of
Analysis of CTP in Predicting Reversible Perfusion Defects as Assessed by CMR-PerfTable 3 Analysis of CTP in Predicting Reversible Perfusion Defects as Assessed by CMR-Perf
CAD (%) n TP TN FP FN k
% Sensit.
(95% CI)
% Specif.
(95% CI)
% PPV
(95% CI)
% NPV
(95% CI) !LR "LR
% Accu.
(95% CI)
Patient-based 45.5 101 31 52 3 15 0.82 67 (58–72) 95 (86–99) 91 (78–98) 78 (71–81) 12.36 0.34 82 (73–87)
Vessel-based 24.1 303 40 219 11 33 0.56 55 (46–61) 95 (93–97) 78 (66–88) 87 (84–89) 11.46 0.47 85 (81–89)
Values for sensitivity, specificity, PPV, and NPV and accuracy are presented with 95% CI.
Abbreviations are as in Table 2.
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patients with contraindications, such as renal dysfunction or
atrial fibrillation. The latter may be present in a significant
proportion of patients with suspected CAD (20% of study
exclusions) and is unclear which test is more susceptible to
this arrhythmia. The studied population may not be reflec-
tive of the usual population sent for CTA or stress testing as
only symptomatic intermediate/high pre-test probability
patients were recruited, including high-risk patients that are
not usually referred for stress-testing but rather directly to
xA. To address this issue, a subanalysis exclusively including
patients with intermediate pre-test probability was
performed.
FFR was only measured in vessels with intermediate steno-
ses and a significant proportion of diseased vessels had to be
excluded from this evaluation. While this was performed to
avoid potential iatrogenic complications, an eventual bias may
exist. To minimize this limitation, a subanalysis of vessels with
an effective FFR assessment was performed.
The MDCT protocol was based on a single-source 64-
MDCT scanner with its known technical limitations, such as
low temporal resolution and misalignment artifacts, which may
be overcome with more advanced technology. However, it is
important to note that low dose CTP imaging is available
today and yields important information missed by CTA alone.
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examinations before or at least 4 hours after MPI are needed.
Other services in which medical staff have prolonged close
patient contact should occur outside of this window. If resched-
uling cannot occur, the use of lead aprons by staff working closely
with patients should be considered during the ﬁrst 4 h following
MPI.
Experts have suggested that it is difﬁcult to generate deﬁnitive
conclusions about the health risks attributable to radiation
doses<50 mSv in 1 year or<100 mSv over a lifetime (5). Although
it is unlikely that repeated exposure to post-MPI patients will exceed
these limits in adults, our data suggest that close and repeated
contact should be avoided in populations that are more radiosen-
sitive, such as pregnant women and children.
An estimation of the total effective dose equivalent was not the
subject of our study and would be exceedingly challenging given the
variability in the time of exposure, distance, and body position. Our
measures of radiation exposure are routinely performed by radiation
safety departments.
MPI is an important tool in the evaluation of patients for coro-
nary artery disease, providing valuable diagnostic and prognostic
information. Current recommendations for the appropriate use of
MPI generally limit its use to those patients with at least interme-
diate risk, inability to exercise, an abnormal baseline electrocardio-
gram, or other situations in which the risk–beneﬁt ratio is favorable.
Our data conﬁrm that radiation exposure to hospital personnel and
the public can be minimized by maintaining adequate distance from
the patient. Instituting appropriate changes in scheduling, the use of
lead shielding, and patient education can further aid in reducing
radiation exposure in others.
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APPENDIX
For more details on the methods, as well as supplemental ﬁgures, please
see online version of this article.
Letters to the Editor
Multidetector Computed
Tomography Stress-Rest
Perfusion Imaging for
Detection of Coronary
Artery Disease
Dr. Bettencourt and colleagues compare the diagnostic perfor-
mance of multidetector computed tomography (MDCT) stress-
rest perfusion imaging (using signiﬁcantly lower dose radiation)
with cardiac magnetic resonance myocardial perfusion imaging
(CMR-Perf) for detection of functionally signiﬁcant coronary
artery disease with fractional ﬂow reserve (FFR) as reference
standard (1).
It would be interesting to know the following. First, did the
authors make an attempt to compare performance of computed
tomography perfusion (CTP) and CMR-Perf among patients
with multivessel disease or those with >70% stenosis? Second, did
the authors make an attempt to investigate the lesions labeled
“false positive” on CTP, which could be incorrectly labeled as
“false positive” in setting of nonobstructive coronaries (due to
thrombus recannalization or post-percutaneous coronary interven-
tion)? The authors measured FFR in vessels with >40% stenosis;
however, abnormal FFR can be found in vessels with lesser degree
of stenosis (2). This is more important in setting of microvascular
disease, which has worse prognosis. CTP could be particularly
helpful in such scenario due to its high resolution and ability to
evaluate parameters of endothelial function and microvascular
circulation (3).
Though use of 17-segment model to compare CTP and CMR-
Perf is itself not perfect, due to overlap of segments between various
coronary territories, the current report is a welcome step in the
ongoing search for “1-stop” cardiac imaging modality.
However, an important practical limitation of CTP at this time
is need for designated software for image analyses and substantial
expertise to interpret images and make accurate diagnoses. Further,
as patient population in current study was very selective, it would be
interesting to see in future studies how MDCT-integrated protocol
performs in “real world.”
*Abhishek Sharma, MD
*Maimonides Medical Center, New York
1016 50th Street, Apartment 2C
Brooklyn, New York 11219
E-mail: abhisheksharma4mamc@gmail.com
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Reply
We thank Dr. Sharma for the interest in our paper (1) and the
recognition of our work as “a welcome step in the ongoing search
for one-stop cardiac imaging modality.” Dr. Sharma highlights
some of the advantages and limitations of our approach and focuses
on several points that merit discussion.
How did computed tomography perfusion (CTP) and cardiac
magnetic resonance myocardial perfusion imaging (CMR-Perf)
perform among patients with multivessel disease (MVD) or high-
grade stenosis? A signiﬁcant proportion of our patients (n ¼ 20)
had MVD as assessed by fractional ﬂow reserve (FFR). In this sub-
group, CMR-Perf and integrative multidetector computed tomo-
graphy integrated protocol (MDCT-IP) had similar sensitivity
(95%) and performed better than isolated CTP (65%). In patients
with MVD as assessed by quantitative coronary angiography (QCA)
(n ¼ 23), CMR-Perf achieved a per-vessel accuracy of 80%
(sensitivity ¼ 77%; speciﬁcity ¼ 86%) performing better than CTP
(accuracy ¼ 58%; sensitivity ¼ 44%; speciﬁcity ¼ 90%). In patients
with stenoses "70% on QCA (n ¼ 44), CMR-Perf was also
superior, with a per-vessel accuracy of 87%, sensitivity of 81%, and
speciﬁcity of 94% (vs. 71%, 55%, and 89% for CTP, respectively).
Nevertheless, CTP speciﬁcity was very important for MDCT-IP
per-vessel performance in these subgroups (accuracies of 68% and
75%, respectively) as computed tomography angiography classiﬁed
almost all these vessels as either “signiﬁcant disease” or “unevaluable.”
Could the false positive CTP be rather misclassiﬁcations in the
setting of nonobstructive coronaries due to thrombus recanalization
or post-percutaneous coronary intervention (PCI)? Following the
study protocol, patients with known coronary artery disease,
including previous infarction and PCI, were excluded and only the
areas with reversible hypoperfusion were classiﬁed as positive.
While perfusion defects at rest and stress were found in 16 patients,
all of these corresponded to scar (conﬁrmed by late gadolinium
enhancement) and were not considered as a marker for functionally
signiﬁcant coronary artery disease to avoid “an incorrect label of
false positive” in comparison with a functional standard.
While we acknowledge that FFR was only determined in
stenosis >40% and that occasionally abnormal FFR can be found
in vessels with lesser degree of narrowing, this is rare. Similarly,
no FFR was performed in patients with subocclusive stenoses or
with tortuous/calciﬁed/complex lesions, which may induce some
remaining level of inaccuracy. The use of a functional reference is
an important improvement compared to the vast majority of pub-
lished studies. However, FFR is not an optimal reference standard,
as it does not account for the amount of ischemic burden. We also
recognize overlap of segments between coronary territories when
a segment-based analysis is used. Having this in consideration, per-
vessel analysis was performed assigning the perfusion segments to
the corresponding vascular territory, as assessed by invasive coro-
nary angiography.
Finally, we support Dr. Sharma’s statement emphasizing the
need for designated CTP software and substantial expertise for
image interpretation, which is still time consuming and observer
dependent. Radiation exposure and the need for medication for
computed tomography angiography are other important limitations
for a generalized use of MDCT-IP. Nevertheless, simultaneous
morphologic and functional analysis is already possible, as we have
shown using a single-source 64-slice generation scanner.
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Comparison of Cardiac Magnetic
Resonance and Computed
Tomography Stress-Rest
Perfusion Imaging for Detection
of Coronary Artery Disease
In their recent paper, Dr. Bettencourt and colleagues (1) report
similar accuracy for the detection of coronary artery disease (CAD)
between cardiac magnetic resonance (CMR) perfusion and an inte-
grated computed tomography (CT) perfusion/angiography protocol.
Unfortunately, the authors did not interpret their CMR images
in the standard way (2,3), which may limit the applicability of
their ﬁndings. They state that only areas with ischemia on CMR
perfusion imaging were regarded as positive for CAD and that
patients with late gadolinium enhancement (LGE) scar but no
additional ischemia were classiﬁed as negative for CAD. Thus,
patients with infarction and an occluded or severely stenotic
supplying vessel would be incorrectly classiﬁed as having no CAD
by their CMR protocol. For this reason, areas of LGE in an infarct
pattern are typically interpreted as demonstrating the presence of
CAD (2,3). Becausew16% of the patients in this study had LGE
in an infarct pattern, it would be useful to know the diagnostic
performance of CMR if standard interpretation of LGE were used.
JACC Vol. 62, No. 4, 2013 Correspondence
July 23, 2013:351–6
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Reply
We are thankful for the interest from Drs. Bauml and Farzaneh-
Far in our paper (1) and the opportunity to provide further
detail of our research. The point highlighted merits discussion
and focuses on an interesting ﬁnding. Considering the presence
of a previous myocardial infarction assessed by late gadolinium
enhancement (LGE) as a marker of signiﬁcant coronary artery
disease (CAD) makes sense for establishing the correct diagnosis.
(2). From the viewpoint of diagnostic accuracy, it has the ad-
vantage of avoiding “false negatives” in patients with infarctions
subtended by occluded or severely stenotic vessels while at the
same time it has the disadvantage of increasing the rate of “false
positives” in the setting of ischemic scar with nonobstructive
coronaries (e.g., due to thrombus with spontaneous resolution).
However, more important than establishing the correct diagnosis
is to inform on the best management strategy (3) a concept that is
vastly underrepresented in the imaging literature. As such, it is
more important to detect ischemia, rather than coronary artery
stenoses, as a stenotic vessel supplying an infarcted territory
without remaining ischemia does not require revascularization.
One of the main components for the success of fractional ﬂow
reserve is based on this understanding, despite the fact that
fractional ﬂow reserve does not account for the ischemic burden.
In our study population, there was 1 additional false positive
patient without reduction of the false negatives when scar
was added as a criterion for signiﬁcant CAD (Table 1). While
this observation further supports the noninferiority of an
integrated computed tomography protocol (including angiog-
raphy and perfusion) to a cardiac magnetic resonance myo-
cardial perfusion imaging/LGE approach, it is important to
highlight the importance of scar assessment in this group of
patients. Even though LGE does not improve the accuracy of
perfusion for the detection of signiﬁcant CAD, it does have
important prognostic implications (4) and may impact patient
management.
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Table 1 CMR in Predicting Functionally Signiﬁcant Coronary Artery Disease (Fractional Flow Reserve !0.80)
TP TN FP FN Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
CMR-Perf (reversible ischemia) 39 50 7 5 89 (79–95) 88 (80–93) 85 (75–91) 91 (83–96) 88 (79–94)
CMR-Perf/LGE (ischemic scar
OR reversible ischemia)
39 49 8 5 88 (78–95) 86 (78–91) 83 (73–89) 91 (82–96) 87 (78–93)
Values are n or percentage (95% conﬁdence interval). n ¼ 101, prevalence for coronary artery disease ¼ 43.6%.
CMR-Perf ¼ cardiac magnetic resonance myocardial perfusion imaging; FN ¼ false negative; FP ¼ false positive; LGE ¼ late gadolinium enhancement; NPV ¼ negative predictive value; PPV ¼ positive
predictive value; TN ¼ true negative; TP ¼ true positive.
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CAD Detection in Patients With
Intermediate-High Pre-Test Probability
Low-Dose CT Delayed Enhancement Detects Ischemic Myocardial Scar With
Moderate Accuracy But Does Not Improve Performance of a Stress-Rest CT
Perfusion Protocol
Nuno Bettencourt, MD,*yz Nuno Dias Ferreira, MD,* Daniel Leite, MD,* Mónica Carvalho,*
Wilson da Silva Ferreira,* Andreas Schuster, MD, PHD,x Amedeo Chiribiri, MD, PHD,y
Adelino Leite-Moreira, MD, PHD,z José Silva-Cardoso, MD, PHD,z Eike Nagel, MD, PHD,y
Vasco Gama, MD*
Vila Nova de Gaia and Porto, Portugal; London, United Kingdom; and Göttingen, Germany
OBJECTIVES This study sought to compare computed tomography delayed enhancement (CTDE)
against cardiac magnetic resonance (CMR) late gadolinium enhancement (LGE) for detection of ischemic
scar and to test the additive value of CTDE as part of a comprehensive multidetector computed tomog-
raphy (MDCT) stress–rest protocol including computed tomography perfusion (CTP) and computed to-
mography angiography (CTA) for the diagnosis of signiﬁcant coronary artery disease (CAD).
BACKGROUND CTDE has been recently described as a promising tool for noninvasive detection of
myocardial scar, similarly to CMR-LGE techniques. Despite its theoretical potential as an adjunctive tool to
improve MDCT accuracy for detection of CAD, its clinical performance has not been validated.
METHODS One hundred ﬁve symptomatic patients with suspected CAD (age 62.0 ! 8.0 years, 67%
men) underwent MDCT, CMR, and x-ray invasive coronary angiography. The MDCT protocol consisted of
calcium scoring, stress CTP under adenosine 140 mg/kg/min, rest CTP þ CTA, and a low-dose radiation
prospective scan for detection of CTDE. CMR-LGE was used as the reference standard for assessment
of scar. Functionally signiﬁcant CAD was deﬁned as the presence of $90% stenosis/occlusion or frac-
tional ﬂow reserve measurements #0.80 in vessels >2 mm.
RESULTS CTDE had good accuracy (90%) for ischemic scar detection with low sensitivity (53%) but
excellent speciﬁcity (98%). Positive and negative predictive values were 82% and 91%, respectively.
On a patient-based model, MDCT protocol without integration of CTDE results had a sensitivity, speci-
ﬁcity, and positive and negative predictive values of 90%, 81%, 80%, and 90%, respectively, for the detec-
tion of functionally signiﬁcant CAD. Addition of CTDE results did not improve MDCT performance (90%,
77%, 77%, and 90%, respectively).
CONCLUSIONS CTDE has moderate accuracy for detection of ischemic scar in patients with sus-
pected CAD. Integration of CTDE into a comprehensive MDCT protocol including stress–rest CTP and
CTA does not improve MDCT accuracy for detection of signiﬁcant CAD in intermediate-to-high pre-
test probability populations. (J Am Coll Cardiol Img 2013;6:1062–71) ª 2013 by the American College
of Cardiology Foundation
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Multidetector computed tomography(MDCT) coronary angiography repre-sents the noninvasive gold standard forthe assessment of the coronary arterial
tree. It is particularly useful for the exclusion
of coronary artery disease (CAD) in patients
with intermediate/low pre-test probability, largely
because of its high negative predictive value (1).
However, in patients with higher pre-test proba-
bility, its performance is limited because the
physiological signiﬁcance of many lesions cannot
be assessed (2). To overcome this limitation,
MDCT stress–rest myocardial perfusion techniques
(computed tomography perfusion [CTP]) have been
described (3–6), and integrated protocols, providing
both morphological (computed tomography angiog-
raphy [CTA]) and functional (CTP) information in a
single MDCT exam, have been tested (7–13).
MDCT ability to identify myocardial ischemic scar
using computed tomography delayed enhancement
(CTDE) has also been reported. This technique fol-
lows the same principles applied to cardiovascular
magnetic resonance (CMR) late gadolinium enhance-
ment (LGE) and could be particularly valuable as part
of a MDCT protocol including CTA and CTP. The
feasibility of performing such a comprehensive exami-
nation has already been shown, but CTDE’s potential
as an adjunctive tool to improve MDCT accuracy for
the detection of CAD has never been validated (14).
The aim of this study was to evaluate the diagnostic
performance of low-radiation-dose CTDE for
detection of ischemic scar using CMR-LGE as the
standard and to test the additive value of CTDE as
part of an comprehensiveMDCTprotocol, including
CTA and stress–rest CTP, for the diagnosis of
functionally signiﬁcant CAD, using invasive x-ray
coronary angiography (XA) with fractional ﬂow
reserve (FFR) evaluation as the reference standard.
METHODS
Population. We prospectively screened 176 con-
secutive patients with suspected CAD referred
by general physicians to our hospital outpatient
cardiology clinic from February 2010 to November
2011. Inclusion criteria were age >40 years, symp-
toms compatible with CAD, and at least 1 of
the following: $2 risk factors or a positive/incon-
clusive treadmill test. Exclusion criteria included
unstable clinical status, known CAD, valvular heart
disease, atrial ﬁbrillation, creatinine clearance
#60 ml/min, and standard contraindications to
CMR, contrast media, and adenosine. A total of
139 eligible patients were tested for exclusion
criteria. Figure 1 summarizes the study ﬂow and
reasons for exclusions. Characteristics of the ﬁnal
population are summarized in Table 1.
Study design. After informed consent, patients
were scheduled for CMR and MDCT in
the week before XA. FFR was measured in
all major patent epicardial coronary arteries
with intermediate diameter stenoses (50%
to 90%) as assessed by quantitative coro-
nary angiography (QCA). CMR and
MDCT results were fully blinded.
CMR protocol. CMR was performed using
established protocols on a 1.5-T Siemens
Symphony Tim (Siemens, Erlangen, Ger-
many) using a 12-channel receiver coil (15).
Long- and short-axis cine images were ob-
tained using a steady-state free precession
breath-hold sequence for volumetric and
functional analysis. LGE imaging was per-
formed using a 2-dimensional phase-
sensitive inversion-recovery breath-hold
sequence $10 min after administration of
contrast (0.2 mmol/kg). The entire volume
of the heart was covered in 8-mm-thick
short-axis projections with a gap of 2 mm
between slices, and in standard long-axis
cardiac planes.
MDCT comprehensive protocol. MDCT stress–rest
protocol was performed as previously published,
with the addition of a low-radiation scan for CTDE
detection (Fig. 2) (8). All scans were performed
using a Somatom Sensation 64 scanner (Siemens
Medical Solutions, Forchheim, Germany) with no
pre-test medication. The comprehensive MDCT
protocol included 4 sequential acquisitions: calcium
scoring, stress CTP, rest CTP, and CTDE. Table 2
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A B B R E V I A T I O N S
A N D A C R O N YM S
CAD = coronary artery disease
CI = conﬁdence interval
CMR = cardiac magnetic
resonance
CTA = computed tomography
angiography
CTDE = computed tomography
delayed enhancement
CTP = computed tomography
perfusion
FFR = fractional ﬂow reserve
LGE = late gadolinium
enhancement
MDCT = multidetector
computed tomography
QCA = quantitative coronary
angiography
ROC = receiver-operating
characteristic
XA = x-ray invasive coronary
angiography
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summarizes the scan parameters of each portion of
the protocol.
First, a low-dose prospective scan to assess coro-
nary artery calciﬁcation was performed using estab-
lished protocols (16). Then, adenosine infusion (140
mg$kg!1$min!1 for 3 to 6 min) was started, and a
retrospectively gated scan was acquired during the
ﬁrst passage of contrast medium, using a bolus-
tracking technique. Adenosine infusion was dis-
continued immediately after stress acquisition.
Intravenous metoprolol targeting a heart rate
#60 beats/min was administered in patients whose
heart rate exceeded 65 beats/min 3 min after the
suspension of the adenosine infusion. All patients
received 0.5 mg of sublingual nitroglycerin before the
rest scan. The latter was acquired 10 min after the
ﬁrst contrast injection, using prospective triggering.
Timing and contrast administration were similar to
the stress scan, using a test-bolus technique. To
detect areas of CTDE, a fourth scan was performed
7.0 " 0.3 min after the rest scan using prospective
triggering at 65% of the RR interval. For this
acquisition, a ﬁxed tube voltage of 80 kV and a tube
current of 160 mA were used, and collimation was
increased to 1.2 mm. No additional contrast was
administered.
CMR analysis. Two blinded independent readers
analyzed all CMR images. In cases of disagreement,
a third reader adjudicated. Each of the 17 segments
was classiﬁed on the basis of the presence and
transmurality (subendocardial vs. transmural) of
scarddeﬁned as areas of myocardial enhancement
using LGE imaging. Ischemic scar was assumed
when subendocardial involvement was noted. Image
quality and the degree of conﬁdence in scar detec-
tion were classiﬁed independently using 4-class (0 to
3) scales: from poor to excellent and from very
unconﬁdent to very conﬁdent, respectively.
MDCT analysis. MDCT images were analyzed using
dedicated software (Aquarius Intuition version
4.4.6, TeraRecon, Foster City, California) on
dedicated workstations by 2 independent blinded
readers. Each component of the MDCT scan was
analyzed independently at a different time point of
the study.
Coronary calciﬁcation was calculated using an
effective slice thickness of 3 mm with a detection
threshold of 130 HU and reported as the mean
Figure 1. Study Flowchart and Reasons for Exclusions
CAD ¼ coronary artery disease; CI ¼ conﬁdence interval; CMR ¼ cardiac magnetic resonance; CTDE ¼ computed tomography delayed
enhancement; MDCT ¼ multidetector computed tomography; pts ¼ patients.
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Agatston score. For CTA and CTP analysis, both
stress and rest acquisitions were evaluated using sets
of 11 retrospective phases from the stress scan, and
a single-phase (65%) reconstruction from the rest
scan (8). Soft (Siemens-B25f) and very smooth
(Siemens-B10f) frequency ﬁlters were used for CTA
and CTP reconstructions, respectively. Resulting
CTA datasets were analyzed for detection of CAD
according to the 17-segment modiﬁed American
Heart Association classiﬁcation (17). On the basis of
the information obtained from both stress and rest
reconstructions, each segment was graded, accord-
ing to stenoses: 1 ¼ normal, 2 ¼ <50%, 3 ¼ 50% to
70%, 4 ¼ $70%/occlusion, 5 ¼ uninterpretable.
Analysis of CTP was performed according to the
standard 17-segment model, using 10-mm-thick
multiplanar reformat planes (short-axis and 2, 3, and
4 chambers) (18). Stress images were analyzed as
cines, integrating perfusion with regional wall mo-
tion information and compared with rest.
For CTDE analysis, a 65% single-phase recon-
struction was obtained using a very smooth ﬁlter
(Siemens-B10f) and a slice thickness of 1.2 mm.
Reading was performed using the same multiplanar
reformat planes and reporting model (18). It was
typically initiated using 10-mm-thick average in-
tensity projections, and set, by protocol, to narrow
window and level settings (W300, L150). The
reading physician was allowed to adjust these display
settings after an initial exploratory reading, and to
change slice thickness and projections as needed.
Each of the 17 segments was classiﬁed based on the
presence and transmurality (subendocardial vs.
transmural) of CTDE, deﬁned as areas of myocar-
dial enhancement when compared with remote re-
gions of the myocardium. Readers were asked to
determine whether ischemic scar was present and to
classify image quality and degree of conﬁdence, as
described for CMR. Interobserver disagreements
were resolved by consensus. Signal-to-noise ratio
(mean signal intensity/standard deviation of signal
intensity) of the CTDE scan was estimated using a
10-mm2 region of interest in the left ventricle.
MDCT RADIATION EXPOSURE ESTIMATION. Effec-
tive radiation dose exposure for each component of
the MDCT comprehensive protocol (calcium score,
stress CTA/CTP, rest CTA/CTP, and CTDE)
was calculated by the method proposed by the Eu-
ropean Working Group for Guidelines on Quality
Criteria in CT: product of the chest coefﬁcient
(0.014) and the dose-length product obtained dur-
ing each scan (19).
XA and FFR assessment. XA was performed ac-
cording to standard techniques. Excluding the left
main, arteries with a caliber>2mm and intermediate
stenosis (diameter stenosis $50% and <90%) as
assessed by QCA (Siemens Leonardo XP, Siemens
AG, Munich, Germany, and IC3D v1.6.8.83A
software, PaieonMedical, Rosh Ha’ayin, Israel) were
evaluated using pressure wire (PressureWire Certus,
Table 1. Patient Characteristics, N [ 105
Male 70 (67)
Age, yrs 62 " 8.0 (41–79)
Body mass index, kg/m2 27.9 " 4.43 (19.9–45.2)
Symptoms 105 (100)
Typical angina 27 (26)
Atypical angina 50 (48)
Chest pain 23 (22)
Dyspnea on exertion/fatigue 5 (5)
Hypercholesterolemia 83 (79)
Hypertension 75 (71)
Diabetes mellitus 40 (38)
Positive smoking history 34 (32)
Current smoker 14 (13)
Ex-smoker 20 (19)
Family history of premature CAD 21 (20)
$2 Cardiovascular risk factors 88 (84)
Systolic blood pressure, mm Hg 149 " 22.9 (99–184)
Diastolic blood pressure, mm Hg 79 " 10.7 (57–102)
Abdominal circumference, cm 98 " 10.8 (76–126)
Modiﬁed Diamond-Forrester score 14.2 " 2.60 (9–20)
On regular medication 93 (89)
Aspirin or clopidogrel 56 (53)
Statin 66 (63)
ACEi or A2 receptor blockers 51 (49)
Beta-blocker 38 (36)
Agatston calcium score 280 (0, 5,879)
#10 19 (18)
11–100 21 (20)
101–400 18 (17)
401–1,000 27 (26)
>1,000 19 (18)
Any stenosis $50% 59 (56)
Any functionally signiﬁcant stenosis 48 (46)
Single-vessel disease 24 (23)
Double-vessel disease 16 (15)
Triple-vessel disease 8 (8)
Left main disease 5 (5)
Values are n (%), mean " SD (95% conﬁdence interval), or median (minimum,
maximum).
ACEi¼ angiotensin-converting enzyme inhibitor; A2 ¼ angiotensin 2; CAD¼
coronary artery disease.
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St. Jude Medical, St. Paul, Minnesota). FFR was
determined by RadiAnalyzer (St. Jude Medical) un-
der steady-state hyperemia, obtained with intrave-
nous adenosine (140 mg/kg/min) infusion over 3 to 6
min. Arteries were recorded as having signiﬁcant
ﬂow-limiting disease if they had stenoses $90%
($50% in the left main stem) or had a FFR value
#0.80 in vessels >2 mm.
Statistical analysis. CTDE per-patient performance
for the detection of ischemic scar was tested against
CMR-LGE as the reference standard. The poten-
tial value of integrating CTDE with the combined
CTA þ CTP analysis was also tested as an additive
tool to increase MDCT performance for the
detection of functionally signiﬁcant CAD as
assessed by XA þ FFR. The diagnostic perfor-
mances of each component of MDCT (CTA,
CTP, and CTDE), as well as the integration
of CTA þ CTP (integrated protocol) and
CTA þ CTP þ CTDE (comprehensive protocol)
were compared against XA þ FFR as the reference
standard. Ninety-ﬁve percent conﬁdence intervals
(CI) were calculated based on the binominal dis-
tribution. “Nonevaluable” coronary segments in
CTA were coded as being positive for CAD when
CTA alone was considered; in the integrated pro-
tocol, they were classiﬁed as negative or positive for
functionally signiﬁcant CAD, according to the CTP
results of their territory. In the comprehensive pro-
tocol, these vessels were coded positive if scar was
detected in the corresponding territory; if not, they
were coded according to the CTP results, similar to
the integrated protocol (Fig. 3). CMR-LGE and
CTDE intraobserver and interobserver agreements
were tested using Cohen’s kappa statistic.
All data are described as means and standard de-
viations for continuous variables and as percentages
for categorical variables. Differences in continuous
variables were assessed using Student paired t tests.
The area under the receiver-operating characteristic
(ROC) curve was calculated for all diagnostic-testing
strategies using XA þ FFR assessment as the gold
standard. A p value<0.05was considered signiﬁcant.
Data analysis was performed using SPSS analysis
software (Release 17, SPSS, Chicago, Illinois).
Ethics. The study protocol was approved by the
local research ethics committee and complies with
the Declaration of Helsinki. Written informed
consent was obtained from all participants.
RESULTS
The ﬁnal population consisted of 105 symptomatic
individuals (age 62 " 8 years; 67% men) with an
intermediate or high pre-test probability according
to the modiﬁed Diamond-Forrester score (20).
All CMR and MDCT scans were performed
within 9.0 " 7.7 days before XA, and all patients
completed the study protocol without adverse effects.
CMR scans. Myocardial LGE was visualized in
24 patients; 17 of those had an ischemic pat-
tern (Fig. 4). In 7, however, an intramural/
Figure 2. Simpliﬁed Scheme of MDCT Protocol
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subepicardial pattern was detected. Intraobserver
and interobserver agreements for ischemic scar
detection were very good (kappa ¼ 0.77 and 0.66,
respectively).
MDCT scans. Among the 105 CTA examinations,
33 (31%) had at least 1 nonevaluable segmentd
usually because of the presence of extensive calciﬁ-
cation. Among the patients who had fully inter-
pretable scans, 10 had no atherosclerotic disease,
24 had mild disease (<50% stenosis), and 38
had signiﬁcant stenosis ($50%). When the non-
evaluable segments were considered to represent
disease, 71 (68%) patients were categorized as
having signiﬁcant CAD. CTP defects were identi-
ﬁed in 38 patients (36%) and in 53 (17%) vascular
territories.
Myocardial CTDE was described in 13 patients
(12%), including 2 with a nonischemic pattern.
Frequently, areas of CTDE had the same density as
the blood pool, appearing in the short-axis plane as
complete or subendocardial interruptions of the
circular shape of the myocardium (Fig. 4). Of the
11 patients with an ischemic CTDE pattern, 9 had
evidence of perfusion defects on rest CTP, whereas
2 were normal. The CTDE image quality of most of
the scans was classiﬁed as good (57) or excellent
(27), and only 1 scan was classiﬁed as poor. Readers
felt conﬁdent or very conﬁdent in the vast majority
of cases (62 or 31 cases, respectively); moderately
low conﬁdence was reported in 12 cases. Compared
with the scans of patients weighing #80 kg, CTDE
scans of patients >80 kg had a lower signal-to-noise
ratio (5.3 " 2.23 vs. 7.3 " 2.65; p ¼ 0.003), worse
image quality (1.6 " 0.61 vs. 1.9 " 0.64; p ¼ 0.03),
and lower reported conﬁdence (1.8 " 0.52 vs.
2.04 " 0.51; p ¼ 0.02).
Mean radiation exposure of the entire MDCT
protocol was 5.5 " 0.95 mSv (3.9 to 9.9 mSv). The
CTDE scan was responsible for only 0.50 " 0.10
mSv of radiation exposure. Estimated effective ra-
diation exposure for each component of the MDCT
protocol is described in Table 2. Good reproduc-
ibility of CTDE analysis was found, with very good
intraobserver (kappa ¼ 0.78) and interobserver
agreement (kappa ¼ 0.76).
XA and FFR results. Seventy patients had some
degree of coronary stenosis on visual analysis and
were evaluated using QCA: of those, 59 had ste-
nosis $50%, including 20 with total occlusions.
Nineteen patients with intermediate stenosis in
vessels >2 mm were evaluated by FFR. Using this
approach, a total of 48 patients were classiﬁed as
having functionally signiﬁcant CAD: single-vessel
disease was seen in 24 patients, 16 had double-
vessel disease, and 8 had triple-vessel disease.
Left main disease was found in 5 of these patients.
(Ischemia) Ischemia)
Figure 3. MDCT Comprehensive Protocol Interpretative Algorithm
CTA ¼ computed tomography angiography; CTP ¼ computed tomography
perfusion; other abbreviations as in Figure 1.
Table 2. MDCT Scan Details
Days from MDCT to XA 4.8 " 4.62 (1–29)
Total volume of contrast used, ml 182 " 14.2 (120–215)
Stress scan 80 " 6.6 (50–110)
Rest scan 84 " 8.8 (50–110)
Effective radiation, total, mSv 5.5 " 0.95 (3.9–9.9)
Effective radiation stress scan 3.3 " 0.48 (2.4–5.2)
Effective radiation rest scan 1.0 " 0.71 (0.2–3.7)
Effective radiation CAC scan 0.5 " 0.24 (0.3–2.2)
Effective radiation CTDE scan 0.5 " 0.10 (0.1–0.7)
Stress–rest delay, min 17 " 9.0 (7–49)
Rest–CTDE delay, min 7 " 0.3 (6–8)
Heart rate
Stress, beats/min 76 " 15.6 (44–118)
Rest, beats/min 63 " 7.1 (48–81)
Late enhancement 63 " 7.3 (47–84)
Values are mean " SD (95% conﬁdence interval).
CAC ¼ coronary artery calciﬁcation; CTDE ¼ computed tomography delayed
enhancement; MDCT ¼ multidetector computed tomography; XA ¼ x-ray
coronary invasive angiography.
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CTDE performance for ischemic scar detection using
CMR-LGE as a reference. CTDE accurately detected
ischemic scar in 9 of 17 patients identiﬁed by CMR.
On a per-patient level, CTDE had good accuracy
(90%) for ischemic scar detection with low sensi-
tivity (53%) but excellent speciﬁcity (98%). CTDE
performed better in patients weighting #80 kg and
was not signiﬁcantly affected by heart rate during
acquisition (Table 3).
Patient-based analysis. MDCT performances for
detection of functionally signiﬁcant CAD are
summarized in Table 4. Isolated CTA analysis had
an excellent sensitivity and negative predictive value
(100%). However, speciﬁcity and positive predictive
value were low (60% and 68%, respectively). CTP,
conversely, had higher speciﬁcity (93%), at a cost of
lower sensitivity (71%). The integration of data
from CTA and CTP resulted in a sensitivity of 90%
and speciﬁcity of 81%. Addition of scar information
as detected by CTDE (CTA þ CTP þ CTDE)
(Fig. 3) did not improve overall MDCT accuracy
(sensitivity 90%, speciﬁcity 77%).
ROC analysis. The ROC analysis for the prediction
of functionally signiﬁcant CAD is represented in
Figure 5. The areas under the curve for signiﬁcant
CAD detection were 0.80 (95% CI: 0.71 to 0.89)
for CTA alone, 0.82 (95% CI: 0.73 to 0.91)
for CTP alone, 0.58 (95% CI: 0.47 to 0.69) for
CTDE alone, 0.85 (95% CI: 0.77 to 0.93) for the
CTA þ CTP integrated protocol, and 0.83 for the
comprehensive protocol, including analysis of
CTDE (95% CI: 0.75 to 0.92).
D I SCUSS ION
The main ﬁndings of our study are that: 1) low-
radiation CTDE performed immediately after a
stress–rest MDCT protocol is capable of scar
detection with reasonable accuracy but low sensi-
tivity; and 2) the addition of CTDE to a stress–rest
CTA þ CTP integrated protocol does not improve
the global accuracy of MDCT for the detection of
functionally signiﬁcant CAD in patients with
intermediate-to-high pre-test probability.
We and others have previously shown that
integration of CTP with CTA improved diagnostic
accuracy of MDCT in patients with intermediate-
to-high pre-test probability, mainly because of an
increased speciﬁcity in heavily calciﬁed coronary
arteries (7–12). In this study, we added CTDE
Figure 4. Two Cases Illustrating CMR-LGE, CTDE, and Angiographic Findings in
Patients With Ischemic Scar
(A) A 67-year-old woman, with typical chest pain, diabetes, and hypertension. Late gado-
linium enhanced (LGE) CMR shows subendocardial hyperenhancement in the mid and
distal segments of the anterior and anteroseptal wall and in the anterolateral basal seg-
ments (arrows). CTDE images are concordant, showing abnormal myocardial intensity in
the same areas (similar to the blood pool). Angiography revealed a chronically occluded
proximal left descending artery and a subtotally occluded marginal coronary artery
(arrowheads). (B) A 54-year-old man with diabetes, hypertension, and dyslipidemia
complaining of typical chest pain. LGE CMR shows subendocardial inferolateral infarction in
the mid and basal segments (arrows). CTDE ﬁndings are concordant. Triple-vessel disease
was detected on x-ray invasive coronary angiography with signiﬁcant left main disease, and
severe proximal stenosis on the left descending and circumﬂex coronary arteries
(arrowheads). Abbreviations as in Figure 1.
Table 3. Patient-Based Analysis of CTDE in Predicting LGE on CMR
CAD (%) n TP TN FP FN k Sensit. (%) Specif. (%) PPV (%) NPV (%) DLR LLR Accu. (%)
CTDE 16.2 105 9 86 2 8 0.59 53 (33–63) 98 (94–100) 82 (51–97) 91 (88–93) 23.29 0.48 90 (84–94)
Weight #80 kg 16.7 72 8 60 0 4 0.77 67 (43–67) 100 (95–100) 100 (65–100) 94 (89–94) d 0.33 94 (86–94)
Weight >80 kg 15.2 33 1 26 2 4 0.15 20 (1–52) 93 (90–99) 33 (2–86) 87 (84–92) 2.80 0.86 82 (76–91)
Heart rate <63 beats/min 10.2 49 2 42 2 3 0.39 40 (8–71) 95 (92–99) 50 (10–89) 93 (90–97) 8.80 0.63 90 (83–96)
Heart rate $63 beats/min 10.3 58 3 50 2 3 0.50 50 (15–76) 96 (92–99) 60 (19–92) 94 (90–97) 13.00 0.52 91 (84–97)
Accu. ¼ accuracy; CAD ¼ coronary artery disease; CMR ¼ cardiac magnetic resonance; CTDE ¼ computed tomography delayed enhancement; FN ¼ false negative; FP ¼ false positive; k ¼ kappa
value; LGE ¼ late gadolinium enhancement; þLR ¼ positive likelihood ratio; #LR ¼ negative likelihood ratio; PPV ¼ positive predictive value; NPV ¼ negative predictive value; Sensit. ¼ sensitivity;
Specif. ¼ speciﬁcity; TN ¼ true negative; TP ¼ true positive.
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analysis to our integrated CTA þ CTP protocol,
aiming to test its potential as an additive tool for the
diagnosis of CAD. A similar approach has been
proposed for CMR using LGE to improve the ac-
curacy of stress perfusion, but currently, this algo-
rithm is seldom used (21).
In our study, ischemic scar was documented in a
signiﬁcant proportion of patients using CMR-
LGE; however, CTDE was only able to detect
about one-half of those cases. Furthermore, the
addition of CTDE to the integrated protocol
including CTA and CTP did not improve MDCT
performance for the detection of functionally sig-
niﬁcant CAD; this occurred because the majority of
patients with ischemic scar also had reversible de-
fects compatible with ischemia (already detected as
positives) and because some patients had ischemic
scar with normal coronary arteries. Inclusion of
CTDE into the comprehensive MDCT protocol
had a limited, but positive, impact because ischemic
scar was detected in 2 patients with normal arteries
and no perfusion defect on rest CTP. However, the
potential advantage of a better prognostic and
therapeutic management has to be balanced against
the extra time needed for the CTDE scan and ra-
diation exposure.
Only 1 previous study analyzed CTDE in the
context of a comprehensive MDCT protocol, in-
cluding CTA and stress/rest CTP: the ﬁnal popu-
lation of 34 patients was selected from those who
underwent a nuclear stress test and XA within 3
months, including a signiﬁcant proportion of pa-
tients with known CAD (14). Integration of CTDE
did not improve MDCT ability to detect CAD, as
deﬁned by stenosis $70%. Differently from Blank-
stein et al. (14), we only included intermediate/high
pre-test probability symptomatic patients without
known history of CAD and used FFR as the refer-
ence standard. Additionally, CMR-LGE was used
as the standard to individually evaluate CTDE per-
formance in scar detection. The entire MDCT
comprehensive protocol, including CTA, CTP, and
CTDE, was completed with an effective radiation
exposure that represents less than one-half of the
exposure usually reported for nuclear studies. The
CTDE acquisition represents a very small proportion
of that value, being responsible for an average radi-
ation exposure of as low as 0.5 " 0.1 mSv.
CMR has the unique capability of scar detection
using LGE techniques, which allow an optimized
contrast between scar and myocardium. Iodinated
contrast agents used in MDCT have similar kinetics
to the gadolinium chelates used in CMR (22).
Thus, images acquired 4 to 30 min after contrast
administration may show regional hyperenhance-
ment, corresponding to areas of myocardial scar,
similar to CMR-LGE (23–25). Despite no
Table 4. Patient-Based Analysis of MDCT Protocol in Predicting Functionally Signiﬁcant CAD
CAD (%) n TP TN FP FN k Sensit. (%) Specif. (%) PPV (%) NPV (%) DLR LLR Accu. (%)
CTA alone 45.7 105 48 34 23 0 0.58 100 (92–100) 60 (53–60) 68 (62–68) 100 (89–100) 2.48 0.00 78 (71–78)
CTP alone 45.7 105 34 53 4 14 0.65 71 (61–76) 93 (85–98) 89 (77–96) 79 (72–83) 10.09 0.31 83 (74–88)
CTDE 45.7 105 8 54 3 40 0.12 17 (9–21) 95 (89–99) 72 (41–93) 57(54–60) 3.17 0.88 59 (52–63)
CTA þ CTP Integ. Prot. 45.7 105 43 46 11 5 0.70 90 (80–96) 81 (72–86) 80 (71–85) 90 (81–96) 4.64 0.13 85 (76–90)
CTA þ CTP þ CTDE Comp. Prot. 45.7 105 43 44 13 5 0.66 90 (80–96) 77 (69–82) 77 (68–82) 90 (80–96) 3.93 0.13 83 (74–89)
Comp. Prot. ¼ comprehensive protocol; CTA ¼ computed tomography angiography; CTP ¼ computed tomography perfusion; Integ. Prot. ¼ integrated protocol; other abbreviations as in Tables 2
and 3.
Figure 5. ROC Curves
CTA, CTP, CTDE, and the integrated (CTA þ CTP) and compre-
hensive (CTA þ CTP þ CTDE) protocols as predictors of function-
ally signiﬁcant CAD. AUC ¼ area under the curve; ROC ¼ receiver-
operating characteristics; other abbreviations as in Figures 1 and 3.
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consensus regarding the optimal protocol for
contrast administration and timing of CTDE im-
aging, our methods are in line with previous studies.
Contrast doses of 120 to 150 ml or 2 ml/kg and
delay times ranging from 5 to 15 min after contrast
material injection have been described (25,26).
Differently from CMR-LGE, where the contrast
may be optimized using speciﬁc inversion times
selected to null the normal myocardium, CTDE has
to rely on different tones of gray, corresponding
to different Hounsﬁeld units, according to the
different degrees of radio-opacity of the tissues.
CTDE areas do not appear as highly contrasted
bright zones surrounded by dark myocardium. In
fact, in our population, CTDE was most commonly
detected as segmental areas where the myocardium
could no longer be deﬁned and differentiated from
the gray area corresponding to the blood pool. Vi-
sual detection of those areas may be difﬁcult, espe-
cially when slight subendocardial involvement is
present; this may explain the relatively low sensi-
tivity when compared to CMR. Furthermore, it has
been suggested that the use of a low-dose approach
by setting tube voltage to 80 kV, despite the
intrinsic advantage of better signal-to-noise and
contrast-to-noise ratios (27–30), may be associated
with an insufﬁcient image quality, especially in
obese patients (30,31). In this context, Habis et al.
(32) proposed a strategy of tube voltage adjustment
according to weight (80 kV for patients #80 kg and
100 kV for patients weighting >80 kg). Our results
seem to support this strategy because image quality,
readers’ conﬁdence, and CTDE diagnostic perfor-
mance for detection of scar were lower in patients
weighting >80 kg.
Study limitations. In this single-center study, only
symptomatic patients without known CAD and
an intermediate-to-high pre-test probability were
included. A small percentage of patients had to be
excluded because of contraindications, such as renal
dysfunction or arrhythmia. As such, these results may
not apply to other groups of patients referred for CTA.
FFR was only measured in vessels with intermediate
stenosis on QCA assessment. Stenoses with QCA
<50% were assumed to be irrelevant, and stenoses
$90% were considered functionally signiﬁcant.
Although this was performed to avoid potential iatro-
genic complications, and reﬂects current clinical prac-
tice in many centers, it may lead to a small bias.
Another limitation concerning study design is the
performance of 2 contrasted scans a few minutes apart:
this assures clinical applicability but is associated with
some drawbacks related to contrast redistribution and
optimization of heart rate for the CTA scan. Further-
more, CTDE was tested using a very low radiation
protocol without the use of any additional contrast.
Despite the appeal of this approach, because it could be
easily implemented in a comprehensive MDCT pro-
tocol without increase of patient risks, it is possible that
CTDE could be optimized using different parame-
tersdnamely higher tube current and current intensity
or dedicated injections of higher doses of contrastdas
the ideal CTDE protocol is still under research. Post-
processing software may also be an important tool for
optimizing scar detection using MDCT. Nevertheless,
our study shows that CTDE integration into aMDCT
comprehensive protocoldusing commercially standard
and widely available software and hardwaredis feasible
and may inform about the presence of scar in patients
with suspected CAD.
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In recent years, cardiovascular magnetic resonance (CMR) myocardial perfusion imaging (MPI) has evolved into a 
robust technique and provides state-of-the-art assessment 
of myocardial ischemia in clinical routine.1,2 The high spa-
tial and temporal resolution, absence of ionizing radiation 
and integration with scar imaging using late gadolinium 
enhancement (LGE) techniques are unequivocal advantages 
of the method. Magnetic resonance coronary angiography 
(MRCA) allows limited morphology evaluation of the coro-
nary arteries that is not possible with CMR-MPI and LGE.3–7 
Background—Cardiovascular magnetic resonance (CMR) myocardial perfusion imaging (MPI) is a state-of-the-art 
noninvasive modality for detection of myocardial ischemia and coronary artery disease. Magnetic resonance coronary 
angiography (MRCA) allows visualization of the coronary tree, but its incremental value as part of a CMR protocol 
including MPI and late gadolinium enhancement (LGE) is not well established. We aimed to evaluate the additive 
diagnostic value of a 3-dimensional whole-heart MRCA integration into a 1.5T CMR-MPI/LGE protocol for the detection 
of functionally significant coronary artery disease.
Methods and Results—Forty-three symptomatic patients (61±8.3 years; 65% men) with suspected coronary artery disease 
and intermediate/high-pretest probability underwent CMR (including CMR-MPI, MRCA, and LGE) and x-ray invasive 
coronary angiography (XA) with fractional flow reserve evaluation. Diagnostic performances of MRCA, CMR-MPI/
LGE, and MRCA+CMR-MPI/LGE integration were determined having XA+fractional flow reserve as standard for 
coronary artery disease (≥90% stenosis/occlusion or fractional flow reserve≤0.80 in vessels>2 mm). MRCA inclusion 
into the CMR protocol was associated with a mean increase of 7.9±4.69 (0–17.7) minutes in total examination duration 
(14%). On patient-based analysis, MRCA had 96% sensitivity, 68% specificity, positive predictive value of 79%, and 
negative predictive value of 93%. CMR-MPI/LGE had 79% sensitivity, 95% specificity, positive predictive value of 95%, 
and negative predictive value of 78%. Integration of MRCA with CMR-MPI/LGE further improved CMR performance 
to 96% sensitivity, 89% specificity, positive predictive value of 92%, and negative predictive value of 94%, with a global 
accuracy of 93%.
Conclusions—In this intermediate/high-pretest population, integration of noncontrast-enhanced whole-heart MRCA 
nonsignificantly improved per-patient diagnostic accuracy of a comprehensive 1.5-T stress-rest CMR-MPI/LGE protocol 
at a cost of longer scanning times.  (Circ Cardiovasc Imaging. 2013;6:730-738.)
Key Words: coronary angiography ◼ fractional flow reserve, myocardial ◼ magnetic resonance imaging  
◼ perfusion imaging
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Therefore, MRCA could potentially be used as a comple-
mentary tool to improve CMR-MPI/LGE diagnostic perfor-
mance in patients with suspected CAD. However, the vast 
majority of MRCA studies included patients with known 
CAD clinically referred for x-ray invasive coronary angi-
ography (XA), which limits the evaluation of MRCA as an 
auxiliary tool.1 Furthermore, the potential additive value of 
MRCA integration into a CMR protocol, including stress-
rest MPI and LGE, is not well established.8,9 All previous 
studies evaluated MRCA performance against diameter of 
stenosis as assessed by XA, using either quantitative coro-
nary angiography (QCA) or visual estimation. The use of 
these anatomic standards as reference may overemphasize 
the value of this morphological test when integrated into 
a comprehensive protocol. Evidence shows that patients 
should be managed according to the functional significance 
of the lesions and this should be the standard against which 
diagnostic tests should be compared.10
The aim of this study was to evaluate the potential additive 
value of integration of a 1.5T whole-heart MRCA sequence 
into a CMR-MPI protocol for the diagnosis of functionally 
significant CAD, as assessed by XA and fractional flow 
reserve (FFR), in the clinical setting of a tertiary cardiology 
center of a nonacademic hospital.
Methods
Population
We prospectively screened 176 consecutive patients with suspected 
CAD referred to the cardiology outpatient clinic from February 
2010 to November 2011. Inclusion criteria were: age >40 years and 
symptoms compatible with CAD and at least 1 of the following: ≥2 
risk factors or positive/inconclusive treadmill test. Exclusion criteria 
included unstable clinical status, known CAD, valvular heart disease, 
atrial fibrillation/irregular heart rhythm, creatinine clearance ≤60 mL/
min and standard contraindications to CMR, contrast media, and ad-
enosine. Figure 1 summarizes the study flow and reasons for exclu-
sions. Forty-three patients completed the entire study protocol and 
constituted the population sample of the study.
Study Design
Patients were scheduled for a CMR scan in the week before XA and 
were instructed to refrain from smoking, coffee, tea, aminophylline, 
β-blockers, calcium-channel antagonists and nitrates for 24 hours 
 before both procedures. At the time of XA, FFR was measured in all 
major patent coronary arteries with intermediate diameter stenoses 
(50% to 90%) as assessed by QCA.
CMR Protocol
CMR-MPI/LGE protocol followed established standards11 on a 1.5T 
Siemens Symphony TIM scanner (Siemens, Erlangen, Germany) 
using a 12-channel receiver coil as previously described,12 with an 
additional 3-dimensional navigator-corrected steady-state free pre-
cession whole-heart MRCA performed between the rest perfusion 
scan and the LGE acquisition. Figure 2 represents the simplified 
scheme of the CMR protocol.
For perfusion imaging, 3 short-axis slices (basal, midventricular, 
and apical) were acquired under maximal hyperemia achieved with 
140 µg·kg−1·min−1 IV adenosine infusion, during the first pass of a 
bolus of 0.07 mmol·kg−1 of gadobutrol (Gadovist, Bayer HealthCare 
Pharmaceuticals, Berlin, Germany) injected at 4 mL·s−1 through a 
dedicated right antecubital vein. A gradient-echo pulse sequence 
with a single saturation prepulse per cardiac cycle shared over the 
3 slices was used. In patients with significant heart rate variability 
or in whom heart rate was still >80 bpm 3 minutes after adenosine 
discontinuation, 5 mg of IV metoprolol were administered.13 Long- 
and short-axis cine images were obtained using a steady-state free 
precession breath-hold sequence for volumetric and functional anal-
ysis and 10 minutes after the first gadolinium injection; perfusion 
imaging was repeated at rest, using the same parameters described 
Figure 1. Study flow-chart and reasons 
for exclusions. CAD indicates coronary 
artery disease; CI, confidence interval; 
CMR, cardiac magnetic resonance; FFR, 
fractional flow reserve; and MRCA, mag-
netic resonance coronary angiography.
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for the stress. Immediately afterwards, additional gadolinium (0.06 
mmol·kg−1, to achieve a total of 0.2 mmol·kg−1) was administered. 
A 4-chamber cine with 50 phases per cardiac cycle was then used 
to determine the timing and duration of the individual cardiac rest 
period visually.14 MRCA number of segments per heart cycle and 
acquisition window were planned aiming to acquire images dur-
ing the heart’s quietest period (usually diastase). Trigger delay and 
temporal resolution were adjusted to each patient. Sublingual nitro-
glycerine (0.5 mg) was administered and volumetric whole-heart 
MRCA transaxial images acquired using a steady-state free preces-
sion free-breathing pulse sequence (TR [repetition time]/TE [echo 
time], minimal/minimal; flip angle, 90º; slice thickness 1.0 mm) 
with fat suppression and T2 preparation prepulse, as proposed by 
Weber et al.15 Breathing motion was compensated using a cranio-
caudal navigator technique (search window: 90 mm; acceptable 
gating window: 5 mm at end expiration). Isotropic spatial resolu-
tion (1.0×1.0×1.0 mm) was achieved. MRCA acquisition was ter-
minated if the scan length was expected to exceed 25 minutes. After 
the MRCA acquisition, a 2-dimensional phase-sensitive inversion-
recovery breath-hold sequence was used for LGE imaging. This ac-
quisition was performed for at least 10 minutes (but no longer than 
30 minutes) after the last administration of gadolinium. The same 
projections performed for functional analysis were used.
CMR Analysis
CMR images were visually evaluated on commercially available 
software by 2 independent readers (level III SCMR) fully blinded to 
the results of XA and to the other components of the CMR examina-
tion. In cases of disagreement between observers, consensus reading 
was performed.
Myocardial Perfusion/Late Gadolinium 
Enhancement
Perfusion defects were defined as subendocardial or transmural vi-
sually dark myocardial areas when compared with remote healthy 
myocardium, persisting for at least 10 frames (Figure 3). In case of 
circumferential perfusion defects, the epi- to endocardial wash-in dy-
namic of the contrast was also evaluated. The stress and rest perfusion 
scans were viewed simultaneously, and areas of hypoperfusion were 
assigned to the ventricular segments, using the standard American 
College of Cardiology/American Heart Association 17-segment mod-
el, excluding the apex.16 Each of the 16 segments was classified using 
a 4-point scoring system: from normal/no defect to transmural-de-
fect. Perfusion defects were then classified as caused by ischemia or 
scar—integrating the information obtained from functional analysis, 
Figure 2. Simplified scheme of cardiac 
magnetic resonance protocol. Times 
indicated are approximate and sequence 
blocks are not drawn to scale.  
TI  indicates inversion time. 
Figure 3. Four cases illustrating CMR-MPI, MRCA, and XA angiographic findings in patients with and without functionally significant 
coronary artery disease. A, In a 62-year-old woman with diabetes mellitus, hypertension, dyslipidemia, and typical angina, both CMR-MPI 
and MRCA were reported normal; XA confirmed normal epicardial coronary arteries. B, In this 49-year-old dyslipidemic, hypertensive, 
ex-smoker, man with atypical angina, CMR-MPI showed a dark area of reversible ischemia in the mid and distal septal wall (arrows); a 
significant stenosis was detected on proximal and mid left descending artery during MRCA and its subocclusive status confirmed in XA 
(arrowhead). C, A subtle subendocardial dark area was noted on CMR-MPI (arrows) of this 75-year-old man with atypical chest-pain and 
no risk-factors, and interpreted as a possible artifact; MRCA correctly identified significant stenoses on proximal and mid left descend-
ing artery (arrowheads), confirmed on XA (FFR=0.92 and 0.69, respectively). D, In this 60-year-old, ex-smoker man with dyslipidemia and 
atypical chest-pain, CMR-MPI was reported normal, whereas MRCA depicted an obstructive stenosis in the mid segment of the right 
coronary artery, confirmed as occlusive on XA (arrowheads). CAD indicates coronary artery disease; CMR, cardiac magnetic resonance; 
FFR, fractional flow reserve; MPI, myocardial perfusion imaging; MRCA, magnetic resonance coronary angiography; and XA, x-ray coro-
nary angiography.
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perfusion, and LGE imaging. Regional wall motion or scar alone was 
not regarded as a sign of ischemia/CAD. Only areas with ischemia on 
perfusion imaging were regarded as positive (patients with scar but 
no additional ischemia were classified as negatives). Image quality 
and degree of confidence were classified independently using 4-class 
scales: from poor to excellent and from very unconfident to very con-
fident, respectively.
MRCA
MRCA volumetric images were reconstructed, anonymized, and 
transferred to a postprocessing workstation (Aquarius WorkStation, 
TeraRecon Inc, San Mateo, CA). Axial-source images, multiplanar 
reformations, and thin-slab maximum intensity projections (1–5 mm) 
were used for detection of stenoses, depicted as local signal attenuation 
(Figure 3), according to the 17-segment modified AHA classification.17 
Each segment was graded as follows: 0: normal; 1: nonsignificant ste-
nosis (<50%); 2: stenosis ≥50%; 3: uninterpretable (significant steno-
ses are impossible to exclude but not definitively present); and 4: not 
visible. The image quality of whole-heart MRCA was visually evaluat-
ed using the following scale: 0: poor (coronary vessel barely evident or 
noisy image); 1: moderate (coronary vessel visible but low diagnostic 
confidence); 2: good (coronary artery adequately visualized and diag-
nostic quality image); and 3: excellent (coronary artery clearly depicted 
with sharply defined borders).3 All coronary arteries were included for 
the evaluation regardless of image quality to avoid overestimation of 
the diagnostic accuracy. Degree of confidence was classified as de-
scribed for CMR-MPI. For the MRCA nondichotomic receiver opera-
tor characteristics curve analysis, the 2 observers visually graded the 
likelihood of coronary artery stenoses according to the following scale: 
0: absent; 1: probably absent; 2: possibly present; 3: probably present; 
and 4: definitely present. Results for the 2 readers were averaged.
X-ray Coronary Angiography and FFR Assessment
XA was performed according to standard techniques. Excluding 
the left main, arteries with caliber >2 mm and intermediate diam-
eter stenoses (≥50% and <90%) as assessed by QCA (Siemens 
Leonardo XP, IC3D version 1.6.8.83A, Paieon, Siemens AG, Berlin 
and Munich, Germany) were evaluated using pressure wire (Pressure 
Wire Certus, St. Jude Medical, St.Paul, MN). FFR was determined by 
RadiAnalyzer (Jude Medical, St. Paul, MN) under steady-state hyper-
emia, obtained with IV adenosine infusion (140 µg.kg−1·min−1) over 
3 to 6 minutes. Arteries were recorded as having significant flow-
limiting disease if they had stenoses ≥90% (≥50% in left main stem), 
or had an FFR value ≤0.80 in vessels >2 mm. This was defined as the 
reference standard against which CMR was compared.
Assignment of CMR Perfusion Segments to the 
Corresponding Vascular Territory
For vessel-based analysis, each of the 16 myocardial segments was 
assigned to 1 of the 3 main vessels (right coronary artery, left ante-
rior descending artery, and circumflex artery). A total of 129 vessels 
(43 patients ×3) were used in this analysis. Left main stenoses were 
managed as simultaneous stenoses in left anterior descending and cir-
cumflex arteries. To ensure correct association of the segments with 
the vascular territory, angiographic visualization of vessel dominance 
and branch distribution was used.16
Statistical Analysis
Functionally Significant CAD was defined on patient- and 
vessel-basis.
The individual diagnostic performances of CMR-MPI/LGE and 
MRCA for the detection of functionally significant CAD were com-
pared against XA+FFR as the reference standard. Four approaches 
for the integration of anatomic and functional CMR results were also 
specified, reporting significant CAD if: (A) any MRCA or CMR-MPI 
positive; (B) both MRCA and CMR-MPI positives; (C) Clearly posi-
tive MRCA or any positive CMR-MPI (Figure 4); and (D) Clearly 
positive MRCA or positive CMR-MPI in territories with nonevalu-
able MRCA segments. For the integrative approaches A and B, 
uninterpretable/nonvisible segments were assumed to be positives 
for significant CAD in the MRCA component. For approaches C and 
D only the clearly positives MRCA segments—classified as stenosis 
≥50% (2)—were assumed to represent significant CAD.
Sensitivity, specificity, positive predictive value, negative predictive 
value, and overall accuracy for each component of the CMR protocol 
and for the different integrative approaches were estimated having 
XA+FFR as a gold standard. A specific subanalysis was also performed 
for patients with intermediate pretest probability. Ninety-five percent 
confidence intervals were calculated based on the binominal distribution.
All continuous variables were expressed as mean±SD or 
median and interquartile range, whereas categorical variables were 
expressed as percentages. The McNemar test was used to calculate 
differences among proportions (sensitivity, specificity, and accuracy) 
obtained from paired observations. Within patient correlations between 
observations in per-vessel analysis were not taken into consideration be-
cause of the exploratory nature of the study. Cohen’s κ statistic was used 
to assess intermodality and intra/interobserver agreements. The area un-
der the receiver operator characteristic curve (AUC) was calculated and 
compared for all diagnostic-testing strategies using the method described 
by DeLong et al.18 Statistical analyses were performed using MedCalc for 
Windows, version 12.3.0.0 (MedCalc Software, Mariakerke, Belgium). 
A P value <0.05 was considered statistically significant.
Ethics
The study protocol was approved by the local research ethics commit-
tee and complies with the declaration of Helsinki. Written informed 
consent was obtained from all participants.
Results
The final population consisted of 43 individuals (61±8.3 years, 
65% males) with an intermediate (n=26) or high-pretest (n=17) 
probability for CAD according to the modified Diamond-For-
rester score.19 Patient characteristics are summarized in Table 1. 
CMR scans were performed within 8±7.5 days (median of 6 
Figure 4. Scheme of the best performing integrated protocol 
(Protocol C). In the best performing integrated CMR protocol if 
stenoses>50% were detected on MRCA, the resulting protocol 
was positive for CAD; for other MRCA results, classification 
would depend on CMR-MPI/LGE findings. CAD indicates coro-
nary artery disease; CMR, cardiac magnetic resonance; LGE, late 
gadolinium enhancement; MPI, myocardial perfusion imaging; 
and MRCA, magnetic resonance coronary angiography.
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days; interquartile range, 5–7 days) before XA. Mean exami-
nation duration was 54.8±9.62 minutes, ranging from 38 to 73 
minutes. Patients’ heart rate, blood pressure, and duration of 
the different CMR modules are shown in Table 2.
Perfusion and Late Gadolinium Enhancement
All CMR-MPI scans were evaluated for visual diagnostic pur-
poses and included in an intention-to-diagnose analysis. Two 
patients (4%) had poor quality images because of inadequate 
ECG-triggering. Image quality was moderate in 8 (19%), good 
in 25 (58%), and excellent in 8 (19%) patients. Readers felt 
unconfident in 3 cases (7%), confident in 27 (63%), and very 
confident in 13 (30%). LGE scanning was performed 17.9±4.69 
minutes (10–28) after the last perfusion sequence. Myocardial 
fibrosis/scar was detected in 12 patients (9 of which had an 
ischemic pattern). Interobserver per-patient agreement for the 
identification of abnormal perfusion produced a κ of 0.72 (95% 
confidence interval [CI], 0.52–0.93; substantial agreement).
MR Coronary Angiography
Whole-heart MRCA was successfully completed in the 43 
patients comprising the final sample, with a mean planning 
time of 6.2±2.58 minutes and a mean effective scan time of 
11.7±3.77 minutes (5.5–22). Inclusion of the MRCA sequence 
into the CMR-MPI/LGE protocol was associated with a mean 
increase of 7.9±4.69 minutes (0–17.7) in examination duration. 
The mean heart rate during MRCA was 65±5.8 bpm and mean 
navigator efficiency was 32±7.7%. MRCA was performed dur-
ing diastole in 40 patients (93%) and during systole in 3 (7%). 
The mean acquisition window was of 126±48 ms.
Eight patients (19%) yielded nondiagnostic images and 
diagnostic confidence was, therefore, classified as very uncon-
fident. Image quality was moderate in 14 patients (33%), good 
in 17 (40%), and excellent in 4 (9%). On those, readers were 
unconfident in 8 cases (19%), confident in 25 (58%), and very 
confident in 2 (5%).
Sixteen patients had at least 1 stenosis>50% based on 
MRCA, 7 had no significant stenosis, and in 20 patients, 
MRCA was inconclusive (classified positive for CAD in the 
dichotomic evaluation of isolated MRCA). The κ value for the 
binary interobserver judgment in per-patient analysis was 0.49 
(95% CI, 0.19–0.79; moderate agreement).
X-ray Coronary Angiography and FFR Results
Twenty-eight patients had some degree of coronary lumen 
stenosis on visual analysis and were evaluated using QCA: 
of those, 27 had stenosis ≥50%, including 16 with total/sub-
total occlusions and 2 with left main disease. Nine patients 
with intermediate stenosis in vessels >2 mm were evaluated 
using FFR invasive assessment. Using this approach, a total 
of 24 patients were classified as having functionally signifi-
cant CAD: single-vessel disease was seen in 11 patients; 8 had 
double-vessel disease; and 5 had triple-vessel disease.
Patient- and Vessel-Based Analysis
Diagnostic patient- and vessel-based performances are sum-
marized in Table 3. Figure 5 represents the receiver operator 
characteristics curve analysis of each component of the CMR 
protocol and different integrative approaches for detection of 
functionally significant CAD.
CMR-MPI
Of the 20 patients with a perfusion defect suggestive of isch-
emia on their CMR-MPI/LGE scan, 19 (95%) had significant 
CAD in at least 1 coronary artery (1 false-positive); of the 23 
patients with no ischemia detected on CMR-MPI/LGE, 5 were 
Table 1. Population Characteristics
Number of patients, n 43
Age, y 61±8.3
Body mass index, kg/m2 28.4±5.43
Symptoms 43 (100%)
  Typical angina 16 (37%)
  Atypical angina 18 (42%)
  Chest pain 6 (14%)
 Dyspnea on exertion/fatigue 3 (7%)
Hypercholesterolemia 37 (86%)
Hypertension 30 (70%)
Diabetes mellitus 19 (44%)
Positive smoking history 14 (33%)
  Current smoker 4 (9%)
  Ex-smoker 10 (23%)
Family history of premature CAD 6 (14%)
≥2 CRF 38 (88%)
Modified Diamond-Forrester score 14.3±2.9
Significant stenoses (FFR≤0.80) 24 (56%)
  Single-vessel disease 11 (26%)
  Double-vessel disease 8 (19%)
  Triple-vessel disease 5 (12%)
  Left main disease 2 (5%)
Values are n (%) or mean±SD. CAD indicates coronary artery disease; CRF, 
cardiovascular risk factors; and FFR, fractional flow reserve.
Table 2. Patients’ Heart Rate and Duration of the Different 
CMR Components
Total scan duration, min (%) 54.8±9.62 (100)
  Survey+localizers+adenosine 
infusion
9.3±1.62 (17)
  Stress perfusion 2.9±1.44 (5)
  Cines 10.0±2.11 (18)
  Rest perfusion 2.4±1.10 (4)
  MRCA planning 6.2±2.58 (11)
  MRCA acquisition 11.7±3.77 (21)
  Late gadolinium enhancement 8.5±2.43 (16)
Heart rate, bpm
  Basal 68±14.6
  Stress perfusion 86±15.1
  One minute after the stop of 
adenosine infusion
71±11.8
  Rest perfusion 65±9.9
  MRCA 65±5.8
Values are mean±SD (%). CMR indicates cardiac magnetic resonance; and 
MRCA, magnetic resonance coronary angiography.
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false-negatives (2 of those patients were the ones with reported 
insufficient image quality because of ECG-triggering failure). 
CMR-MPI/LGE had a sensitivity of 79/71%, specificity of 
95/97%, and global accuracy of 86/88% in patient- and ves-
sel-based analysis, respectively. Excluding the 2 poor quality 
scans, sensitivity would be 86/77%, specificity 95/96%, and 
global accuracy 90/90%, respectively.
MRCA
The AUC for MRCA was 0.89 (95% CI, 0.75–0.96) in patient-
based and 0.83 (95% CI, 0.76–0.89) in vessel-based analysis. 
Spearman’s rank correlation coefficient between the 2 readers 
was 0.46. Using a dichotomic classification and having none-
valuable segments as positives, isolated MRCA had a sensitiv-
ity of 96/90%, specificity of 68/63%, and global accuracy of 
83/73% in patient- and vessel-based analysis, respectively. In 
per-vessel analysis, MRCA accuracy was significantly inferior 
to CMR-MPI/LGE (88% versus 72%; P=0.004). If nonevalu-
able/not-visible vessels (n=28) were excluded from analysis, 
isolated MRCA would have a global accuracy of 89/83%, 
with a sensitivity of 95/90% and specificity of 81/80%, in per-
patient and per-vessel analysis, respectively.
Integrated Analysis
Integration of anatomic and functional data from MRCA and 
CMR-MPI/LGE slightly increased overall CMR accuracy for 
detection of functionally significant CAD in the tested popula-
tion. In per-patient analysis, the best performing protocol (C) 
followed CMR-MPI/LGE results in all cases but when a defi-
nite significant stenosis was depicted by MRCA (Figure 4). 
This approach had a trend to perform better (AUC=0.93 
[95% CI, 0.80–0.98]) than isolated MRCA (AUC=0.82 [95% 
CI, 0.67–0.92]; P=0.06), isolated CMR/LGE (AUC=0.87 
[95% CI, 0.73–0.95]; P=0.22), and all the other integrative 
approaches. The additive value of this protocol is represented 
by a nonsignificant 17% increase in sensitivity (79% versus 
96%; P=0.13) and an irrelevant 5% decrease in specific-
ity (95% versus 90%; P=1.0) when compared with isolated 
CMR-MPI/LGE. This nonsignificant benefit seems particu-
larly evident in the subgroup of patients with intermediate pre-
test probability, in which per-patient performance increased 
from a sensitivity of 64% to 91% (P=0.25), whereas keeping 
the excellent specificity (100%). Global accuracy improved 
from 85 to 96% (P=0.25).
In per-vessel analysis, isolated CMR-MPI/LGE (AUC=0.84 
[95% CI, 0.77–0.90]) performed similarly to the best perform-
ing integrated protocol (AUC=0.85 [95% CI, 0.78–0.91]; 
P=0.80). Addition of MRCA to the isolated CMR-MPI/LGE 
results, significantly increased per-vessel sensitivity in 17% 
(71% versus 88%; P=0.02); however, this was associated with 
a decrease in specificity (97% versus 82%; P=0.0002) because 
of an increased rate of false-positive readings.
Table 3. Patient-Based and Vessel-Based Analysis of CMR in Predicting Functionally Significant CAD
CAD, % n TP TN FP FN κ  Sensit. (%)  Specif. (%)  PPV (%) NPV (%) +LR −LR Accu. (%)
Patient-based
  CMR-MPI/
LGE
55.8 43 19 18 1 5 0.72 79 (65–83) 95 (77–100) 95 (78–100) 78 (64–82) 15.04 0.22 86 (71–91)
  MRCA 55.8 43 23 13 6 1 0.66 96 (82–100) 68 (51–73) 79 (68–83) 93 (69–100) 3.04 0.06 84 (68–88)
  Integrated 
Protocol
55.8 43 23 17 2 1 0.86 96 (83–100) 89 (73–94) 92 (80–96) 94 (77–100) 9.10 0.05 93 (79–97)
  Intermediate pretest probability subgroup
   CMR-MPI/
LGE
42.3 26 7 15 0 4 0.67 64 (40–64) 100 (82–100) 100 (62–100) 79 (65–79) 0.36 85 (64–85)
   MRCA 42.3 26 11 11 4 0 0.70 100 (75–100) 73 (55–73) 73 (55–83) 100 (75–100) 3.75 0.00 85 (63–85)
   Integrated 
Protocol
42.3 26 10 15 0 1 0.92 91 (67–91) 100 (74–100) 100 (80–96) 94 (78–94) 0.09 96 (76–96)
Vessel-based
  CMR-MPI/
LGE
32.6 129 30 84 3 12 0.72 71 (61–77)* 97 (91–99)* 91 (77–98)* 88 (83–90) 20.71 0.30 88 (82–92)*
  MRCA 32.6 129 38 55 32 4 0.46 90 (79–97)* 63 (58–66)* 54 (47–58)* 93 (85–98) 2.46 0.15 72 (64–76)*
  Integrated 
Protocol
32.6 129 37 71 16 5 0.65 88 (76–95)* 82 (76–85)* 70 (61–76)* 93 (87–97) 4.79 0.15 84 (76–88)*
  Intermediate pretest probability subgroup
   CMR-MPI/
LGE
19.2 78 9 62 1 6 0.67 60 (39–66) 98 (93–100) 90 (58–100) 91 (87–93) 37.80 0.41 91 (83–94)
   MRCA 19.2 78 15 42 21 0 0.44 100 (77–100) 67 (61–67) 42 (32–42) 100 (92–100) 3.00 0.00 73 (64–73)
   Integrated 
Protocol
19.2 78 13 52 11 2 0.56 87 (62–98) 83 (77–85) 54 (39–61) 96 (89–99) 4.96 0.16 83 (74–88)
Accu. indicates accuracy; CAD , coronary artery disease; CMR-MPI/LGE, cardiac magnetic resonance myocardial perfusion imaging and late gadolinium enhancement; 
FN, false-negative; FP, false-positive; MRCA, magnetic resonance coronary angiography; NPV, negative predictive value; PPV, positive predictive value; sensit., 
sensitivity; Specif., specificity; TN, true-negative; TP, true-positive; +LR, positive likelihood ratio; and −LR, negative likelihood ratio. 
*P<0.05.
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Discussion
The main finding of our study is that in symptomatic patients 
with intermediate/high pretest probability, integration of 
MRCA into a CMR-MPI/LGE stress-rest protocol nonsig-
nificantly improved per-patient diagnostic performance for 
detection of functionally significant CAD, at a cost of pro-
longed scanning times. This small improvement in diagnos-
tic performance was obtained from a per-vessel significant 
increase in sensitivity and an associated decreased specificity.
Differently from previous studies, which used QCA or 
visual assessment of the degree of stenosis as the reference 
standard for CAD, we used XA with FFR assessment. This 
approach avoids overestimation of the incremental value 
that MRCA can bring into a comprehensive CMR protocol 
if a purely anatomic standard is used for reference and fol-
lows evidence showing that patients should be guided by 
the physiological importance of a stenosis rather than by 
luminal assessment.10
Figure 5. Receiver operating characteristic curves of each CMR component and of the different interpretative algorithms. A and B rep-
resent per-patient and per-vessel performances of CMR-MPI/LGE and MRCA for detection of functionally significant CAD. C and D 
represent the performance of the different integrated protocols tested. Protocol C was the best performing interpretative approach in 
both analyses, but no statistically significant differences were found (P>0.05 for all comparisons). Protocol A= positive if MRCA positive/
inconclusive OR CMR-MPI positive; Protocol B=positive if MRCA positive/inconclusive AND CMR-MPI positive; Protocol C=positive if 
MRCA clearly positive OR CMR-MPI positive (Figure 4); Protocol D=Positive if MRCA clearly positive OR positive CMR-MPI in territo-
ries with nonevaluable/inconclusive MRCA segments. AUC indicates area under the curve; CAD, coronary artery disease; CMR, cardiac 
magnetic resonance; LGE, late gadolinium enhancement; MPI, myocardial perfusion imaging; and MRCA, magnetic resonance coronary 
angiography.
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The entire comprehensive CMR scan, including functional 
and volumetric assessment, stress and rest perfusion analy-
sis, coronary angiography, and scar imaging was completed 
in <1 hour, on average. This duration is inferior to previ-
ously published protocols8,9 and was achieved by acquiring 
all the cine images between the 2 perfusions scans and per-
forming MRCA between the last perfusion and LGE imag-
ing. This approach allowed the use of medication (nitrates 
and β-blockers) aiming to improve MRCA quality without 
influencing perfusion results8 and reduced scan time, as a 
significant part of the MRCA scanning is planned, prepared, 
and acquired in the 10-minute gap existing between the last 
perfusion acquisition and the beginning of LGE scanning. 
Nevertheless, MRCA inclusion into a CMR-MPI/LGE pro-
tocol represented a significant prolongation of the scanning 
time (14% increase), and in a few patients, the entire scan 
exceeded 70 minutes. Furthermore, some patients were 
excluded from the study because of irregular breathing pat-
terns and extremely low gating efficiency that would prolong 
MRCA scan to >25 minutes. Besides the effective acquisi-
tion time, sequence planning is also time-consuming and 
represented 35% of the total time required for the MRCA 
component in our study. Additionally, MRCA analysis 
requires extratime (15–20 minutes on average) of dedicated 
postprocessing and image interpretation. Therefore, the 
interesting concept of anatomic and functional integration 
into a single radiation-free test has to be tempered by the 
limited additional information obtained and the extra scan-
ning time needed. Scan time availability is usually an impor-
tant issue in busy CMR clinical lists and other available tests 
might be considered in those rare cases in which noninva-
sive morphological evaluation is considered determinant. 
Based on our data, MRCA integration does not seem to be 
routinely justified in clinical stress-rest 1.5T CMR-MPI/
LGE protocols aiming to detect significant CAD because 
its additive value is still limited. Nevertheless, it is inter-
esting to observe that anatomic and functional integration 
further improved CMR ability to detect functionally signifi-
cant CAD and represented 3/43 (7%) of additional correct 
diagnosis in our study. Together with the recently described 
prognostic value of MRCA,20
 this finding should prompt fur-
ther research aiming to improve robustness of the technique 
as well as simplification/automation of procedures, namely 
in sequence/scanning preparation, which are still cumber-
some and time-consuming.
In our study, MRCA had lower interobserver agreement 
than CMR-MPI. Furthermore, 19% of MRCA scans had poor 
image quality, and a large number of coronary segments were 
found to be unavailable, significantly limiting MRCA poten-
tial as an auxiliary tool for noninvasive detection or exclu-
sion of CAD. The use of a tight-fitting abdominal belt to 
suppress the motion of the diaphragm in relation to breathing 
has been described to reduce imaging artifacts and scanning 
time and may result in increased performance.7,21 However, in 
clinical practice, most CMR studies are not directed toward 
isolated visualization of coronary arteries, but are rather com-
bined with CMR-MPI/LGE; in these combined approaches, 
we may expect MRCA performance to be less efficient as 
reported in MRCA-centered studies.22 Two previous studies 
tested 1.5T-MRCA value in a comprehensive protocol; in 
both, MRCA performed significantly worse than CMR-MPI/
LGE and did not increase global diagnostic accuracy.8,9 In our 
intermediate/high risk population, MRCA was also inferior to 
CMR-MPI/LGE, but a small positive impact of integration, 
mainly restricted to an increased sensitivity, was noticed. This 
was especially important in cases of poor ECG-triggering 
in the stress perfusion scan, which represented 2 of the 4 
false-negatives correctly depicted by MRCA. Inclusion of all 
patients despite image quality may justify differences from 
previous studies.
Based on the large published trials, CMR-MPI weakness 
is expected to reside in its specificity,23 possibly because of 
inherent difficulties in distinguishing multivessel disease 
from microvascular disease patterns. In our study, MRCA 
potential ability to increase CMR specificity by excluding 
3-vessel disease in the differential diagnosis with micro-
vascular disease7 could not be tested as all the multivessel 
disease diagnoses based on the CMR-MPI/LGE component 
were true-positives and no patterns of microvascular disease 
were reported.
Study Limitations
In this single-center study, only patients without known 
CAD and with an intermediate/high-pretest probability were 
included. A non-negligible percentage of patients had exclu-
sion criteria and a significant proportion of eligible patients 
were not included because of scanner-time limitations. Fur-
thermore, MRCA images could not be acquired in ≈8% of 
patients undergoing CMR; this was not taken into consider-
ation for the diagnostic performance analysis.
New available technology, namely the use of higher field 
scanners and higher number of channels coils may outperform 
the method described. Contrast-enhanced MRCA at 3.0-T 
has improved contrast-to-noise ratio, allows faster scanning 
and seems to superiorly compare with noncontrast-enhanced 
1.5T-MRCA.24–26 However, this has never been validated in a 
multicenter trial and its additive value as part of a comprehen-
sive CMR protocol was never tested.
The limited number of patients of our study does not allow 
definitive conclusions on the added value of MRCA in this 
context. However, our data reveals that integration of anatomic 
and functional information can be achieved using CMR in the 
clinical setting and that this approach might lead to improved 
performance in detecting functionally significant CAD. Larger 
prospective studies testing are, therefore, warranted.
Conclusions
In this intermediate/high-pretest population, integration of 
noncontrast-enhanced whole-heart MRCA nonsignificantly 
improved per-patient diagnostic accuracy of a comprehensive 
1.5-T stress-rest CMR-MPI/LGE protocol at a cost of longer 
scanning times.
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CLINICAL PERSPECTIVE
In this study, magnetic resonance coronary angiography (MRCA) was evaluated as an additive tool to a stress-rest adenos-
ine perfusion cardiac magnetic resonance (CMR) protocol, including functional analysis and late gadolinium enhancement. 
Despite the limitations associated with the technique, integration of MRCA did not significantly improve the performance 
of CMR for detection of functionally significant coronary artery disease, as assessed by invasive coronary angiography and 
fractional flow reserve. Addition of MRCA was associated with a significant scan time prolongation. Of note, the study was 
conducted with standard and widely available software, using regular slots of a CMR clinical list of a nonacademic tertiary hos-
pital, thus reflecting what may be achieved in real-world practice. Although this pilot study was underpowered to demonstrate 
incremental value of MRCA over stress CMR techniques, our results suggest that routine addition of MRCA to stress CMR 
may not be an effective strategy in the investigation of coronary artery disease. Further research is warranted to determine if the 
combined strategy of stress CMR and MRCA may be useful in selected patients.
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VI. Discussion 
 
CMR and MDCT are state-of-the-art, high-resolution techniques for detection of 
coronary artery disease and myocardial ischemia, being the “rising stars” in non-invasive 
evaluation of patients with suspected or known ischemic cardiomyopathy. Performance of 
both techniques is intimately related to pre-test probabilities: MDCT is usually applied for 
exclusion of coronary artery disease in patients with intermediate/low probability, taking 
advantage of the detailed and unparalleled high-quality non-invasive coronary angiography; 
CMR is especially tailored for ischemia and scar detection and is particularly useful in the 
discrimination of the functional relevance of coronary artery disease in patients with 
intermediate/high pre-test probabilities or in guiding management in ischemic 
cardiomyopathy. The main conducting idea of our project was to investigate the ability of both 
techniques to further improve their diagnostic ability for detection of relevant coronary 
disease, potentially enlarging their applicability to other groups of patients with different pre-
test probabilities. Specifically, integrated protocols of anatomy and function were tested and 
the additive value of each component was evaluated. We studied the addition of stress 
perfusion and delayed enhancement to the standard CT angiography using MDCT. We also 
tested the utility of MR coronary angiography to the clinically established sequences of MR 
perfusion and late-gadolinium enhancement for scar imaging. 
Our research shows that functional and anatomic integration in a single test using 
either MDCT or CMR is feasible and that, in patients with intermediate or high pre-test 
probability, may provide incremental value for the detection of obstructive coronary artery 
disease. We have shown that in this group of patients, myocardial CT perfusion used as an 
adjunctive tool for CT angiography improves accuracy for detection of significant stenoses as 
assessed by quantitative coronary angiography (QCA) and fractional flow reserve (FFR). 
Additionally, we have shown that a low-radiation scan for CT delayed enhancement can be 
integrated in a comprehensive MDCT protocol and allows the detection of ischemic scar with 
reasonable accuracy in this population. Furthermore, we confirmed the high diagnostic 
accuracy of CMR for the detection of functionally relevant coronary disease1-3 and its 
incremental value over exercise treadmill stress testing. Additionally, we found that 
integration of MR coronary angiography into a CMR perfusion/late gadolinium enhancement 
stress-rest protocol may further improve diagnostic performance (in our study this non-
significant improvement was due to a per-vessel significant increase in sensitivity and was 
associated with a decreased specificity). 
Of notice, these results were obtained in a real world clinical cardiology setting, using 
available slots of MDCT and CMR clinical routine lists and exploring acquisition protocols and 
sequences that are widely available in current MDCT and MR scanners, and not only in the 
last-generation machines. 
The vast majority of previous studies used only quantitative invasive coronary 
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angiography (QCA) or visual assessment of the degree of stenosis as the reference standard 
for the diagnosis of significant coronary disease.4-6 However, this approach is limited since 
isolated anatomic evaluation cannot accurately predict the functional significance of a 
coronary stenosis. Evidence shows that patients should be guided by the physiological 
importance of a stenosis rather than luminal assessment and pressure wire–derived 
fractional flow reserve (FFR) has emerged as the reference invasive tool to provide this 
essential information.7, 8 It is independent of heart rate, blood pressure and left ventricular 
contractility and takes into account the contribution of collateral flow to myocardial perfusion. 
Therefore, it represents a better comparator for the assessment of ischemia.9-11 Prompted by 
this evidence, we evaluated quantitative coronary angiography as a morphologic standard 
but used FFR as our reference standard for the diagnosis of functionally significant coronary 
disease.   
Some important contributions were achieved with our research project. One of these 
was the significant reduction of radiation exposure achieved with our MDCT protocol, when 
compared with previous methods. The entire MDCT comprehensive protocol, including CT 
angiography, CT perfusion and CT delayed enhancement were performed with an effective 
radiation exposure that represents less than one-half of the exposure usually reported for 
SPECT studies. Limitation of tube voltage to a maximum of 100 kV, use of prospective 
scanning at rest and implementation of strict tube current modulation in all stress scans 
resulted in a radiation exposure much lower than previously reported.12-14 Based on these 
results, low-dose comprehensive MDCT protocols might be ready for routine use in clinical 
practice, using standard 64-MDCT scanners, even in obese patients. Another important 
contribution concerning MDCT was the perfusion interpretation methodology: the described 
simultaneous visualization of perfusion and contraction using multiphasic cine images 
acquired during stress may allow a better discrimination of true findings from artifacts. The 
potential drawback is a decreased sensitivity - as inducible contraction abnormalities appear 
later in the ischemic cascade. However, since CT angiography is highly sensitive, it is 
reasonable to keep CT perfusion as specific as possible, taking advantage of the potential 
integration of results. 
CT perfusion performed equally well in patients with or without ischemic scar 
revealing that it is capable of detecting perfusion defects that represent true ischemia and not 
only scar. Furthermore, CT perfusion performance in discriminating functionally relevant 
coronary disease in patients with stenosis>40% as assessed by invasive coronary 
angiography was clearly superior to CT angiography. One particular case is that of extremely 
calcified arteries. In this group of patients, visual analysis of vessel lumen is significantly 
hampered by calcium. Previous studies reported a low CT angiography accuracy in patients 
with an Agatston calcium score higher than 400.15, 16 Therefore, some centers exclude these 
patients from CT angiography and proceed to functional tests or invasive angiography. Our 
research confirmed the reduced accuracy of CT angiography with higher calcium scores, 
mainly due to reduced specificity, which was significantly improved by the use of CT 
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perfusion in these patients. According to our data, a MDCT protocol including an initial 
acquisition for calcium score quantification could be used to guide subsequent acquisitions: if 
no calcium or low calcification is present, we could probably skip the stress acquisition, 
focusing the aim of the MDCT study in a correct luminal assessment, and placing all efforts in 
reducing heart rate and acquisition artifacts; then, if needed (unevaluable segments present), 
stress perfusion MDCT could still be performed at a second time, taking advantage of the CT 
perfusion incremental value in this context. In most patients with higher calcium scores 
(≥400), an integrated protocol of stress-rest perfusion would most probably represent an 
added accuracy (mainly due to a higher specificity) for detection of significant coronary 
disease. In these cases, its use immediately following the calcium-score acquisition would be 
recommended, aiming to reduce false positives and, to spare unnecessary catheterizations 
or to guide treatment. 
In our study CT perfusion was directly compared against CMR perfusion using FFR 
as reference standard. Intra-/inter-observer agreement and self-reported confidence were 
lower for CT perfusion than CMR. This is an expected finding, as CMR perfusion is a well-
validated and better-established technique. The use of a new technique, despite the 
similarities, involves a certain degree of uncertainty and a learning curve that may explain the 
results. Despite being globally inferior to CMR perfusion imaging, CT perfusion integration 
with CT angiography increased accuracy, mainly due to a significant increase in specificity. 
According to our data, this MDCT integrated protocol may be as effective as CMR perfusion 
for detection of functionally significant coronary disease in patients with intermediate to high 
pre-test probability. If our findings can be confirmed in future studies, the use of stress-rest 
perfusion protocols may extend MDCT indications to higher risk / higher pre-test probability 
populations – presently restricted to other imaging methods approaches, based on ischemia 
detection (Dobutamine Stress echocardiography, SPECT and stress CMR). CMR has several 
advantages over MDCT for the detection of myocardial ischemia: it does not expose patients 
to ionizing radiation and provides dynamic real-time imaging of myocardial perfusion over the 
first-passage of contrast.17 MDCT perfusion is limited to the “one-shot” opportunity to 
visualize differences of x-ray attenuation between the ischemic and remote myocardium.18 
The potential advantages of CT perfusion over CMR are availability and the ability to acquire 
high-resolution isotropic 3D “whole heart” datasets that allow for simultaneous coronary 
anatomy and myocardial perfusion analysis; this may be of particular interest for decision and 
management of revascularization.  
In current clinical practice myocardial ischemia assessment is often performed using 
SPECT. CMR perfusion imaging is potentially superior to this nuclear technique in terms of 
diagnostic performance – mainly due to its superior spatial resolution and is increasingly 
used for clinical decision-making.19-22 However, while SPECT is well established, clinically 
implemented, and widely available, CMR perfusion had been restricted to specialized 
academic centers and only recently increased its availability and emerged as a clinical tool. 
Our results confirm the excellent performance of the technique in the clinical setting and its 
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incremental value over exercise treadmill testing. In this context, according to our data, 
symptomatic patients with suspected coronary artery disease and a high pretest probability 
benefit from undergoing CMR rather than being directly referred for invasive coronary 
angiography.  A diagnostic strategy combining treadmill exercise testing and CMR performs 
better in patients with low to intermediate pretest probability. In those, exercise testing can be 
used to correctly select patients with intermediate pretest probability that benefit from being 
referred to the invasive angiography and to exclude coronary disease in patients with low 
pretest probability. CMR is recommended in patients with intermediate pretest probability of 
CAD without a clearly positive exercise test and in patients with low pretest probability of 
CAD presenting a clinically and/or electrically positive exercise test, in order to improve the 
diagnostic accuracy for CAD detection. 
Besides ischemia detection, CMR provides comprehensive assessment of function 
and detailed scar imaging. In the studied population, ischemic scar was detected in a 
significant proportion of patients. Interestingly, the integration of isolated ischemic scar 
detection as a marker of coronary disease in the CMR perfusion interpretation algorithm did 
not improve CMR overall performance for detection of functionally significant coronary 
disease; this occurred because the majority of patients with ischemic scar also had additional 
reversible defects compatible with ischemia (already detected as positives) and because 
some patients had ischemic scar with normal coronary arteries. The absence of additional 
value for diagnostic performance of scar detection found in our study does not diminish the 
value of an integrated protocol including stress-rest perfusion and late gadolinium 
enhancement for scar detection as the latter has proved a significant prognostic impact even 
when small areas of scar were detected in patients with unrecognized previous ischemic 
events.23 Similarly, and for the same reasons, CT delayed enhancement did not improve the 
global accuracy of the stress-rest MDCT protocol. However, inclusion of CT delayed 
enhancement into the comprehensive MDCT protocol had a limited but positive impact, as 
ischemic scar was detected in a few patients with normal coronary arteries and no perfusion 
defect on rest-CT perfusion. These potential advantages in terms of prognostic assessment 
and therapeutic management have to be balanced against the extra time needed for the CT 
delayed enhancement-scan and the radiation exposure (as low as 0.5±0.1 mSv in our study). 
Visual detection of CT delayed enhancement may be difficult, especially when slight 
subendocardial involvement is present; this may explain the relatively low sensitivity when 
compared to CMR.  
Another innovation of our research project was the CMR comprehensive protocol 
design, aiming to optimize available scanning time. The entire comprehensive CMR scan, 
including functional and volumetric assessment, stress and rest perfusion analysis, coronary 
angiography and scar imaging was completed in less than one hour, on average (when the 
MR coronary angiography was excluded, the entire protocol was usually performed in less 
than 40 minutes). This duration is inferior to previously published protocols3, 24 and was 
achieved by acquiring all the cine images between the two perfusions scans and performing 
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MR coronary angiography between the last perfusion and the late gadolinium enhancement 
imaging. This approach allowed the use of medication (nitrates and beta-blockers) aiming to 
improve MR coronary angiography quality without influencing perfusion results24 and reduced 
scan time, as a significant part of the MR coronary angiography scanning was planned, 
prepared and acquired in the 10-minutes gap existing between the last perfusion acquisition 
and the beginning of late gadolinium enhancement scanning. Nevertheless, MR coronary 
angiography inclusion into a CMR perfusion/late gadolinium enhancement protocol 
represented a significant prolongation of the scanning time (14% increase) and in a few 
patients the entire scan exceeded 70 minutes. Besides the effective acquisition time, 
sequence planning is also time-consuming and represented 35% of the total time required for 
the MR coronary angiography component in our study. Additionally, MR coronary 
angiography analysis requires extra-time (15-20 minutes on average) of dedicated post-
processing and image interpretation. Therefore, the interesting concept of anatomic and 
functional integration into a single radiation-free test has to be tempered by the limited 
additional information obtained and the extra scanning-time needed. Scan-time availability is 
usually an important issue in busy CMR clinical lists and other available tests might be 
considered in those rare cases in which non-invasive morphologic evaluation is considered 
determinant. Based on our data, MR coronary angiography integration does not seem to be 
routinely justified in clinical stress-rest CMR perfusion/late gadolinium enhancement 
protocols aiming to detect significant coronary disease as its additive value is still limited. 
Nevertheless, it is interesting to observe that anatomic and functional integration further 
improved CMR ability to detect functionally significant coronary disease and represented 3/43 
(7%) of additional correct diagnosis in our study. Together with the recently described 
prognostic value of MR coronary angiography,25 this finding should prompt further research 
aiming to improve robustness of the technique as well as simplification/automation of 
procedures, namely in sequence/scanning preparation, which are still cumbersome and time-
consuming.  
In our study, MR coronary angiography had lower inter-observer agreement and was 
globally inferior to CMR perfusion/late gadolinium enhancement. A significant proportion of 
scans had poor image quality, with a large number of unevaluable coronary segments, 
significantly limiting MR coronary angiography potential as an auxiliary tool for non-invasive 
detection or exclusion of coronary disease. Nevertheless, in our intermediate/high risk 
population, MR coronary angiography integration had a small, non-significant, but positive 
impact in CMR performance, mainly restricted to an increased sensitivity. This was especially 
important in cases of poor ECG-triggering in the stress-perfusion scan, which represented 2 
of the 4 false-negatives correctly depicted by MR coronary angiography. 
 
Study limitations 
In this single-center protocol, only symptomatic patients without known coronary 
disease and with an intermediate or high pre-test probability were included. A small 
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percentage of patients had to be excluded because of contraindications, such as 
claustrophobia, renal dysfunction or arrhythmias. In our study, there were no exclusions due 
to CMR-incompatible devices; however, in other populations, namely in those with known 
coronary disease, the proportion of patients with implanted devices like pacemakers and 
implanted defibrillators that cannot be tested using CMR may be significant. Furthermore, a 
significant proportion of eligible patients were not included in the MR coronary angiography 
study due to scanner time limitations. As such, our results may not apply to other groups of 
patients with suspected or known coronary artery disease / ischemic heart disease.  
Fractional flow reserve was only determined in stenosis>40%; similarly, fractional 
flow reserve was not performed in patients with subocclusive stenoses or with 
tortuous/calcified/complex lesions. While this was performed to avoid potential iatrogenic 
complications, and reflects current clinical practice in many centers, a remaining level of 
inaccuracy may exist.  
Other limitation concerning study design is the performance of two contrasted scans 
with a few minutes apart both in the CMR and in the MDCT protocol: this assures clinical 
applicability but is associated with some drawbacks, related to contrast redistribution and 
optimization of heart rate for the coronary angiography. Nevertheless, this approach is widely 
used and is well validated for CMR in clinical practice and should have a minor impact in our 
MDCT results.  
Additionally, the strict lose-dose protocol design, with limitation of tube voltage to 100 
kV for CT angiography and 80 kV for CT delayed enhancement imaging could have a 
potential negative impact in performance, especially in the obese patients, artificially 
increasing the additive value of CT perfusion in this subgroup. Furthermore, we may 
speculate that other approaches, namely the use of dedicated injections of higher doses of 
contrast for CT delayed enhancement could perform better, as the ideal protocol is still under 
research.  
Finally, given the rapid evolution of scanner hardware, the diagnostic accuracy of 
newer MDCT scanners with more detectors and higher temporal resolution might be different: 
the higher temporal resolution achieved may translate in less artifacts and improved 
perfusion visualization. Similarly, new available CMR technology, namely the use of higher-
field scanners and higher number of channel coils may outperform the described methods. 
Contrast-enhanced MR coronary angiography at 3.0 T has improved contrast-to-noise ratio, 
allows faster scanning and seems to superiorly compare with non-contrast-enhanced 1.5T 
MR coronary angiography.26-28 
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VII. Conclusions 
 
Advanced cardiac imaging techniques, namely Cardiac Magnetic Resonance and 
Multidetector Computed Tomography are able to provide accurate information concerning 
coronary artery disease. Integration of functional and anatomic information using either 
technique is feasible and may further improve diagnostic performance for detection of 
coronary artery disease. Its use may expand the indications and clinical utility of these 
techniques. 
In patients with intermediate/high pre-test probability, in which MDCT for CT 
angiography is usually not a good clinical option for determining the functional relevance of 
coronary disease (due to its low specificity and positive predictive value), the integration of 
functional information using CT perfusion with the morphologic data obtained from CT 
angiography improves overall performance of the method. This integration protocol is able to 
detect functionally significant coronary disease with a global accuracy that is comparable to a 
CMR stress-rest perfusion protocol. Scar imaging is also possible using CT, similarly to CMR, 
but is less sensitive and, in the studied population, did not improve MDCT accuracy for 
detection of functionally relevant coronary artery disease. 
Magnetic Resonance Myocardial Perfusion Imaging is a robust and accurate method 
for detection of relevant coronary disease in the clinical setting and adds incremental value 
over exercise testing in all groups of pre-test probabilities. In this context, a combined 
protocol of exercise treadmill testing and CMR imaging may further improve accuracy for 
detection of significant disease, while maintaining a low proportion of inadequate referrals to 
invasive angiography. MR coronary angiography, despite limited, may add anatomic 
information to a CMR protocol and its use in the clinical setting is feasible. In the 
intermediate/high pretest population studied, integration of this morphologic information was 
able to slightly improve sensitivity but did not significantly improve CMR global accuracy for 
detection of functionally relevant disease.  
The results of our studies support the value of anatomic and functional integration 
using a single imaging modality. In the near future, hardware and software improvements are 
expected to further expand integration possibilities. Nevertheless, anatomic and functional 
integration is already possible in the clinical setting using current standard equipment. Recent 
data, including our findings, should prompt further research aiming to explore the advantages 
of a comprehensive cardiac imaging approach using advanced techniques in patients with 
suspected or known coronary artery disease. 
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